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Executive summary  
 
Regulation (EC) No 2003/2003 (the Fertilisers Regulation) lays down rules 
relating to the placing on the market of fertilisers. It covers only a part of the 
inorganic (mineral) fertilisers i.e. “EC fertilisers” that meet its legal requirements 
regarding their minimum nutrient content, their safety, and their absence of 
adverse effect on the environment and as such may circulate freely on the 
European market.  
The Commission has conducted an evaluation of the functioning of the Fertilisers 
Regulation and, in the light of the outcome of that exercise, extensive 
preparatory work for a revision of the Fertilisers Regulation took place in 2012-
2013, in particular with the objective to extend its cope to other fertilising and 
related materials, of which plant biostimulants and agronomic fertiliser additives. 
At large, these two categories can be distinguished from each other and from 
fertilising materials by the following main characteristics, related to their 
functionalities: 
 Plant biostimulants act on plant processes, improving nutrition and 
vigour; 
 Agronomic fertiliser additives act on fertilisers and fertilising materials, 
prior uptake by the plant of the released nutrients, enhancing their 
efficacy for plant nutrition and reducing losses to the environment. 
For the purpose of the future legislation, extended definitions of both categories 
are elaborated and proposed as outputs of the study. 
 
Study objectives 
The present study aims at supporting the ongoing activities for the revision of 
the Fertilisers Regulation by proposing appropriate data requirements and 
efficient administrative procedures to carry out the assessment of risks and 
efficacy of plants biostimulants and agronomic fertiliser additives (PB&AFA). 
Arcadia International was commissioned to undertake this study on “a legal 
framework for plant biostimulants and agronomic fertiliser additives” between 
July 2013 and February 2014.  
The objectives of the study were fourfold: 
 To examine the main national and international legislations related to the 
placing of plant biostimulants and agronomic fertiliser additives to the 
market. How do Member States and Third Countries currently 
address the marketing of such type of products?   
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 To analyse existing and comparable EU regulatory system which could be 
found suitable for regulating the marketing of plant biostimulants and 
agronomic fertiliser additives. What can be learned from existing and 
comparable EU legal frameworks?  Can any of the existing EU 
framework fit for the purpose of placing PB&AFA to the EU 
market? 
 To study the current & future EU business environment for plant 
biostimulants and agronomic fertiliser additives;    
 To develop a proposal for the most appropriate regulatory 
framework including data requirements and efficient administrative 




After an initial project scoping, the methodological approach consists of 
analytical tasks based on deep literature review, interviews with experts, 
national competent authorities, business and trade associations representatives 
of PB&AFA sectors, and Commission. These analytical tasks have been followed 
by a reporting task which brought together the study findings that are presented 
in this final report. 
 
The plant biostimulants and agronomic fertiliser additives business and 
usage by producers’ context 
The PB&AFA industry: The plant biostimulant category is in its relative infancy, 
but the rapidly increasing level of investment in research is beginning to yield 
insights into the potential of these products.  Its market driven by economic and 
socio-political factors seems to be growing rapidly (>10% per year). The 
European Biostimulants Industry Consortium (EBIC) considers that the 2012 EU 
market value (sales) of plant biostimulants can be estimated at € 400-500 
million with potential to grow to more than € 800 million in 2018. 
Factors driving this growth of the plant biostimulants sector are multiple:  
1. European agricultural and food safety policies have integrated 
environmental considerations and are promoting the safe use of 
agricultural inputs. This applies to alternative solutions being, in 
between others, the use of plant biostimulants and biopesticides that 
are used under the integrated crop management schemes ; 
2. In response to consumer demands for healthy food products with 
minimal environmental impacts growers are looking for ways to use 
synthetic chemicals and mineral fertilisers more efficiently. 
Biostimulants are increasingly seen as a response to these consumer 
demands for “softer” agricultural practices;  
3. The use of plant biostimulants is spreading from some pioneer EU 
countries (FR, IT, Spain) to a wider number, both within Europe and 
the rest of the world.  
Most of the plant biostimulant companies are small and medium-sized 
enterprises (SMEs). In total EBIC considers that the EU plant biostimulant sector 
is composed of about 200-250 companies of which about 90% are SMEs. 
Additionally, it can be observed an initial consolidation of the sector with entry of 
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large R&D companies which leads to increase of investment in research for plant 
biostimulants. 
The business situation for agronomic fertiliser additives is diametrically opposite. 
It is dominated by a small number of international companies which have 
developed new innovative products that are, mainly, incorporated in commodity 
fertiliser formulations. 
Markets for agronomic fertiliser additives are globalised for several years 
already. They are nearly mature. The projected average annual growth rate to 
2015 is estimated at about 1.5%-2.5% in Western Europe, slightly lower than 
growth rate in the US (2.0%-3.5%) and in Japan (3.0%-4.5%). Most of the 
business actors claim to have an important R&D division which is often 
structured internationally to simultaneously support several markets. 
The experience linked to the use of PB&AFA: Plant biostimulants and 
agronomic fertiliser additives have already been used by producers for several 
years and several decades e.g. dried seaweeds extracts. Historical data on the 
efficacy of PB and AFA indicate some variability in time and space, which could 
handicap the trust rising among users and scientists. While PB substances show 
good efficacy in laboratories in the large majority of cases, this efficacy is not 
always confirmed in field situations and therefore the PB are not fully recognised 
by all producers as reliable commodity.  
 
How do EU MS and Third Country authorities regulate the placing of 
PB&AFA on the market? 
This analysis has been performed by screening eleven regulatory frameworks at 
both EU MS level (BE, DK, ES, DE, FR, IT, and HU) and international level 
(Brazil, Canada, South-Africa, and USA). The focus has been placed on plant 
biostimulants as most of agronomic fertiliser additives are already included in 
Annex I of the Fertilisers Regulation. 
None of the studied regulatory frameworks defines the term “plant 
biostimulants” but substances/products can be placed on the market in all 
countries covered under the study. PB&AFA are regulated either under the 
fertiliser acts or the plant protection products acts. In some cases by both 
schemes (e.g. Canada). 
The regulatory processes are highly variable ranging from free access to the 
market (e.g. UK) to a registration scheme based on pre-market approval (e.g. 
FR, IT) including notification procedures with data requirements (e.g. BE, DE, IT) 
or limited data requirements. The majority of the different regulatory schemes 
ask for a detailed characterisation and identification of the substances but allow 
the registration of non-fully defined/characterised substances. In several 
schemes the provision of an analytical method for quality control is not a 
mandatory requirement.  
Toxicological and ecotoxicological data are required by only a few schemes (the 
ones based on a pre-market approval). However the required tests and studies 
to be provided by applicants are never listed as such. Safety to human and the 
environment has to be demonstrated while risk management measures shall be 
presented whenever necessary but none of the studied regulatory schemes lists 
the studies requirements. It is of the registrant responsibility to present data to 
proof safety of its product on an ad hoc basis. 
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Efficacy has to be demonstrated in all countries. Data requirements are 
preferably based on field trials data but efficacy can also be demonstrated by 
results from laboratory testing or other dedicated assays. Belgium and France 
have established a system which leads to the obligation for applicants to 
demonstrate field efficacy preferably before granting of authorisation as part of 
the registration dossier or (and) after registration. 
The most demanding schemes as regards data requirement are based on a pre-
market approval approach. This appears to entail long (> 1 year) and quite 
unpredictable examination timing (from application to registration).  
 
What can be learned for existing and comparable EU legal frameworks?  
Can any of the existing EU framework fit for the purpose of placing 
PB&AFA to the EU market? 
The analysis of the existing EU regulatory schemes for comparable products  (i.e. 
cosmetic products, chemical products (REACH), food additives, feed additives, 
plant protection products, biocides) shows that two types of EU regulation co-
exist: REACH and the regulatory frameworks based on a pre-market approval 
(the food safety frameworks). Each type of approach is tailored to the specificity 
of the risks in its own area.  
The majority of these regulatory frameworks have been developed at earliest in 
the 1960s and have all been designed to assess safety of chemical substances. 
These sectorial frameworks are “risk based” approaches that consider the 
business environment of each sector. The majority of these have developed 
specific schemes and requirements for non-fully synthetic chemical 
substances/products which are not perceived by the majority of the stakeholders 
to be fully satisfactory. 
Several substances that are used as PB&AFA are already registered under other 
EU regulatory frameworks. These substances can be ranged in three categories: 
 Substances already registered under REACH for fertiliser and/or other 
usages; 
 Substances already registered/notified at MS level; 
 Substances authorised at EU level (e.g. seaweed extracts in cosmetics, 
feed additives). 
In conclusion to this analysis, it can be considered that each of these two main 
types of regulatory frameworks includes interesting obligations for the drafting of 
a regulation for PB&AFA but none of these two types of approaches can be 
considered as fully suitable for PB&AFA for the main following reasons: 
 REACH doesn’t fully consider the potential risks linked to food and 
PB&AFA are mainly used in specialty food crops such as fruit and 
vegetables;   
 REACH does not consider microorganisms in its registration process, while 
biostimulants include a expanding list of microbial products; 
 Applying a pre-market approval system with a risk assessment procedure 
which has primarily been designed for synthetic chemical products would 
lead to too high costs for applicants (> € 500,000) of products which are 
often not of synthetic chemical nature (mainly true for PB). 
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Which approach to a legal framework for plant biostimulants and 
agronomic fertiliser additives? 
For the purpose of the future legislation, the initially proposed definitions have 
been discussed and are slightly amended as proposed: 
 A plant biostimulant is any substance or microorganism, in the form in 
which it is supplied to the user, applied to plants, seeds or the root 
environment with the intention to stimulate natural processes of plants 
benefiting nutrient use efficiency and/or tolerance to abiotic stress, 
regardless of its nutrients content, or any combination of such substances 
and/or microorganisms intended for this use. 
 An agronomic fertiliser additive is any substance or microorganism, in 
the form in which it is supplied to the user, added to a fertiliser, soil 
improver, growing medium with the intention to improve the agronomic 
efficacy of the final product and/or to modify the environmental fate of 
the nutrients released by the fertilisers, or any combination of such 
substances and/or microorganisms intended for this use. 
In the above definitions, substance means a chemical element and its 
compounds, as it occurs naturally or by manufacture, including any impurity 
inevitably resulting from the manufacturing process.  
In order to address the specific issues potentially associated with the use of such 
a wide and varying group of substances, the placing to the market procedure is 
based on an approach with the obligation for individual or group of similar 
PB&AFA to be registered in a EU registry before being lawfully placed on the 
market. 
In accordance with existing EU and national regulatory frameworks for similar 
substances, the applicant company (the registrant) will have to submit a 
registration dossier that shall include a relevant set of information to a EU 
Agency (ECHA or EFSA). The registration dossier will have to include the 
following informations: 
 Identification and characterisation of the substance (incl. biological 
properties when relevant and physico-chemical properties); 
 Mode of action and function of the substance; 
 Absence of contaminants; 
 Manufacturing, quality control, and analytical method(s); 
 Toxicology, ecotoxicology, environmental fate, and residues in plants 
where relevant; 
 Demonstrated agronomic efficacy of the concerned claim(s). 
Applicants are encouraged to use existing data submitted in other EU regulatory 
contexts. The future PB&AFA scheme shall allow applicants to use existing data 
(data sharing and data bridging) as long as technical equivalence is 
demonstrated in order to avoid repeating studies (especially animal testing) and 
optimise costs. Registrants shall be allowed to waive certain data when the 
nature of the registered substances or the absence of exposure of a given 
environmental compartment is not of concern. Mechanisms for the grouping of 
substances and grouping of crops for the demonstration of efficacy are proposed 
to limit the number of applications for similar substances.  
 A legal framework for plant biostimulants and agronomic fertiliser additives in 
the EU………………………………………………………………………………………………………………… xii 
In order to secure an optimal registration process, each above-mentioned (group 
of) requirement has been defined to fit the largest majority of registration cases.  
Data requirements for characterisation have been developed to allow registration 
of non-fully defined substances due to their natural origin. This approach is very 
much in line with the UVCB1 approach under REACH and the botanicals under the 
Plant Protection Products Regulation. Requirements for the provisions of tools for 
quality control have been developed to cover all types of substances (from well-
defined substances for which an analytical method has to be provided to non-
well-defined natural extract for which the quality control will relay on a detailed 
description of the raw material and of the manufacturing process).  
For proof of human and environmental safety a 3 tier risk-based approach is 
proposed to capture the specificities of these wide and varying groups of 
substances.  
Registrants have to demonstrate agronomic efficacy of their products (2 options 
are discussed) and guarantees product efficacy to producers. 
The procedure after submission of the dossier will entail the following potential 
steps: 
 Step 1: Reception of the application dossier by the EU Agency (EFSA or 
ECHA) which will immediately perform a completeness check.  The 
completeness check will be systematically required for each application 
and limited to a validation of the correct classification of the substance 
and a control of the existence of all elements expected for a dossier. 
 Step 2: Compliance check will be performed on a limited number of 
dossiers on the basis of the following rules: 
o For dossiers containing only Tier 1 toxicological and 
ecotoxicological data: 30% of the total number of dossiers will be 
randomly selected for compliance; 
o For all other dossiers a compliance check will be automatically 
performed. 
 Additionally it is recommended that at least one dossier per applicant 
company is selected for compliance. Compliance checks will aim (1) at 
ensuring that the dossier includes all necessary information and 
documentation as prescribed by the future Fertilisers Regulation and the 
relevant guidance documents to be developed, (2) at assessing whether 
data waivers in tier 1 dossiers are well justified and (3) at conducting 
deeper analysis of tier 2 and 3 dossiers. 
 Step 3: If the completeness check can be cleared by the Agency, the 
latter will deliver a registration number, which then allows the placing of 
the plant biostimulant or the agronomic fertiliser additive on the market 
under the conditions specified by the registrant and reported in a 
transparent way in the EU registry. The registration will remain valid for a 
period of 15 years and the data submitted by the applicant will be subject 
to data protection for the equivalent period of time. Confidentiality will be 
granted on registrant request. As under similar regulatory framework a 
data sharing mechanism will be provided for if a second applicant applies 
for a similar substance. 
                                           
1
 Unknown or Variable compositions, Complex reaction products and Biological materials 
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The results of the compliance check could lead either to keep the 
registration, to require mitigation measures to be mentioned in the 
Registry, to a request from the Agency to complement the existing 
information, or finally to a rejection of the application if a non-
manageable risk is identified. In the latter case, the substance will be 
included in the negative list which will be a part of the Fertilisers 
Regulation and will be amended by delegated/implementing Act. 
 Step 4: At any moment after registration was granted and eventually 
confirmed, the data submitted by applicants as well as their conclusions 
regarding the safety and/or the efficacy of the PB&AFA may be subject to 
re-examination by Member State Competent authorities on a voluntary 
basis in view of changing or confirming the conditions of the existing 
registration; 
 Step 5: If this/these reviewing Member State(s) conclude(s) that there is 
a need for reconsidering an existing registration, the Agency will be 
organising a peer-review of the conclusions drawn by this(ese) Member 
State(s); 
 Step 6: The conclusion of the peer-review will be formalised as an opinion 
of the Agency and submitted to the Commission if its conclusions are 
putting the existing registration into question. The Commission might 
then proceed with an adaptation of the negative list provided in one of 
the Annex of the Fertilisers Regulation through a Commission 
delegated/implementing Act.  
The steps described above strike a balance between a relatively simple 
administrative approach allowing rapid access to the market for PB&AFA and 
several safety nets allowing appropriate ways to address unexpected risks or 
lack of efficacy in a timely manner. This will be addressed both via randomly 
quality control of the submitted dossier before full registration but also via 
possibility for post-registration re-assessment by volunteering Member States. At 
the same time this approach will provide the producers with some guarantee of 
agronomic efficacy of the registered PB&AFA.  
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1 Introduction 
The European Commission intends to revise Regulation (EC) No 2003/2003 of 
the European Parliament and of the Council of 13 October 2003 relating to 
fertilisers (the Fertiliser Regulation) pertaining to inorganic fertilisers and to 
extend its scope to also include: 
 Organic fertilisers; 
 Soil improvers; 
 Liming materials; 
 Growing media;  
 Plant biostimulants; and 
 Agronomic fertiliser additives. 
In line with Article 114 of the Treaty, the new legislation pursues two objectives:  
 To establish an effective internal market by ensuring the free circulation 
of and a level-playing field for all categories of fertilising materials and 
related non-fertiliser materials on the whole EU territory; and  
 To support the competitiveness of the different industries falling under 
the scope of the Regulation while providing for a high level of health, 
safety, environmental and consumer protection.  
More specifically, the new Regulation will aim to:  
 harmonise legislation for all fertilisers and related products;  
 guarantee the safety of the material placed on the market with regard to 
human health and the environment;  
 ensure efficacy/utility and the ability of farmers to rely on the quality of 
the products bought;  
 facilitate the access to the market of innovative products; and  
 To reduce the administrative burden for authorities and for industry. 
To date, the Commission has developed several policy options in view of the 
future revision of the Fertiliser Regulation and has conducted extensive 
stakeholders’ consultations with the intention of developing a regulatory 
proposal.  
The question related to plant biostimulants became quite predominant in the 
discussions and an EU stakeholders association (i.e. EBIC) has been created to 
follow the works carried out by the Commission in view of developing EU 
legislation for this type of products. 
In July 2013, Arcadia International was commissioned by DG Enterprise and 
Industry to undertake a study aiming at contributing to the proposal for an EU 
legal framework for the placing of plant biostimulants and agronomic fertiliser 
additives on the market. In this regard, the study will help to support the case 
for defining and implementing a regulatory framework for the above mentioned 
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1.1 Policy background 
The first pan-European Fertiliser Regulation regarding the placing on the market 
of fertilisers in the EU dates back to Directive 76/116/EEC of 18th December 
1975
2
 (Basic Directive), after which it was amended several times. In the 
context of the SLIM initiative
3
, the Basic Directive and 17 associated Directives 
on fertilisers were replaced by a unique legal text: Regulation (EC) 
No 2003/2003 aiming to ensure the free circulation of so-called “EC fertilisers”4 
within the EU. Regulation (EC) No 2003/2003 has not brought any substantial 
changes to the Basic Directive. 
The Fertiliser Regulation co-exists with national regulatory frameworks related to 
the placing of fertilisers on the market. In the large majority of MS, specific 
legislation has been developed leading to the possibility for individual companies 
to decide to place inorganic fertiliser on the market under the national label or 
under the EC label. More information on these national schemes can be found in 
the previous studies performed by DG ENTR in support to the ongoing revision of 
the Fertiliser Regulation5.  
Regulation (EC) No 764/2008
6
 on mutual recognition aims to allow for a product 
lawfully marketed in one Member State and not subject to EU harmonisation to 
be marketed in any other Member State. This Regulation applies to the placing 
on the market of non-harmonised goods legally present on national markets, 
including fertilisers (e.g. mineral, organic and organo-mineral fertilisers) and 
other fertilising materials e.g. growing media, soil improvers, agronomic fertiliser 
additives and plant biostimulants.  
However, several issues have been identified during the last years leading to the 
conclusions that a fundamental review of the existing legislation on fertilisers 
was required in order to fully harmonise the EU fertilising materials market(s) 
including mineral and organic fertilisers, soil improvers, growing media and 
possibly biostimulants and allow free movements of goods within the EU. 
Issues that have been identified during the last years are as follows: 
 At present only mineral products are classified as ‘EC fertilisers’, while 
organic, organo-mineral, soil improvers, growing media and biostimulants 
are governed by national legislations and internal market is expected to 
be established via applicability of the principles of the Regulation (EC) No 
764/2008 on mutual recognition. However, MS are reluctant to accept 
mutual recognition for national fertilisers, as they are not convinced that 
the requirements in other MS related to public safety, health or the 
environment are equivalent to their own requirements leading to potential 
                                           
2 Council Directive 76/116/EEC of 18 December 1975 on the approximation of the laws of the 
Member States relating to fertilisers. 
3
 SLIM: Simpler legislation for the internal market. The SLIM initiative was launched in May 1996 
and it was targeted to identify ways in which Single Market legislation could be simplified. 
4
 EC fertilisers meaning mineral fertilisers that meet the requirements of the Regulation for their 
nutrient content, their safety, and the absence of adverse effects on the environment. 
5
 Available at: http://ec.europa.eu/enterprise/sectors/chemicals/documents/specific-
chemicals/fertilisers/index_en.htm#h2-8 
6
 Regulation (EC) No 764/2008 of the European Parliament and of the Council of 9 July 2008 laying 
down procedures relating to the application of certain national technical rules to products lawfully 
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market distortions and technical barriers for trade of fertilising products 
with the EU; 
 Most stakeholders and national Competent Authorities are interested in 
extending the scope of the current Regulation (EC) No 2003/2003 to 
include not yet covered mineral fertilisers, organic fertilisers, organo-
mineral fertilisers, soil improvers, growing media, and possibly 
biostimulants; 
 Application of Regulation (EC) No 764/2008 might lead to administrative 
burden as many MS are reluctant to apply de facto the mutual recognition 
principles to fertilisers;  
 Timeline for the inclusion of new fertilisers types for “EC fertilisers” in 
Regulation (EC) No 2003/2003 is considered as too long and current 
procedures as cumbersome by a large majority of the producers and 
authorities; 
 The current provisions of Regulation (EC) No 2003/2003 are not always 
fully addressing the safety and environmental concerns (e.g. presence of 
heavy metals in mineral fertilisers);  
 In the absence of harmonised rules for organic and organo-mineral 
fertilisers as well as for growing media and soil improvers, a level playing 
field for product  safety and protection of the environment is not achieved 
(more affirmative sentence). 
1.2 Study objectives 
The study contributes to the proposal of the Commission for an EU legal 
framework for the placing on the market of plant biostimulants (PB) and 
agronomic fertiliser additives (AFA).  
In more details, the objectives of the study are to: 
 Analyse existing regulatory systems for plant biostimulants and 
agronomic fertiliser additives in the EU, Member States and Third 
Countries; and  
 Develop a proposal for the most appropriate regulatory 
framework that should be established in the context of the revised 
Fertiliser Regulation.  
In particular, the study aims to elaborate on the relevant data requirements and 
administration of a registration process for these two sub-categories. 
1.3 Methodology 
The study methodology entails three main tasks: 
 Task 1 consists in 3 subtasks. First a review of existing regulatory 
frameworks at EU, at Member States and at international levels, which 
apply to chemical substances/microorganisms comparable to the ones 
used as plant biostimulants (sub task 1.1) and agronomic fertiliser 
additives (sub task 1.2) is carried-out. The aim is in particular to 
describe data requirements as well as administrative procedures 
established by these regulations with regard to risks assessment for 
human health and the environment, as well as the assessment of the 
efficiency/efficacy of these products. A comparison of the average time 




A legal framework for plant biostimulants and agronomic fertiliser additives in 
the EU………………………………………………………………………………………………………………… 4 
access to the market has also to be performed. Eventually, an estimate of 
expected market volumes in the EU for typical plant biostimulants or 
agronomic fertiliser additives (range from “low volume” to “high volume 
products”) has to be provided (sub-task 1.3); i.e. the turnover that a 
company could expect after successful introduction of such 
substances/mixtures on the market. As the plant biostimulants and 
agronomic fertiliser additives markets are currently developing, the data 
collection for sub task 1.3 aims at estimating potential business size and 
future development to be expected in this field for the coming decades. 
 Task 2 consists in proposing the most appropriate set of data to be 
required in a future EU legislation concerning plant biostimulants and 
agronomic fertiliser additives in order to evaluate in a proper way the 
risks associated with their use, as well as their efficiency/efficacy. Under 
this task a distinction has to be made between chemical and microbial 
biostimulants when defining the most suitable data requirements. This 
distinction does not in principle apply to agronomic fertiliser additives as 
they are in the majority of cases (but not always) of chemical nature. A 
tiered approach and opportunities for waiving certain data based on 
appropriate justification is discussed in the analysis. An estimation of the 
costs associated with the recommended set of data is provided and 
compared to the expected turnover as determined under Task 1.3. 
 Under Task 3, the study team recommends a policy option with regard to 
the submission and evaluation of the proposed data set and describes (1) 
the main principles of the procedure (processes, requirements, expected 
timing) (2) the actors to be involved and their respective role (applicant 
companies, administrative/scientific bodies, Member States competent 
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Figure 1 Overall project workflow 
 
 
1.4 Structure of this report 
This report is structured as follows: 
 Section 2 provides a general overview of the policy and business context 
of the plant biostimulant and agronomic fertiliser additives (PB&AFA). 
discusses first the current national and international regulatory 
frameworks for products comparable to PB&AFA and then describes the 
existing EU registration regulatory framework for food safety and for 
chemicals; 
 Section 3 lists data requirements for applicants for PB&AFA and presents 
the proposed regulatory process and. Then costs for implementation and 
managing the proposed regulatory approach are discussed. 
Annexes provide supporting documents and detailed results of Task 1 are 
presented in an Excel DB that is part of the final deliverable of the study and will 
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2 Context 
This section summarises preliminary facts and evidences required to set-up the 
scene before drafting the regulatory process for PB&AFA and listing data 
requirements for the designed process. It starts by presenting the definitions to 
be used as well as the scope of the future regulation. Any regulation has to be 
placed in its business context which is then described. Then we present how 
PB&AFA are currently placed to the market at national level and in Third 
Countries. The section ends with a presentation of comparable EU regulatory 
frameworks with the aim of identifying relevant and accurate provisions for the 
building of the PB&AFA regulation.  
2.1 Preliminary definitions and scope of the future regulation 
The Terms of Reference of the study define plant biostimulants and agronomic 
fertiliser additives as follows: 
 Plant biostimulant means a material which contains substance(s) 
and/or microorganisms whose function when applied to plants or the 
rhizosphere is to stimulate natural processes to benefit nutrient uptake, 
nutrient efficiency, tolerance to abiotic stress and/or crop quality, 
independently of its nutrient content; 
 Agronomic fertiliser additive means any substance added to a 
fertiliser, soil improver or growing medium to improve the agronomic 
efficacy of the final product or modifying the environmental fate of the 
nutrients released by the fertilisers
7. 
These preliminary definitions raise several comments: 
1. As such, the definitions are not clear about whether they cover the 
products in the form they are supplied to the user, or the components of 
the products; 
2. The terms “material” and “substance” need to be clarified, or alternative 
terms should be proposed, in order to avoid possible confusions with the 
uses of these terms in relevant regulations, like the REACH, PPP and 
biocide regulations;  
3. Further amendments can be proposed to fit into the actual and potential 
uses of plant biostimulants, i.e. application of plant biostimulants to 
“plants or the rhizosphere”, as indicated, appears to be too restrictive 
(the rhizosphere is a limited part of the root environment only, and 
“plants” in the common sense do not comprise seeds which are worth 
mentioning explicitly); 
4. “Crop quality”, indicated in the definition of plant biostimulants, is a 
poorly defined, hence potentially very broad, concept. Overlaps with the 
effects of plant growth regulators (PGRs), regulated as PPP in the EU, are 
obvious and challenge the proposed definition of plant biostimulants in 
the future regulation. 
                                           
7
 Additives can also be used to improve the manufacturing, processing, preparation, treatment, 
packaging, transport or storage of fertilisers without any direct agronomic effects. These are referred 
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In line with these considerations, this report will propose and justify amended 
definitions in section 3.1.1 and clarify some of the issues raised on the nature of 
the registered items in the future regulation in section 3.3.2. 
The future legislation aims at regulating the placing of PB&AFA on the market. 
Therefore the concept and definition of “placing on the market” is fundamental 
for the application of the future legislation and for the exact definition of its 
scope.  
Several EU regulatory frameworks provide definitions of placing on the market. 
Specific definitions have been created to adjust to sectorial needs. In the context 
of this study, definitions as listed in Regulation (EC) No 765/2008 of the 
European Parliament and of the Council of 9 July 2008 setting out the 
requirements for accreditation and market surveillance relating to the marketing 
of products and repealing Regulation (EEC) No 339/937 can be considered.  
Regulation 765/2008 defines the term “placing on the market” in Article 2(2), 
which reads as follows: 
“‘Placing on the market’ shall mean any supply of a product for 
distribution, consumption or use on the Community market in the course 
of a commercial activity, whether in return for payment or free of 
charge”. 
In addition, Article 2(1) of Regulation (EC) No 765/2008 introduces a definition 
of the term “making available”. The provision is worded as follows: 
"‘Making available on the market’ shall mean the first making available of 
a product on the Community market ".  
The Guide to the implementation of directives based on the New Approach and 
the Global Approach ("Blue Guide")8 states that the placing on the market takes 
place when the product is transferred from the stage of manufacture with the 
intention of distribution or use on the Community market. 
“Placing on the market” has to be clearly differentiated from the “use” which is 
allowed after the “authorisation” of the product. “Authorisation“ means an 
administrative act by which the competent authority authorises the placing on 
the market of a product in its territory9.  
According to the indications made by the Commission the scope of the future 
legislation is limited to the placing on the market and does not apply to the use 
of an authorised product. 
2.2 Industry description, business dynamics and future 
opportunities 
According to findings from research and advisory services, the use of plant 
biostimulants and agronomic fertiliser additives in agriculture offers significant 
opportunity for farmers. Improved root and shoot growth, better stress 
                                           
8 Published by the European Commission (1999), see http://ec.europa.eu/enterprise/policies/single-
market-goods/files/blue-guide/guidepublic_en.pdf, in particular page 18. 
9
 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 
concerning the placing of plant protection products on the market and repealing Council Directives 
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resistance, better root growth potential, improvement of nutrient uptakes, and 
reduction in nitrogen levels of fertilisation are some of the possibilities that these 
compounds connote to sustainable agriculture. 
The use of products to promote plant growth and vigour is not really new as 
some of these products, e.g. seaweeds, have been used by farmers for many 
decades before their use was significantly reduced as a result of the preference 
given to synthetic fertilisers during the Green Revolution. Historically, 
biostimulants were applied to high-value crops: mainly greenhouse productions, 
orchards (grapes, citrus, stone fruits, apples, pears) open-field vegetables 
(tomatoes, salads, etc.) and horticultural products (flowers and ornamentals). 
Farmers were encouraged to use chemical products to further increase 
productivity as the efficacy to cost ratio was much greater. In some countries 
regulations were encouraging farmers to use chemical fertilisers by the mean of 
direct subsidies when buying chemical fertilisers.  
Since the reform of the Common Agricultural Policy in 1992 (“the MacSharry 
Reform”) environmental consequences have been taken into considerations and 
the sector for alternative products has emerged at the same time that producers 
of plant nutrients were looking for ways to improve nutrient use efficiency and 
plant protection producers are looking for alternatives to traditional synthetic 
chemistry.  
Plant biostimulants and agronomic fertiliser additives sectors appear to be quite 
specific, with few similarities despite the fact that they are both often 
incorporated into regular fertilization practices in order to boost plant nutrition. 
Therefore we present these two business sectors separately.  
Market overview for plant biostimulants 
Although plant biostimulants were originally popularised in organic agriculture, 
they are increasingly moving into conventional agriculture. Plant biostimulants 
first moved into specialty crops, e.g. high-value agricultural and horticultural 
productions, and are increasingly being introduced into conventional crop 
production to respond to economic and sustainability imperatives. 
Several studies have been undertaken on the growth of the plant biostimulants 
market in recent years, either by market research firms or by agriculture 
industry organisations. In many cases, widely divergent statistics have been 
offered for the size and value of this market as not all research uses the same 
criteria to define the market. Overlaps exist with mainly biopesticides and liquid 
fertilisers. Despite these differences, however, the growth of the plant 
biostimulants market is concluded by most studies. 
The biostimulants market seems to be growing rapidly, driven by economic and 
socio-political factors. The European Biostimulants Industry Consortium (EBIC) 
considers that the 2012 EU market value (sales) of biostimulants can be 
estimated at € 400-500 million. EBIC carried out informal surveys within its 
members in late 2011 and early 2013 to better estimate the size of the European 
plant biostimulants markets. EBIC also reported that more than 6.2 million 
hectares in the EU are treated with biostimulants (about two applications of 
biostimulants per year on 3 million hectares).  
According to the survey responses received by EBIC in 2011, the EU market is 
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levels (market forecast of € 800 million in 2018). For EBIC, another sign of 
market growth is the number of new users which is rapidly increasing even if no 
statistics can be reported. Because plant biostimulants have not been widely 
used in the past, many growers are testing them on a limited area for one or two 
seasons before scaling up their use.  
EBIC further highlights that the factors driving this continued growth are 
multiple:  
4. European agricultural and food safety policies have integrated 
environmental considerations and are promoting the safe use of 
agricultural inputs. This applies to alternative products being plant 
biostimulants or biopesticides that are used under the integrated crop 
management schemes including integrated pest management; 
5. In response to consumer demands for healthy food products with 
minimal environmental impacts growers are looking for ways to use 
synthetic chemicals and mineral fertilisers more efficiently and 
effectively. Biostimulants are therefore increasingly seen as a way to 
improve the return on their investment in other inputs and as a way 
to respond to consumer demands for “softer” agricultural practices;  
6. Recent high and volatile prices for agricultural inputs like fertilisers 
have created incentives for farmers to optimise the efficiency of input 
use; 
7. Plant biostimulants use is spreading from some pioneer countries to a 
wider number, both within Europe and the rest of the world. Related 
to this, biostimulants companies are expanding their professional 
networks and connecting with new global distributors that are helping 
them target previously inaccessible markets; and 
8. The biostimulants sector has developed new innovative products 
targeting specific agronomic needs, thus attracting new customers. 
EBIC member companies currently have biostimulants products on the market in 
several countries. EBIC added that “despite the small size of many biostimulants 
producers, they already have significant cross-border activity”. As shown in the 
following table, the national home market is a minority of the current market for 
EBIC member companies. 














Company 1 Medium 25 50 25 
Company 2 Medium 35 25 40 
Company 3 Medium 40 50 10 
Company 4 Medium 70 25 5 
Company 5 Medium 35 25 40 
Company 6 Small 30 0 70 
Company 7 Large 1 2 98 
Company 8 Medium 75 10 15 
Company 9 Small 50 30 20 
Company 10 Small 20 20 60 
Company 11 Large 20 30 50 
Company 12 Large 15 18 67 
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With regard to employment, EBIC considers difficult to provide a highly reliable 
estimation of the total number of jobs in the plant biostimulant industry. Most of 
the biostimulant companies are small and medium enterprises (SMEs)10 less than 
250 employees. The respondents of the 2011 and 2013 EBIC surveys together 
employs about 2,000 staff in Europe and every respondent reported a growing 
employment trend for their company in Europe. In total EBIC considers that the 
EU plant biostimulant sector is composed of about 200-250 companies of which 
about 90% are SMEs.  
Two additional key criteria have to be taken into consideration to assess the 
development of the plant biostimulant sector: consolidation of the sector and 
level of investment in research. 
The plant biostimulant category is in its relative infancy, but the rapidly 
increasing level of investment in research is beginning to yield insights into the 
potential of these products. A recent study by PiperJaffray11 estimates the global 
plant biostimulants market to be approximately $ 1 billion and see it growing at 
about 20% annually per year. The same study indicates that the largest regional 
market for bio-based products (including plant biostimulants and biopesticides) 
is North America, currently accounting for around 40% of sales. Europe, Asia and 
Latin America, represent 25%, 20% and 10%, respectively. PiperJaffray 
indicates that there are a couple of significant explanations for these trends. 
First, growers in North-America and Western Europe are generally about 5-10 
years ahead of developing country growers in the new product adoption cycle. 
Second, most biological developers and distribution networks are situated in 
developed countries. Finally, middle-class demand for organic foods, residue-free 
produce and overall wellness has been much stronger in developed countries. 
“While developed countries will still continue to be the volume drivers of 
biologicals in coming years, with the USA leading sales of biopesticides and plant 
biostimulants and Europe leading demand growth for both group of products, 
trends in developing agriculture powerhouses such as Brazil, eastern Europe and 
China are aligning to allow more industry growth to be tackled on”.  
Biopesticides/biostimulants are attracting greater interest as core options in crop 
protection programmes, with a number of recent high profile acquisitions by 
major R&D based companies. According to industry players, consolidation will 
further expand.  
Table 2 Large agrochemical companies move into the biological industry 




2012 BASF Becker Underwood Acquisition 1.02 billion 
2009 BASF AgraQuest Strategic partnership  
2013 Bayer Prophyta  Acquisition N/A 
2012 Bayer AgraQuest Acquisition 500 million* 
2009 Bayer AgroGreen Acquisition N/A 
2011 DuPont AgraQuest Strategic partnership  
2007 DuPont Marrone Bio Strategic partnership  
2013 Monsanto Agradis Acquisition N/A 
                                           
10
 Less than 250 employees 
11
 PiperJaffray, Industry note, “Agriculture: Biological crop chemistry primer: green shoots through 
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2012 Monsanto Alnylam Strategic partnership  
2011 Monsanto Beelogics Acquisition N/A 
2012 Novozymes EMD(Merck) Acquisition N/A 
2011 Syngenta Pasteuria Bioscience Strategic partnership N/A 
2013 Syngenta Isagro Strategic partnership  
2012 Syngenta Pasteuria Bioscience Acquisition 123 million* 
2012 Syngenta Devgen Acquisition 523 million 
2012 Syngenta Novozymes Strategic partnership N/A 
2013 Makhteshim  ChileAgro Solutions Acquisition N/A 
2013 Bayer  Stoller-China Strategic partnership N/A 
Source: PiperJaffray, Industry note, “Agriculture: Biological crop chemistry primer: green 
shoots through green products”; August 27, 2013 
In addition to these alliances, the recent published strategic partnership between 
Novozymes BioAg and Monsanto is another key relevant indicator of the ongoing 
of large traditional R&D groups’ strategy to invest in bio-based agricultural inputs 
businesses.  
On 10 December 2013, Novozymes and Monsanto Company announced a long-term 
strategic alliance to transform research and commercialisation of sustainable microbial 
products that will provide a new platform of solutions for growers around the world. The 
BioAg Alliance will allow the companies to leverage employees, technologies and 
commercial assets in the companies’ agricultural biologicals portfolios (biopesticides and 
plant biostimulants). The result will be a comprehensive research, development and 
commercial collaboration to help farmers globally meet the challenge of producing more 
with less in a sustainable way – for the benefit of agriculture, consumers, the 
environment and society at large. 
As momentum grows, the level of applied knowledge around biostimulant 
technologies is increasing as well. EBIC considers that R&D efforts can be 
estimated at between 5% to 10% of the total sales, but some reinvest an even 
higher share in innovation. Many companies have between 10% and 33% of 
their staff involved in R&D activities with a few companies slightly below that 
range.  
EBIC 2011 survey results indicate that: “In addition, respondents of the 2011 
survey reported almost 150 R&D partnerships with universities and other public 
research institutes. While most of these are in Europe, they also include partners 
in Australia, Brazil, Canada, Chile, Ghana, Mexico, New Zealand, Turkey and the 
United States. It generally takes 2-5 years to bring new products to market, a 
significant investment considering how little protection there is to prevent 
copies/reverse engineering of biostimulant products. Several companies reported 
in 2011 that less than 10% of their products are patentable (and some even said 
none can be patented). A handful of others report that 60% or more of their 
products contain some patented element, although this does not mean the 
product as a whole is protected by patent. In many cases, it is a specific aspect 
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Market overview for agronomic fertiliser additives 
There is a common understanding that the current fertiliser additives are 
indiscriminately grouped in two categories with very different functions.  A first 
category, i.e. the technological additives, covers additives that modify the 
physical characteristics of the final fertiliser product aiming at improving the 
manufacturing, handling and application of fertilisers. The other category, which 
should be clearly separated from the previous one, covers 
performance-enhancing additives (i.e. agronomic fertiliser additives) that use 
fertiliser technology to improve nutrient use efficiency. These performance-
enhancing additives covers additives that modify the release of nutrients from 
commercial fertilisers, but are not restricted to this category of effects as other 
performance-enhancing additives act on the stability of the nutrient, e.g. by 
protecting them from chemical and biological degradation in soils. 
The International Fertilizer Industry Association (IFA) has developed several 
definitions which are currently being used by industry, as follows: 
 Fertiliser technology: substances that improve the efficacy of the final 
product; 
 Slow or controlled-release fertiliser: A fertiliser containing a plant nutrient 
in a form which delays its availability for plant uptake and use after 
application or which extends its availability to the plant significantly 
longer than a reference rapidly available nutrient fertiliser; 
o Slow-release fertiliser (SRF): nutrient-containing compounds that 
decompose over an extended time by biological or chemical means 
into plant-useable nutrient forms; 
o Controlled-release fertiliser (CRF): nutrients coated by 
hydrophobic polymers or matrices to restrict the dissolution of the 
nutrient and therefore extending the release of available nutrients; 
 Stabilised nitrogen fertiliser: A fertiliser to which is added a substance 
which extends the time the nitrogen component remains in the soil in the 
urea-N or ammoniacal-N form; 
 Nitrification inhibitor: A substance that inhibits the biological oxidation of 
ammoniacal-N to nitrate-N; 
 Urease inhibitor: A substance that inhibits hydrolytic action on urea by 
the enzyme urease. 
Chelating and complexing agents which are not recognised by IFA as agronomic 
fertiliser additives are however already included in the Annex I to the Fertiliser 
Regulation and it is assumed from indications given by the Commission that 
these categories of products described above will be considered in the future EU 
legislation. 
According to the International Fertilisers Development Center (IFDC), there are 
very few reports and market data to describe the specific business related to 
agronomic fertiliser additives.  
The most comprehensive recent one is the presentation made by AgIndustries 
Research & Consulting presented at the International Conference on slow and 
controlled release (CRFs) and slow released fertilisers (SRFs) in 201312.  
                                           
12
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According to this report, the key characteristics of the market for the 
above-mentioned products are: 
 Markets for CRFs and SRFs are globalised for already several years: 
 The United States, Western Europe and Japan have historically been the 3 
largest world regional markets for CRFs. The US CRFs market 
(700,000 tons) is almost 5 times larger than the Western European 
market (150,000 tons), based on product volume, and nearly 13 times 
larger than the Japanese market (about 50,000 tons); 
 In the EU, the CRFs market distribution reads as follows (2009 data): 
o 61% of the total volumes go to professional markets (BtoB); 
o 29% to consumers (hobby market)(BtoC); and 
o 10% directly to farmers. 
 The projected average annual growth rate to 2015 is about 1.5%-2.5% in 
Western Europe, slightly lower than growth rate in the US (2.0%-3.5%) 
and in Japan (3.0%-4.5%); 
 The global market for N stabilisers and SRFs is developing rapidly: 
o US consumption of SNFs amounted to an estimated 3,381,000 
metric tons of nitrogen in 2010; 
o SNFs consumption in Western Europe totaled an estimated 
129,000 metric tons in 2009; 
o Nitrification inhibitor-stabilised fertilisers are widely used in Japan; 
however consumption data are not available. 
It can be observed that business is dominated by a small number of large 
companies (e.g. BASF, Kock, Dow, Everis (ICL), SKW in Germany) which have 
developed new innovative products that are added to commodity fertiliser 
formulations.  
Significant events in the world market for AFA since 2010 have been observed: 
 Formation of a manufacturing and marketing alliance between Koch 
Fertiliser Trading SARL and Agrotain International, followed by the launch 
in April 2010 of Koch Advanced Nitrogen (urea stabilized with NBPT) in 
the UK; 
 Kock Agronomic services’ October 2011 acquisition of Agrotain 
International’s N stabiliser and SNF assets; 
 Launch of several new products : 
o Arborite AG:  NBPT-based urease inhibitor product,  
o Nexen: new SNF by Koch. 
Agronomic fertiliser additives are often incorporated into regular fertilisation 
practices in a supplementary way that boosts nutrition. Value creation come 
from premium that the fertiliser manufacturers can add on the price of the 
commodity fertilisers. For example, BASF is keeping most of its additives for its 
own fertiliser business and in these cases do not sell them to any third 
commercial partners. For BASF, the annual added sale revenue is estimated at € 
18 million13.  
                                           
13
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Most of these actors have an important R&D sector which is often structured 
internationally to support several markets (e.g. Kock has 10 R&D international 
staff for the development of new agronomic fertiliser additives and Everis in 
between 10 and 15 high qualified R&D staff).  
This introduction to the plant biostimulants and fertiliser additives markets 
clearly highlights that we are facing two very different sectors in many criteria as 
summarised in Table 3 below. 
Table 3 Comparison between the EU plant biostimulants and the agronomic 
fertiliser additives business sectors 
Criteria Plant biostimulants 
Agronomic fertiliser 
additives 
Market trend (estimated 
annual growth rate) 
> 10% 1.5-2.5% 
Business maturity Low High 
Business structure Ongoing consolidations Mature  
R&D investment Medium to high Medium 
Type of industry Mainly SMEs Mainly large companies 
Business perimeter Often local to national Regional to international 
Number of industry players High (>200) Low  
Marketing approach Twofold: 
- Marketing of stand-alone products 
- Incorporation into fertilisers to optimise nutrient 
uptake 
 
2.3 How are plant biostimulants and agronomic fertiliser 
additives currently placed to the market at EU/MS level? At 
international level? 
This section summarised the current situation regarding the placing of plant 
biostimulants and agronomic fertiliser additives on the market at national level in 
the EU and at international level in Third Countries.  
The description of the national regulatory frameworks is concentrating on plant 
biostimulants as most of the AFA are already included in the Fertiliser Regulation 
2003/2003. The term “agronomic fertiliser additives” is not defined per se in the 
current Fertiliser Regulation but some types of additives have been added (M4, 
M5 and M9) to Annex I of the Regulation.  
Today, the Regulation lists the following agronomic fertiliser additives: 
 Chelating agents: list E.3.1 of Annex I of Regulation (EC) No 2003/2003; 
 Complexing agents: list E.3.2 of Annex I of Regulation (EC) No 
2003/2003; 
 Nitrification inhibitors: list F1 of Annex I of Regulation (EC) No 
2003/2003; 
 Urease inhibitors: list F2 of Annex I of Regulation (EC) No 2003/2003. 
The procedure for introducing a new type of fertiliser to Annex I so that it can be 
marketed as an “EC fertiliser” is defined in Article 31 of Regulation (EC) No 
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by the Commission14 in co-operation with Member States experts. The guidance 
document describes the content of the technical file to be submitted including 
information relating to health and safety, REACH registration data, information 
on the agronomic effects, the methods of use and the efficacy of the product and 
a proposal for an internationally recognised method for analysis of the specific 
product. The procedure also requires that the application with the technical file is 
submitted to one of the Member States that will act as rapporteur to the Working 
Group on Fertilisers on the basis of the tests and review conducted at the 
national level. Finally, the Fertilisers Working Group (with participation of the 
Member States and industry) is the main body where issues are raised and 
discussed, proposals for solutions and necessary revisions are formulated and 
where an agreement on a proposal to include new fertilisers types in Annex I is 
made. The Working group meets normally twice a year15. 
The analysis has been performed by considering several EU MS mainly BE, DE, 
ES, FR, IT and HU and four Third Countries (TCs) (Brazil, Canada, South-Africa, 
and the USA). The selection of these countries has been made to secure that the 
main types of regulatory schemes would be described.  
As an introduction, the following elements should be considered: 
 The term “Plant biostimulants” is not defined in any of the regulatory 
framework under analysis; therefore our analysis has been performed by 
considering comparable products and products that will fall as plant 
biostimulant under the future EU Regulation;   
 “Agronomic fertiliser additives” is solely defined in the French legislation 
(NFU 44-204 standard which has been made compulsory under Articles 
L255-1 to L255-11 of the “Code Rural”).  
The description of the national and TC regulatory schemes aims at highlighting 
the main similarities and differences of the schemes and should not be perceived 
as an exhaustive description of each of them. Additionally this analysis aims at 
identifying interesting features that could be considered in the building of the 
future EU regulatory framework for PB&AFA. 
The descriptions of the different schemes are sorted by level of data 
requirements (low to high requirements) (from simple notification to registration 
approaches). 
The Belgian regulatory scheme 
The legislation related to the placing on the market of plant biostimulants ( or 
associated to this type of products) takes place in the context of the “Arrêté 
Royal du 28 Janvier 2013” in which a category concerning “other fertilisers”16 
has been created. Other fertilisers can be fertilisers, growing media, soil 
improvers, and other products of which plant biostimulants. 
                                           
14
 Communication from the Commission, Guide to the compilation of a technical file on application to 




 Source: Evaluation of Regulation (EC) 2003/2003 relating to Fertilisers - Final Report – CSES 
available at : http://ec.europa.eu/enterprise/sectors/chemicals/files/fertilizers/final_report_2010_en.pdf 
16
 Definition: « tout produit auquel est attribué une action spécifique de nature à favoriser la 
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Applicants have to notify the national authority (Service Public Fédéral Santé 
publique, Sécurité de la Chaîne alimentaire et Environnement DG Animaux, 
Végétaux et Alimentation, Service Pesticides et Engrais, hereinafter “SPF”)) that 
it wants to place on the market a new fertilising material that do not fall under 
the scope of the existing categories.  This notification should be as complete as 
possible but there is no defined guidance documents regarding the required 
composition of the dossier. The national authority examines the dossier and 
grants the authorisation (called “dérogation”) by communicating the applicant 
the registration code/number when the dossier is considered complete and when 
no unacceptable safety issue has been identified. However, in the large majority 
of cases, the SPF asks the applicant for additional questions and for the provision 
of additional information on a dossier by dossier basis. In these cases, 
authorisation is granted when SPF considers that enough information has been 
submitted to assess that the product would not pose any significant safety or 
environmental issues.   
SPF does not ask the applicant to provide toxicological and ecotoxicological data. 
However applicants are required to provide information proving the efficacy of 
the product by mean of field trials data or/and laboratory tests results or/and by 
providing scientific literature evidences (in this case applicants are requested to 
provide field results after approval is granted). 
The mode of action of the product intended to be placed on the market has to be 
described by the applicant. It is being used to analyse whether or not the 
product is a plant protection product.  
On average the SPF receives 250 new dossiers per year of which about 10 of 
these can be considered as plant biostimulants products. SPF applies a flat fee 
system of € 1,500 per dossier (one single payment at application). 
The Danish regulatory scheme 
The Danish AgriFish Agency (DAA) is the National Authority in charge of the 
questions related to placing on the market of specific fertilisers category in which 
plant biostimulants can be placed. 
Like the current Fertiliser Regulation, the Danish Order on Fertiliser and soil 
improvers etc. has no separate category for plant biostimulants. Hence, they 
have been registered as soil improvers under national legislation. We do not 
have very many products registered, which could be categorised as 
biostimulants; our estimate is about 15. Traditionally, they are not used very 
much in Denmark and if so, mostly by organic farmers. We have recently had an 
increasing number of requests regarding biostimulants and applications for 
registration. As some of those contain ingredients or are described as having 
properties interfacing with plant protection products, we have started a 
collaboration with the Danish Environmental Protection Agency (the DEPA) 
handling the requests.  
If the product is not categorised as a soil improver (in which case it would be the 
responsibility of the AgriFish Agency), nor clearly as a plant protection product 
(which falls under the responsibility of the DEPA), the general chemicals 
legislation applies, belonging to the DEPA’s area of expertise.  
If this does not require registration (e.g. dried sea weeds extracts), the product 
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If the product is categorised as a soil improver, or any other product regulated 
by the Danish Order on Fertiliser and soil improvers etc., companies are required 
to register their product with the AgriFish Agency. The register is made public 
online; earlier a hard copy is made available. DAA asks for data regarding the 
contents – all ingredients making up minimum 1 % have to be labelled – and 
documentation for the agronomic efficacy according to Danish conditions (e.g., 
soil type, abiotic factors). According to the Order on payment a registration fee is 
charged, plus a yearly fee according to the amount of product ant type sold.17  
As for Belgium the Danish approach is not requiring to provide toxicological nor 
ecotoxicological data. In some limited cases (e.g. sea weed extracts with no 
chemical products being used during the process, notification is voluntary and 
not mandatory). The fee level is lower than for (about €300-500 per notification 
payable when submitting the application).  
The Spanish regulatory scheme 
The current national legislation that includes plant biostimulants is the “ORDEN 
APA/1471/2007” regulating the placing on the market of “otros medios de 
defensa fitosanitaria”18 (called “fitofortificantes”). This legislation was developed 
and overseen by the “fertiliser section” till end of 2011 before it moved into the 
“agrochemical section” of the Ministry of Agriculture.  
Under the current regulation, commercial products that have been notified can 
immediately be placed on the market without waiting for any approval. This 
approach had led to a large number of products being sold. A new royal decree is 
being prepared to correct the shortcomings of the current situation and should 
be issued by early 2014. 
The definition being used in the existing Orden does not clearly identify whether 
or not plant biostimulants as being defined under Section 2.1 would fall under 
the scope of this legislation. The current definition reads as follows: 
“Products included in this scope of application are the organisms of biological 
control, the traps and other means or devices for the control of pests, as well as 
the products that could favour that the crops develop vigour or resistance in 
front of the adverse effects related to pathogen attacks, or environmental 
conditions, or allow mitigate in another manner the devastations that they could 
cause, and other products…”. This definition clearly includes a range of products 
affecting both biotic and abiotic stress.  
In the new legislation, the name of this product group will be simplified to 
“MDF: medios de defensa fitosanitaria” but the question whether or not plant 
biostimulant (as defined at EU level) will be included in the scope of the 
legislation remains open. 
The draft royal decree calls for two types of products, those requiring 
authorisation before commercialisation and those simply requiring notification 
before commercialisation (the current situation but with some changes to the 
notification process). Notification requirements will include data to justify the 
safety of products and the claims and registration fees will apply. Notification 
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dossiers will have to be submitted to one autonomous community and marketing 
will start immediately without awaiting for any authorisation.  
Authorisation by the Ministry of Agriculture – subdireccion General de Sanidad e 
Higiene Vegetal y Forestal (MAGRAMA) will apply to a range of product 
categories, among which “plant extracts and others” and “certain fertilisers” 
(based on a list of raw materials yet to be published).  
MAGRAMA will have 3-6 months (depending on the product in question) to grant 
or refuse authorisation for a product that is not eligible for commercialisation 
immediately after notification. In case MAGRAMA does not publish an opinion 
before the deadline, the product is automatically approved for sales.  
Data requirements are listed in Article 2 of the new draft decree and can be 
listed as follows: 
 List of raw materials; 
 Characterisation methods or identification methods (depending on type); 
 Analytical methods; 
 Analysis of active components; 
 Presence/absence of contaminants (list to be defined); 
 Physico-chemical and technical properties by a third accredited laboratory 
applying ISO 17025 standard; 
 Safety information and toxicology obtained through Good Laboratory 
Practices (GLP) (no list defined); 
 Ecotoxicity and environmental fate information (no list defined); 
 Field trials (4 crops * 3 growing cycles) conducted by official authorised 
entity; and 
 For micro-organisms, each of them must correspond to a pure strain that 
is identified and characterised, which does not come from a species that 
is pathogenic to people, crops, animals, flora or fauna. 
Data requirements will be retroactive in the spirit of providing a level playing 
field. Data will have to be submitted for products already on the market within 
12 months, unless there is a justifiable reason to extend the period to 2 years 
(e.g. to conduct adequate field trials).  
The Spanish industry representatives19 have estimated that this approach will 
lead to regulatory costs ranging from € 30,000 to more than € 100,000.  The 
number of applications to be submitted under the new scheme has not yet been 
estimated by the national industry.  
The German regulatory scheme 
The German Federal Office of Consumer Protection and Food Safety (BVL) has 
developed a regulatory framework for “plant strengtheners” (PS) that 
corresponds to plant biostimulants as defined under Section 2.1.  
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A detailed description of this category, the notification procedure, the data 
requirements and the list of plant strengtheners is clearly presented on the BVL 
website20.  
The segmentation between PS and PPP on one hand and PS and fertilisers on the 
other are also clearly mentioned. 
The approach is based on a notification to BVL that leads to an automatic 
authorisation. In case there are indications that the notified product does not 
fulfil the definition of plant strengtheners or may cause harmful effects on 
human and animal health, groundwater or the environment, BVL prohibits the 
placing on the market of the product by informing the notifier in writing.  
Commercial products containing more than 5% of seaweed extracts cannot be 
considered as PS. In the majority of cases they are classified as PPP or as Plant 
Aids (under the national Fertiliser Acts). 
BVL insists that notifications include a detailed description of the characteristics 
of the product even if BVL doesn’t list requirements. That allows identifying 
whether or not a safety and/or environmental risk could be anticipated. In more 
than 90% of cases, BVL request additional information to the notifier but this 
approach does not suspend the marketing authorisation. 
BVL does not require the mandatory furniture of an analytical/quality method in 
all cases.  
Between March 2012 and July 2013, about 300 notifications have been 
submitted by BVL. About 15% of these have been rejected mainly due to poor 
submitted datasets and wrong categorisation (BVL is of the opinion that the 
systems leads to difficulties differentiating between PS and PPP). About 1.5 Full 
Time Equivalent (FTE) is dedicated to the processing of notification dossiers. This 
is considered as not sufficient by BVL. 
Fees for notification are low: € 400. This is explained by the fact that most of 
applicants are small SMEs (more than 100 companies are listed in PS register).   
The Italian regulatory scheme 
Italy has a national fertiliser legislation called Decreto Legislativo 75/201021 
which covers fertilisers groups not covered by Regulation (EC) No 2003/2003 
and in particular products that could fall under the plant biostimulant category as 
defined under Section 2.1. The national authority in charge of fertilisers is the 
Ministry of Agriculture (“Ministero delle politiche agricole alimentari e forestali”). 
Plant biostimulants can be considered as falling in the product category called 
“Prodotti ad azione Specifica” (specific action products) as defined under Annex 6 
of the Decree. Annex 6 list three different sub-categories (each including 
sub-sub categories): 






 Decreto legislativo 29 aprile 2010, n. 75 (So n. 106 alla Gu 26 maggio 2010 n. 121) Riordino e 
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 Products acting on fertilisers (including inhibitors of urease, nitrification); 
 Products acting on the soil; and 
 Products acting on the plant in which plant biostimulants are listed.  
Registration applies to add a new designation type to the Annex 6 of the 
regulation. The register lists 7 designation types for PB&AFA and commercial 
products are not registered by authorities.   
New type designations are inserted after a company submits a dossier 
(according to Annex 10 of the decree) containing the following details: 
 Production methods, raw materials used; 
 Final product composition, physico-chemical nature, heavy metal content;  
 Analytical method for quality control; 
 Biological contaminants if relevant;  
 Material Safety Data Sheet (MSDS) according to Regulation (EC) No 
1907/2006, if relevant;  
 Toxicity data (no list of tests provided);  
 Ecotoxicity and environmental fate data (no list of tests provided); 
 Agronomic information (crops, application method, effects).  
The compilation of a dossier costs about € 30,000 to 50,000. The dossier is 
assessed by a special commission, appointed by the Ministry. Typical assessment 
time is 12-18 months, but varies a lot depending on the quality of the dossier.  
It is to be noted that currently the Commission has been dissolved, so the 
situation is frozen.  
When a new designation type is created and inserted in the register, any 
company can market similar products (same approach than for the Fertiliser 
Regulation).  
The Hungarian regulatory scheme 
The legal basis of the Hungarian scheme is the “Decree 36/2006 (V.18.) FVM” of 
the Ministry of agriculture and rural development on the authorisation, storage, 
marketing and use of yield enhancing substances. 
Yield enhancing substances covers chemical, mineral and organic fertilisers, 
composts, worm composts, soil improvers, soil conditioner preparation, 
microbiological preparations, group of products, plant conditioner preparation. 
Plant biostimulants could be ranged under the category of plant conditioner 
preparation as its definition reads as follows:  
“Plant conditioner preparation: means a preparation manufactured from 
organic or inorganic materials with favourable influence on the growth, 
yield and general conditions of plants and which have an effect on plant 
life cycles primarily by influencing the nutrient supply”.  
Article 3 of the Decree indicates that: “Yield enhancing substances may be 
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a) they have favourable effects on the soil and cultivated crops supported 
by tests and studies, in case of technically reliable use they do not have 
any harmful effect on plants, soils, human or animal health or any 
unacceptable risk to the environment and nature, 
b) they have an authorisation for placing on the market and use of yield 
enhancing substances (hereinafter: authorisation) granted by the Central 
Agricultural Office (hereinafter: competent authority). 
Authorisation for yield enhancing substances is granted for commercial products 
and may also be granted as product family. The provisions of other legislation on 
the authorisation of plant protection products shall also apply to yield enhancing 
substances containing plant protection products.” 
Data requirements for plant conditioner preparation are as follows: 
 Physical, chemical description of the product including the complete 
composition of the preparation, name of active substances, basic 
materials; 
 Field of uses and doses of applications provided by the manufacturer; 
 Description of the manufacturing technology; 
 Presence of heavy metals (quantification required on 3 samples); 
 Testing results of organic contaminants. The requirements are only listed 
in case waste is being used (then testing results of total polycyclic 
aromatic hydrocarbons  (PAHs) content, benz(a)pyrene content, mineral 
oil content, polychlorinated biphenyls (PCBs) content and polychlorinated 
dibenzodioxins (PCDDs) content have to be reported); 
 Test verifying biological efficacy: 3-6 field trials or under greenhouse for 
each crop group. These efficacy trials may be carried out by the 
competent authority or an organisation accredited for this field, of 
Hungary or of the EEA Member States by respecting the provisions of the 
European and Mediterranean Plant Protection Organisation on Good 
Agricultural Practice and the relevant test methodology. The tests made 
in the EEA Member States may be accepted if they were carried out under 
Hungarian or comparable agro-ecological conditions (climatic, 
agricultural, environmental and pedological) as well as plant health 
conditions. Field trials for non-crop-specific preparations may be 
substituted by pot tests, while trials carried out for crop groups may be 
substituted by tests for cultivation sectors; 
 Microbiological tests; 
 MSDS of the preparation, in accordance with the provisions of Act on 
chemical safety; 
 In case of yield enhancing substance containing hazardous substance, 
under provisions of the CLP legislation, demonstration of the behaviour of 
hazardous materials in soils, their effects on sub-surface waters22; 
 If waste was (also) used for the production of plant conditioner 
preparation, additional ecotoxicological (Daphnia-test, fish test, algal test) 
and other tests may also be required, depending on the quality of the 
waste. 
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Authorisation is valid for ten years and can be renewed. 
The French regulatory scheme 
Rules for placing plant biostimulants and agronomic fertiliser additives on the 
market are included in the fertiliser acts called “matières fertilisantes et support 
de cultures” (MFSC). This regulatory framework includes all types of fertilisers, 
growing media, liming materials, soil improvers and any other MFSC. The legal 
basis is Article L255-1 to L255-11 of Code Rural.23 
All MFSC in their form of commercial products require a pre-market approval 
(“homologation”) but about 90% of the commercial products are exempted from 
registration when an history of safe use has been demonstrated. In these cases, 
standards (similar approach than the current one in the Fertiliser Regulation) 
have been created (i.e. the NFU24 standards). 
Most agronomic fertiliser additives as defined under Section 2.1 are included in 
several standards and therefore no registration of commercial products is 
required. 
For plant biostimulant as defined under Section 2.1, a standard (NF U 44-204) 
has been introduced in September 2011 to cover plant biostimulants when added 
to fertilising materials. Commercial products can be placed on the market if the 
label or any other commercial document specifies that the product fulfils the 
requirements of the standard. 
For all other plant biostimulants (e.g. used alone and not in addition to 
fertilisers) a full registration process applies. This approach is rather similar to 
the Hungarian one and it applies to individual commercial product with the 
possibility to apply for product families and on group of crops.  
A detailed methodological guidance is available25. All requirements are fully 
described in details to the exception of the requirements for proving safety and 
efficacy of the product. Applicants are required to prove safety and efficacy of 
their product but no detailed information on the required test data is provided 
(case by case approach). It is of the responsibility of the applicant to provide 
enough information in its application dossier to prove safe use of the product 
(health & environmental safety).  
Programme 10826, a testing protocol that covers a large number of criteria 
(heavy metal content, nutrient content, physico-chemicals properties, and 
microbiological analysis), has to be performed for any application. Only a few 
laboratories are accredited to run this test.   
Fees of € 6,000 have to be paid when submitting the application for the first 
time. Fees are less important in several cases (e.g. renewal, second application 
of the same substance, modifications of the product composition, modification of 
the claim, etc.). The total cost for producing all required information and for 
compiling the registration dossier ranges from € 20,000 to > € 50,000. While the 
registration process is expected to take one year, it has been observed that in 




 NFU: Norme Française (French Norm) 
25
 Available at : http://www.anses.fr/fr/content/documents-dinformation-pour-les-dossiers-sur-les-
mati%C3%A8res-fertilisantes-et-supports-de 
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the majority of cases more than two years were necessary to complete the 
registration process.  
The list of registered products is reported in the French catalogue available at 
http://e-phy.agriculture.gouv.fr/. It contains about 120 entries of which less 
than 15 can be considered as plant biostimulants. 
Third Countries regulatory schemes 
The analysis of the description of some Third Countries regulatory frameworks 
for plant biostimulants and agronomic fertiliser additives do not lead to the 
identification of major differences in comparison to the EU approaches. 
In the USA registration of PB&AFA takes place in the context of the fertilisers’ 
acts27. Since there is no federal fertiliser law for the placing of fertiliser products 
on the market28, the registration of plant biostimulants (as well as fertilisers) are 
regulated at state level. State regulations for fertilisers are generally developed 
and administered by state agriculture departments.   
Such regulations primarily address efficacy claims and composition statements of 
the active ingredients displayed on fertiliser labels. Most states have fertiliser 
regulations requires registration and/or licensing of each brand and grade of 
fertiliser by the person whose name appears on the label before the product may 
be distributed.  
None of the stakeholders that have been consulted during the study have 
indicated any specific requirement or process for plant biostimulants or 
agronomic fertiliser additives. The state legal schemes are based on notification 
systems in which basic information on product composition and agronomic 
efficacy have to be submitted by applicants. Fees are low (< USD $ 1,000 and 
variable across states) and the regulatory processes seem to be fast 
(authorisation is generally granted within a 6-9 months period)29. 
In Canada, the “Fertilisers Act and Regulations” requires that all regulated 
fertiliser and supplement products must be effective and safe for humans, 
plants, animals, and the environment. They must also be properly labelled. The 
mandate of the Canadian Food Inspection Agency (CFIA)'s Fertiliser Program 
covers a wide range of products sold for agricultural, commercial, and home and 
garden purposes. Products include farm fertilisers, micronutrients, lawn and 
garden products as well as supplements such as water holding polymers, 
microbial inoculants, and composts. 
The Canadian fertiliser Act contains a definition related to “supplements” that 
could be considered as being PB&AFA which reads as follows: “any substance or 
mixture of substances, other than a fertiliser, that is manufactured, sold or 
represented for use in the improvement of the physical condition of soils or to 
aid plant growth or crop yields”.  
Supplements, subject to the authority of the “Fertilisers Act and Regulations”, 
are products that claim to aid crop yields. They include, but are not limited to, 
products that: 
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 See http://www.aapfco.org/ 
28 Federal legislations are in place regarding the production, use and disposal of fertilisers  
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 Enhance root or vegetative development; 
 Break dormancy; 
 Induce early germination or sprouting; 
 Condition soil; and 
 Contain vitamins with growth regulating properties. 
Most supplements are subject to registration and require a comprehensive 
pre-market assessment prior to their sale in Canada. Products that are exempt 
from registration are still subject to regulation and must meet all the prescribed 
standards at the time of sale. Companies that manufacture these products may 
approach the CFIA and request a voluntary pre-market assessment to verify that 
their products meet the requirements. 
The CFIA's pre-market assessment consists of a detailed, science-based 
evaluation of product safety information, efficacy, and labelling. To assess a 
product, the Agency requires that supporting information, which varies in scope 
depending on the nature of the product, is submitted. The basic supporting 
information includes the product label, the manufacturing method, and a 
complete list of ingredients and source materials.  
For certain supplements, additional information such as a detailed description of 
the physical and chemical properties of each ingredient, results of analytical 
tests that show freedom from biological and chemical contaminants, a 
toxicological data package derived from either laboratory studies or scientific 
publications, or data supporting product efficacy may be required. 
Efficacy assessments of fertiliser and supplement products can range from 
simple calculations, ensuring that the product delivers a sufficient amount of 
nutrients to satisfy plant needs, to highly complex statistical analysis of 
performance data generated from field or greenhouse trials. In all instances, the 
efficacy claims that appear on a product label must be supported by scientifically 
valid information and the product benefits must be substantiated in a clear and 
definite way. A variety of factors are considered by CFIA evaluators when 
evaluating product performance including product application rates, nutritional 
requirements of the target crop, usage pattern, frequency of application, current 
agricultural practices, appropriate statistical methods, research trial designs, and 
Canadian climate and soil conditions. 
Plant growth regulators may be subject to the authority of either the “Fertilisers 
Act” or the “Pest Control Products Act”, or both, depending upon the 
interpretation of the definitions in the two acts. 
Products containing only growth regulators, which carry mixed claims, are 
subject to registration under the Pest Control Products Act contingent upon 
acceptance of the supplement claims under the Fertilisers Act. All other products 
with mixed claims are subject to registration under the Fertilisers Act. 
According to stakeholders contacted during the study, the national competent 
authority seems to ask for more data when it relates to the registration of new 
supplements (PB&AFA) the data requirements. Trends are to ask for more 
toxicological and ecotoxicological evidences to the applicants.  
In South-Africa according to “Fertilizers, Farm Feeds, agricultural remedies and 
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application to the Ministry of Agriculture which includes basic toxicological, 
ecotoxicological and efficacy testing results. Any approved new product is listed 
in the national Register. There exists three product-types under which approved 
product will be listed.  
Most often, products are listed under the fertiliser product-category, as macro-
nutrients, or micro-nutrients. Minimum requirements are needed for specific 
nutrients. If the product analysis fulfils minimum requirements, no further data 
is required. Biostimulants are often enriched with nutrients to fulfil these 
requirements. 
Products may be listed as biostimulants where the active is seen as an extract 
that does not need to be quantified. Statistical significant trial data per crop 
needs to be submitted to support label agronomic claims. 
Finally, products may be listed as pesticide, usually under the category of plant 
growth regulators. In that case, the specific plant growth regulators need to be 
specified and quantified. Additionally the statistically significant trial data needs 
to be submitted per crop to support label claim.  
Applicants have to decide which information it considers necessary to submit. 
However, toxicology and ecotoxicology data might also be required by 
authorities, depending on the source of the plant biostimulant that may indicate 
a potential risk and on a case by case basis. If the source is known to be a food 
source, with no toxic inserts being added, these tests are normally waved. There 
is no predefined list of tests to be submitted.  
Brazil approach is very similar to that of Hungary where individual plant 
biostimulants products have to be registered based on the fertiliser acts. Data 
requirements are dossier specific. National competent authorities are used to ask 
for more information to applicants. These requirements include more and more 
toxicological and ecotoxicological evidences.  
The description of these regulatory national schemes shows that several 
regulatory approaches exist ranging from no intervention (free access to the 
market) to a pre-market authorisation on individual commercial products. 
Figure 2 EU & TC regulatory processes for placing of PB (and AFA) on the market 
 
Source: compiled by Arcadia International 
The main conclusions of this analysis in support to the definition of a legal 
framework for PB&AFA can be found in the introduction part of Section 3. 
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with tox&ecotox data 
requirements
Notification with data 
















A legal framework for plant biostimulants and agronomic fertiliser additives in the EU………………………………………………………………………... 27 
In more details, when considering a plant biostimulant the following processes, data requirements and costs apply: 
 
Table 4 Registration process and data requirements for placing of PB on the market at EU and TC levels 
Item 
EU Third Countries 
BE DE DK ES30 FR IT HU BR CA SA USA 
Process 
Simple notification   Yes Yes        
Notification with provisions of 
data 
Yes Yes        Yes Yes 
Data assessment/review Yes Yes No No Yes  Yes Yes Yes Yes  
Registration     Yes  Yes Yes Yes   
Time to authorisation Short Short Short Short >1year >1year >1year >1year >1year Short Short 




Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Analytical method No No No No No Yes Yes Yes Yes No No 
Manufacturing process Yes Yes No No Yes Yes Yes Yes Yes No No 
Toxicity data No No No No Yes Yes Yes Yes Yes No No 
Ecotoxicity data No No No No Yes Yes Yes Yes Yes No No 
Environmental fate data No No No No Yes Yes Yes Yes Yes No No 
Efficacy data Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Labelling requirements Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
            
Fees (in €) 
 1,500 400 200  6,000 3,000      
Average costs (in €) 
For applicant31 <10,000 <10,000 <2,000 <2,000 >30,000 >30,000 >20,000 >15,000 >15,000 <10,000 <10,000 
                                           
30
 Current situation 
31
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2.4 What can be learned from comparable EU regulatory 
frameworks? 
This section presents the results of Task 1 which was aims at reviewing several 
existing regulatory frameworks at EU level which apply to chemical 
substances/microorganisms comparable to the ones used as plant biostimulants 
and agronomic fertiliser additives. According to the ToR of the study, the aim is 
in particular to describe the data requirements as well as the administrative 
procedures established by these regulations with regards to risk assessment for 
human health and the environment, as well as the assessment of the 
efficiency/efficacy of these products. A comparison of the average time and 
related costs (for both authorities and applicants) needed for granting access to 
the market shall also be performed. 
On the basis of a proposal by the study team, the Commission validated the 
following list of regulatory framework to be analysed: 
 REACH (chemical products): Registration is a requirement on industry 
(manufacturers/importers) to collect and collate specified sets of 
information on the properties of those substances they manufacture or 
supply at or above 1 ton per year. This information is used to perform an 
assessment of the hazards and risks that a substance may pose and how 
those risks can be controlled. The amount of data required is 
proportionate to the amount of substance manufactured or supplied.  
 Plant protection products (PPP): Registration of PPP in the EU has 
been in place for more than 20 years now. The core legislation regulating 
the approval of PPPs on the EU market is Regulation (EC) No 1107/2009, 
directly applicable in Member States. Based on the predominance of 
health and environment protection over agricultural production, it sets 
EU-wide requirements for their placing on the market. Active substances 
are registered at EU level and corresponding commercial products at MS 
or zonal level. As the majority of plant biostimulants are of 
non-synthesised chemical nature, the study has focused on the analysis 
of the registration process for botanicals, plant extracts and low risky PPP 
products as well as for basic substances32. 
 Biocides (BPR): All biocidal products require an authorisation before 
they can be placed on the market and the active substances contained in 
that biocidal product must be previously approved based on the 
requirements of the Biocidal Products Regulation (BPR, Regulation (EU) 
No 528/2012). There are, however, certain exceptions to this principle. 
For example, existing active substances for which the review has not yet 
been achieved as well as biocidal products containing these active 
substances can be placed on the market while awaiting the final decision 
on the approval of the active substances. Provisional product 
authorisations for new active substances that are still under assessment 
are also allowed on the market. 
                                           
32
 Regulation 1107/2009 introduces the new category of "basic substances" which are described in 
recital as "active substances, not predominantly used as plant protection products but which may be of 
value for plant protection and for which the economic interest of applying for approval may be 
limited". On this basis, specific provisions are set to ensure that such active substances, as far as they 
do not have an immediate or delayed harmful effect on human and animal health nor an unacceptable 
effect on the environment, can be legally used in the EU after having been approved as "basic” under 
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 Cosmetics products (CoP): Free movement of cosmetic products in the 
internal market is permitted if they comply with the new Regulation (EC) 
No 1223/2009 (entry into force on 11 July 2013). A responsible person 
established in the Community shall be designated for each product placed 
on the market that shall ensure compliance with requirements relating to 
human health, safety and consumer information. They shall maintain a 
product information file accessible to public authorities. The Annexes of 
this Regulation give a list of prohibited substances (Annex II) or restricted 
substances (Annex III) with respect to use in cosmetic products. Certain 
colorants (other than those in Annex IV), preservatives (other than those 
in Annex V) and UV-filters (other than those in Annex VI) are also 
prohibited.  
 Food additives (FoA): Food additives are substances added 
intentionally to foodstuffs to perform certain technological functions, for 
example to colour, to sweeten or to help preserve foods. All EU food 
additives are identified by an “E” number and must be authorised before 
they can be used in foods. Authorisation by risk managers follows a 
thorough safety assessment carried out by EFSA. Once authorised, these 
substances are compiled in an EU list of authorised food additives, which 
also specifies their conditions of use. 
 Feed additives (FeA): Feed compounds can be freely marketed in the 
EU after being listed in an EU register. Individual commercial products are 
approved (holder authorisation) on the basis of a pre-marketing approval 
process managed by EFSA for risk assessment and by the SANCO 
standing Committee on animal health for risk management. All 
technological, sensory and nutritional additives have no holder-specific 
authorisations (they are registered based on the active substance they 
contain and not individually). Authorisations for zootechnical additives, for 
coccidiostats, histomonostats, as well as for additives consisting, 
containing or produced from GMOs are “holder-specific authorisations” 
(proprietary)33. 
This analysis has been based on a deep literature review (i.e. review of individual 
guidance documents for each registration process completed by interview(s) with 
relevant policy makers and business operators when required). 
Results have been compiled in an Excel Database which will be published 
together with the present report the analysis of which is presented below. 
2.4.1 General information 
2.4.1.1 Distribution of responsibilities and the actors 
The majority of the EU regulatory frameworks under analysis are under the 
responsibility of DG SANCO with the exception of the Biocides Products 
Regulation which is under the authority of DG ENV and REACH under the 
co-responsibility of DG ENTR and DG ENV. All regulatory approaches are based 
on clear distinction of risk assessment versus risk management, as follows: 
 
                                           
33
 See definition in Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 
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REACH registration Not applicable ECHA DG ENTR / DG ENV 
REACH authorisation ECHA ECHA DG ENTR / DG ENV 
PPP EFSA EFSA DG SANCO 
BPR ECHA ECHA DG ENV 
CoP DG SANCO DG SANCO 
FoA EFSA EFSA DG SANCO 
FeA EFSA EFSA DG SANCO 
 Source: Compiled by Arcadia International 
The EU legal procedures related to placing materials on the market engaged two 
specific EU bodies, authority in charge of the risk assessment (the risk assessor) 
and the body in charge of delivering the authorisation (the risk manager). 
Regulatory processes require the adoption of a scientific opinion by a risk 
assessor (EFSA or ECHA) that will be the scientific basis for the adoption of an 
EU authorisation by the risk manager. 
This implies that the authority in charge of risk assessment acts as the sole 
responsible for the adoption of a scientific opinion (independence of risk 
assessment from risk management). This split of responsibilities between risk 
assessment and risk management has been identified in each regulatory 
framework studied.  
In the specific area of pesticides (PPP and BPR), the authorisation procedure is 
partly decentralised and Member States play a major role in the preliminary 
scientific assessment of applications for authorisation. In these cases, 
applications for new active substances are being filed at MS level (rapporteur 
Member State, “RMS”) which is performing the first evaluation of the data 
package submitted by the applicant and EFSA is performing a peer-review of the 
RMS before providing conclusions to the risk manager.   
ECHA is fully dedicated to REACH and biocides regulatory processes (and Prior 
Information Consent-PIC Regulation34 as well). EFSA performs scientific 
assessment of applications35 submitted by applicants that want to obtain an 
authorisation to put a regulated product on the market.  
                                           
34
 Regulation (EC) No 689/2008 Publication made in accordance with Article 23 of Regulation (EC) 
No 689/2008 of the European Parliament and of the Council of 17 June 2008 concerning the export 
and import of dangerous chemicals 
35
 The sectors interested by authorisation applications to EFSA are the following 19:  
          1.       Plant Protection Products: active substances (PPP)                                                              
          2.       Maximum Residues Levels (MRL
35
 ) of PPP  
          3.       Genetically Modified Organisms (GMO)  
          4.       Flavourings  
          5.       Smoke flavourings  
          6.       Extraction solvents  
          7.       Food enzymes  
          8.       Food contact materials  
          9.       Food additives  
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Under the REACH authorisation process of substances of very high concern 
(SVHC) (annex XIV of REACH) that may cause some risks, a complete risk 
assessment is performed by ECHA that delivers an opinion and the regulatory 
committee of the Commission adopt a decision which is being published in the 
Official Journal of the EU. 
All EU authorities for risk assessment and risk management are supported by 
experts’ panels and standing committees, respectively.  




Expert groups  Committees  
REACH  Not applicable Regulatory Committee of Commission 
REACH 
authorisation 







PPP EFSA - PPR37 Panel DG SANCO – Standing Committee (incl. 
MS representatives 
BPR ECHA - Biocidal 
products committee-
BPC 
DG ENV - Regulatory Committee 
CoP DG SANCO - 
Scientific Committee 
on Consumer Safety 
("SCCS") 
DG SANCO – Standing Committee (incl. 
MS representatives 




DG SANCO – Standing Committee (incl. 
MS representatives 
 
                                                                                                                       
          11.      Feed additives  
          12.      Transmissible Spongiform Encephalopathy (TSE) tests  
          13.      Animal by-products  
          14.      Antimicrobial treatments  
          15.      Health claims  
          16.      Novel foods  
          17.      Infant formulae  
          19.      Food allergies (exemption from labelling)  
36
 The ECHA-SEAC Committee is in support of ECHA in formulating an opinion and is considering 
socio-economic criteria therefore this Committee could also be considered as part of Risk 
Management.   ECHA calls this activity: technical risk management. In some other areas where socio-
economic committees exits (e.g. GMO in the NL-COGEM or in France–HCB they are placed under 
RA bodies)  
37
 The Panel on Plant Protection Products and their Residues 
38
 The Panel on Food Additives and Nutrient Sources Added to Food  
39
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2.4.1.2 Structure of the legislations 
The structure of the legislations analysed in this study and the way they have 
been defined are based on two different approaches: 
 For all legislations under the responsibility of DG SANCO and DG ENV, the 
structural approach is based on the use of products/substances. 
Regulation are first organised per intended use regardless of the nature of 
the product. Each regulatory framework (PPP, BPR, FoA, FeA, CoP, etc….) 
includes a sub-categorisation of products/substances for which individual 
requirements for registration purposes may be asked. For example the 
PPP Regulation segments the active substances in 17 categories 
(insecticides, fungicides, etc…). The Feed Additives Regulation is 
composed of six different categories of use. This sub-categorisation has 
been designed in a flexible manner that allows modifications and 
re-organisation if/when required to adapt to scientific progress and the 
registration of new types of products. 
These legislations are based on a clear Risk Assessment and Risk 
Management approach in which the two activities are clearly separated 
and performed by different bodies.. In the majority of cases the 
products/substances are only placed on the market after a scientific 
review/analysis of the possible adverse effects of the product to food and 
human safety and to the environment (pre-market approval). Most 
commonly a risk assessment is mandatory. An exception to this approach 
is observed under the Cosmetic Regulation for which the authority in 
charge of risk assessment40 is under the authority of DG SANCO and is 
not included in any of the independent EU agency. 
 In the single case of REACH under the co-responsibility of DG ENTR and 
DG ENV a registration and authorisation procedures coexist. As the large 
majority of chemical substances are already marketed, a registration 
approach has been set-up in order to draw up an inventory of individual 
substances covered by the Regulation. For the most risky substances 
(e.g. SVHC) (based on their CLP classification)41 an authorisation process 
applies during which a complete safety assessment is performed. 
Restrictions of use of these more risky substances can apply.  
This concept of risk assessment (RA)/risk management (RM) is only about 15-20 
years old. In 1997, the Commission Communication on Consumer Health and 
Food Safety42 stressed the importance attached to securing the food safety and 
health of consumers. The risk assessment approach forms the foundation of 
scientific advice with regard to consumer health. Scientific risk assessment offers 
the regulator a sound basis for proposals and measures in the field of consumer 
health and food safety. 
There is at present a general agreement that risk assessment is best addressed 
in four stages, i.e. hazard identification, hazard characterisation, exposure 
assessment and risk characterisation. These four stages are key common 
elements between all regulatory processes under analysis even if this 
classification is not always fully visible in the individual risk assessment guidance 
documents. Differences have been identified in the way risk assessments are 
                                           
40
 Scientific Committee on Consumer Safety ("SCCS") 
41
 Detailed information available at http://echa.europa.eu/regulations/reach/authorisation/applications-
for-authorisation/authorisation-process 
42
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conducted by the different Scientific Committees and Panels. The observed 
differences may, to a certain extent, be explained by a series of factors such as 
the specific characteristics of the technological sector, the availability of 
information and data, or by historical, administrative, legislative or regulatory 
requirements which, in a number of cases, impose constraints on how the risk 
from a particular factor should be assessed. These factors impacts on the use of 
specific methodologies which may range in sophistication from basic algorithms 
to use of mathematical modelling and detailed prescribed procedures. 
This approach leads to the situation that the same product/substance/item will 
have to be registered independently via several regulatory frameworks if the 
business operator wishes to market it for several purposes. For example the 
benzoic acid substance is registered in several fields on the basis of individual 
sectorial authorisation/registration processes relying on the use claimed by the 
business operator. If the business operator claims to use the product/substance 
as a PPP, then it has to prepare an application for PPP, if it wants to market the 
same substance/product as a biocides, it will have to submit a separate 
application to the biocides registration authorities.  
Whilst in most cases it is rather simple to identify the regulatory framework to 
be followed, there are situations where the framework to be applied for placing 
products on the market is not that obvious. These situations have been 
described for the cosmetic Regulation where “borderline situations” have been 
described between cosmetics and toys, cosmetics and biocides, cosmetics and 
pharmaceutical products, and cosmetics and medical devices. In these cases 
specific guidance documents have been developed to help applicants in defining 
which regulatory route should be followed. 
These borderline situations are considered by the majority of the regulatory 
frameworks under analysis (see Table 7). In most cases, provisions on “dual 
use” are intended to address the case of products/substances which have a dual 
function, such as for instance biocidal products, which are used as both plant 
protection products and biocidal products.  
Table 7 Regulatory provisions related to dual use and borderline products 
Regulatory framework Provision 
European legislations 
REACH registration Not applicable: REACH excludes 
from its scope, substances 
already covered by the PPP and 
BPR regulations for respectively 
PPP and BPR uses only. 
REACH authorisation 
PPP Dual use provisions 
BPR Dual use provisions 
CoP Border line provisions 
FoA Dual use provisions 
FeA Dual use provisions 
    Source: compiled by Arcadia International 
For each case, detailed guidance on the interpretation of the provisions exist to 
allow applicants to clarify their approach to registration. 
As mentioned above, most of the regulatory frameworks under analysis have an 
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granted under sectorial EU regulatory frameworks will, in principle, be valid in all 
Member States subject to the same terms and conditions. For regulatory 
frameworks where the commercial product is registered at MS level (BPR and 
PPP43), there is no common understanding related to the “usage” of products. 
The way to define the uses typology is not harmonised at EU level leading to 
possible issues when addressing the placing to the market of commercial 
products via mutual recognition or the zonal authorisation for PPPs. 
Harmonisation work is ongoing in the PPP field (the European and Mediterranean 
Plant Protection Organization-EPPO has initiated some work leading to the 
development of comparative tables of use) and a recent technical guideline has 
been developed for BPR products44.  
2.4.2 Types of authorisation granted 
Risk managers grant two different types of authorisation: 
 Generic authorisation applies when the sectorial legislation foresees 
the granting of a generic authorisation meaning that all operators can 
use/produce/market the regulated product/ingredient/item/substance 
independently of who submitted the (first) application ;  
 Holder authorisation is granted in cases the legislation provides for an 
individual authorisation granted to a specific authorisation holder. This 
means that the applicant submitting the application is the single one that 
can produce/market the regulated product under the authorisation for 
which it applied. 
Table 8 Type of authorisation issued by legislative sector 
                                           
43
 Via zonal authorisation 
44
 Note for Guidance on the Definition of Similar Conditions of Use across the Union CA-Feb13-








REACH   X 
PPP  X 
BPR  X 
CoP X  
FoA X  
FeA (partly, < 20%)  X 
FeA (majority), >80%) X  
Other legislations (source: EFSA) 
GMO  X 
TSE tests  X 
Smoke Flavourings   X 
Recycling Plastic Processes   X 
Novel Foods   X 
Flavourings  X  
Extraction Solvents  X  
Food Contact Materials  X  
Animal by products  X  
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Source: Compiled by Arcadia and Commission working document45 
For the EU sector of feed additives the legislation foresees generic authorisations 
for most of the categories46, but individual authorisations called “brand specific 
authorisation – BSA” are delivered for 3 categories of feed additives 
(zootechnics, coccidiostats and histomonostats, representing roughly 14.5%47 of 
the applications/authorisations). It seems that this segmentation is the result of 
a compromise between the regulator and the industry. The regulator wanted to 
have generic authorisation only, when business operators (additives producers) 
favoured a holder authorisation approach. 
The latest EFSA annual reports mention that about 58% of the sectors applying 
to EFSA for the scientific evaluation of regulated products deliver a generic 
authorisation leading to the conclusion that there is about a 50/50 ratio between 
regulatory frameworks delivering generic authorisations and holder 
authorisations. Safety of products deriving from generic and holder authorisation 
is ensured by using similar schemes adapted to the nature of the product to the 
exception that for generic authorisation, any company can placed products on 
the market when for holder authorisation, only companies that have access to 
data can place products to market. 
2.4.3 What has to be authorised? 
The different sectorial regulatory frameworks under analysis define several terms 
as the basis of the registration process. While the definitions of these terms are 
rather homogeneous across regulatory frameworks, each of these frameworks is 
based on a specific approach. 
The main terms defining item(s) to be authorised are the followings: 
 Substance or active substance; 
 Material; 
 Source material; 
 Product; 
 Commercial product; 
 Preparation; 
 Mixture; 
 Compound, premixture; 
 Article (specific to cosmetic products). 
 
                                           
45
  Commission staff working document: Impact Assessment on the Revision of Regulation 178/2002 
laying down the general principles and requirements of food law, establishing the European Food 
Safety Authority (EFSA) and laying down procedures in matters of food safety on the establishment 
of fees for EFSA -  SWD(2013) 45 final 
46
 Substances belonging to the following categories of additives "technological additives", "sensory 
additives" and "nutritional additives". 
47
 Historical SANCO data. 
Health Claims  X  
Enzymes  X  
Nutrient sources  X  
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Table 9 Scope definition of the various sectorial legislations under analysis 
Regulatory framework Registration item 
REACH registration “substance” means a chemical element and its 
compounds in the natural state or obtained by any 
manufacturing process, including any additive necessary to 
preserve its stability and any impurity deriving from the 
process used, but excluding any solvent which may be 
separated without affecting the stability of the substance or 
changing its composition. 
“preparation” means a mixture or solution composed of 
two or more substances. 
“article” means an object which during production is being 
a special shape, surface or design which determines its 
function to a greater degree than does its chemical 
composition. 
REACH authorisation 
PPP “substance” means chemical elements and their 
compounds, as they occur naturally or by manufacture, 
including any impurity inevitably resulting from the 
manufacturing process.  
“preparations” means mixtures or solutions composed of 
two or more substances intended for use as a plant 
protection product or as an adjuvant. 
BPR “biocidal product” means 1) any substance or mixture, in 
the form in which it is supplied to the user, consisting of, 
containing or generating one or more active substances, 
with the intention of destroying, deterring, rendering 
harmless, preventing the action of, or otherwise exerting a 
controlling effect on, any harmful organism by any means 
other than mere physical or mechanical action Border line 
provisions or 2) any substance or mixture, generated from 
substances or mixtures which do not themselves fall under 
the first indent, to be used with the intention of destroying, 
deterring, rendering harmless, preventing the action of, or 
otherwise exerting a controlling effect on, any harmful 
organism by any means other than mere physical or 
mechanical action. 
A treated article that has a primary biocidal function shall 
be considered a biocidal product.  
“active substance” means a substance or a micro-
organism that has an action on or against harmful 
organisms.  
BPR Regulation defines 17 Product types (see annex of 
Regulation).  
CoP “cosmetic product” means any substance or mixture. 
“substance” means a chemical element and its compounds 
in the natural state or obtained by any manufacturing 
process, including any additive necessary to preserve its 
stability and any impurity deriving from the process used 
but excluding any solvent which may be separated without 
affecting the stability of the substance or changing its 
composition; 
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Regulatory framework Registration item 
FoA “Food additives” means any substance not normally 
considered as a food in itself and not normally used as a 
characteristic, ingredient of food, whether or not it has a 
nutritive value. 
“Substances” is not further defined in the basic legislation  
FeA “feed additives” mean substances, micro-organisms or 
preparations, other than feed material and premixtures, 
which are intentionally added to feed or water in order to 
perform, in particular, one or more of the functions 
mentioned in Article 5(3); 
“premixtures” means mixtures of feed additives or 
mixtures of one or more feed additives with feed materials 
or water used as carriers, not intended for direct feeding to 
animals 
    Source: compiled by Arcadia International 
All legislations provisions are based on the registration of fully characterised 
products/substances/materials. These legislations have initially been established 
for the registration of chemical items for which the molecular characterisation 
was established (synthesized substances). During the last two decades, several 
alternative types of products with different origins and not fully characterised 
have emerged, such as plant extracts substances referred to as botanicals in the 
PPP Regulation.  
The draft guidance documents on PPP botanicals clearly summarise the situation 
as follows: 
“Synthesized chemicals are based on chemical reactions whereas oils and 
extracts are manufactured by physically processing material of biological 
origin. The significant difference between botanical active substances and 
synthetic chemicals is the composition or specification. Synthetic 
chemicals can be produced in standardised processes resulting in 
repeatable purity ranges. The composition of a botanical active 
substance, however depends on the material of biological origin, the 
manufacturing process(es) and may depend on further processing. 
Therefore, botanical active substances have a larger variation in the 
qualitative and quantitative composition than synthetic chemicals. 
The production of substances of (living) biological origin depends on the 
climatic conditions, e.g. time of sunshine, rain, soil etc. and differs each 
year. Therefore, the nature and concentrations of substances vary 
naturally and affect the quantitative and qualitative composition of the 
extract/oil produced from the biological material. 
In addition, the way of processing the botanical active substance has an 
impact on the composition of extracted material which varies depending 
on the technique applied, e.g. cold-pressing, water-steam-distillation, 
extraction with (organic) solvents or a combination of several steps but 
always resulting in a complex mixture of several components. As a result 
of this, a botanical active substance of the same biological origin could 
have different compositions. Therefore, certain physical parameters could 






A legal framework for plant biostimulants and agronomic fertiliser additives in 
the EU………………………………………………………………………………………………………………. 38 
2.4.3.1 Who are the applicants? 
In the large majority of cases that have been studied, applicants are individual 
private business operators only. However in the case of food additives applicants 
can also be private bodies such as trade or other type of associations as well as 
Competent authorities (CA) from Member States. Individuals can also apply. 
For food additives and for REACH, the applicant can take the legal form of a 
consortia composed of several private or a mixture of public and private actors in 
the case of food additives. The applicant is then the consortium. All members of 
the consortium are allowed to market the product for which the consortium was 
built in case of successful registration. 
Table 10 Type of applicants per sectorial legislation 
Legislation 
Who may  apply for an authorisation as defined 
in the sectorial Regulation 
European legislations 
REACH  Any legal person established in the Community  
PPP 
1.  The producer of an active substance  
2.  An association of producers 
BPR 
1.  The producer of an active substance  
2.  An association of producers 
CoP Any legal person established in the Community  
FoA 
1. MS  
2. Interested parties   
     a) Collectively  
     b) Individually  
3 COM may ask EFSA on its own initiative 
FeA  
Any person established in the Community acting as the 
responsible for placing the product on the market 
Other legislations (source: EFSA) 
GMO Any person established in the Community 
MRLs for PPP and Biocides 
1.  The party who requested from a MS the 
authorisation for the use of PPP 
2.  All parties demonstrating a legitimate interest in 
health 
3.  Manufacturers, growers, importers and producers 
4.  MS 
TSE 
1.  Any natural or legal person, public or private body 
established within the EU   
2.  public or private body established within the EU 
Smoke Flavourings  Not specified  
Recycling Plastic Processes  Any person established in the Community 
Novel Foods  
“The person responsible for placing the product on the 
EU market" 
Flavourings  
1.  MS  
2.  Interested parties   
     a) Individually  
     b) Collectively  
3.  COM may ask EFSA on its own initiative 
Extraction Solvents  Not specified  
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Legislation 
Who may  apply for an authorisation as defined 
in the sectorial Regulation 
Animal by products 
1.  COM  
2.  MS (following an application)  
3.  Interested party which may represent several 
interested parties 
Antimicrobial treatments Not specified  
Health Claims Food Operators 
Enzymes 
1.  MS  
2.  Interested parties   
   a) Individually  
   b) Collectively  
3.  COM may ask EFSA on its own initiative 
Nutrient sources Not specified  
Food Allergies (exemption 
from labelling) 
Not specified  
  Source: compiled by Arcadia International  
 
2.4.4 The regulatory process and timing 
This process is in most cases specified within the relevant legislation. The 
workflow for authorisations linked to the different sectors are heterogeneous and 
involve different sharing of work and responsibilities among EU and national 
staff, EU risk assessors (EFSA or ECHA), Scientific Committee/Panels, Member 
States and the European Union Reference Laboratories (EURL).  
In most cases, the legislation provides for a detailed authorisation procedure 
including the procedural steps related to the risk assessment and risk 
management. The following common step procedure applies in the large majority 
of cases: 
 Step 1: Reception of the application dossier by the European 
Commission, the risk assessor (EFSA or ECHA), or one MS. In certain 
cases, applications have to be submitted to the risk assessor directly (e.g. 
under REACH, FeA); in other cases the application is sent to the European 
Commission that forwards it to the corresponding authority in charge of 
risk assessment (e.g. FoA). In a limited number of sectors (plant 
protection products), the procedure is de-centralised and involves a 
preliminary scientific assessment by a designated Member State risk 
assessment agency.  
 Step 2: Completeness check/compliance check/validation of the 
dossier is generally performed within a given period (about 30 working 
days) from the date of receipt of the application. This step involves a 
review of the dossier to check whether or not it includes all necessary 
information and documentation as prescribed by legislation.  
In case a dossier is considered not complete, the authority may contact 
and inform the applicant. The authority in charge of the completeness 
check may request the applicant to submit the missing or incomplete 
parts of the application dossier in order to fulfill the conditions of validity 
or may reject the dossier in the current form. The deadline for submitting 
the missing information is usually about 30 working days. However, this 
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A dossier is considered complete, and therefore the application 
considered valid, when it fulfills the requirements laid down in 
implementing regulations and further detailed in guidance documents.  
Once a dossier is considered complete, a statement of validity is sent to 
the applicant. The date of validity is the starting point for the scientific 
assessment of the dossier. In the majority of cases, the risk assessor 
make all information supplied by the applicant available to the risk 
manager and other bodies whenever required (MS, EURL for analytical 
methods, etc…) via electronic means (secured and confidential intranets). 
Under REACH the completeness check is performed by electronic means. 
An IT system (IUCLID) has been developed to automatically perform the 
completeness check. This completeness check does not go into details to 
verify whether or not the dossier contains all required information. 
Therefore a compliance check is performed on a limited number of 
registration dossiers (objective of 5% of the total number of registration 
dossiers). This compliance check has the objective of checking into details 
whether or not all required information is included in the dossier.  It is 
obviously more than an administrative control, as a first look on the 
quality of the data is performed to verify whether or not enough 
information is provided to perform the evaluation of the dossier. It is 
however not yet a scientific/risk assessment. This compliance check is 
performed by staff experts. 
 Step 3: Scientific evaluation of the dossier by the competent 
scientific committee or panel that the product/substance/ingredient 
meets the scientific requirements to allow its 
authorisation/registration/placing on the market. This scientific evaluation 
can take various forms and is generally performed at MS level or at EU 
level. However, depending on the sector, the scientific evaluation process 
foresees different sharing of work and responsibilities between RA's staff, 
RA's Panels, Member States and the EURL. Particular cases are, for 
instance, plant protection and biocides products where a Rapporteur MS 
carries out a preliminary risk assessment on active substances and in a 
second stage EFSA carries out a peer review. Timing for performing the 
scientific evaluation is always specified by legislations and ranges from 6 
to 9 months.  
During this process, the risk assessor may request the applicant to submit 
supplementary information. In that case, the deadline may be extended 
at the request of the applicant. The risk assessor decides on the 
acceptability of the extension requested based on justification given by 
the applicant and the nature of data requested. In other specific cases 
(e.g. PPP, MRLs, GMOs), the regulation does not stipulate to set deadlines 
for submitting missing data. In these cases, the request for additional 
information will “stop the clock” regarding the time limit assigned to the 
risk assessor. After the missing information has been submitted by the 
applicant the risk assessor has to incorporate it in a new revision of the 
evaluation report. The clock will be started again when the evaluation 
report is revised and completed with the additional information. This 
procedure can take place several times for the same dossier. 
 Step 4: Adoption of a scientific opinion by the competent body. 
After its adoption by the Committee in charge of the risk assessment, the 
opinion/conclusion is checked for editorial review and confidentiality 
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opinion/conclusion is commonly published within a given period from the 
date of adoption.   
 Step 5: Submission of this opinion/decision to the Risk Manager 
that takes the final decision of granting or not granting the authorisation 
to the applicant. Within a given period mentioned in the legislation (about 
3 months) of receipt of the opinion decision of the risk assessment 
authority, the risk manager (the Commission) shall prepare a draft 
proposal/regulation to grant or deny authorisation. When the draft is not 
in accordance with the opinion of the risk assessor, it has to provide an 
explanation of the reasons for differences. In exceptionally complex 
cases, the deadline may be extended. In the majority of cases, the 
Commission is assisted by representatives in the Standing Committees 
where all MS competent authorities are represented and where the 
decision of granting an authorisation or not is taken. 
 Step 6: Publication of the granting of authorisation in EU (and/or 
national) official journal (refusals are not published on the OJ but in the 
standing committee’s minutes which are available on the dedicated 
Commission websites and distributed to NCAs that are in charge of 
forwarding the decision to dedicated bodies (e.g. control bodies).  
This procedure applies in all cases when a pre-market approval is 
required. Steps 3 to 5 do not apply in case of procedure based on 
notifications (e.g. REACH registration).  
Under REACH the completeness check process comprises two distinct sub-
processes:  
 Technical completeness check: This process is aimed at checking the 
technical completeness of the dossier. The main purpose is to make sure 
that all required information has been provided. After being accepted for 
processing, each received dossier is screened for technical completeness 
using a specially created algorithm specific for each type of dossier, 
depending on the legal requirements. The system checks whether all 
required fields are filled and all testing proposals, derogation statements, 
waving statements etc. are included. In the case of a negative result, 
ECHA will verify the outcome of the completeness check to make sure 
that the decision is fully correct.  
 Financial completeness check: ECHA monitors the payment of the fee as 
specified in the invoice and consider the dossier to be complete only once 
the fees have been paid by the applicant. 
Once the registration is complete, the REACH IT system at ECHA automatically 
assigns a registration number to the registrant for the substance concerned and 
a registration date that will be the same as the submission date “retroactively”. 
Without delay ECHA communicates the registration number and date to the 
concerned registrant(s). From that moment onwards the registrant(s) shall use 
the registration number for the subsequent correspondence regarding 
registration procedures. Marketing authorisation of the product under REACH is 
granted.  
The registrant(s) may have to update his(their) registration as a consequence of 
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There are two main types of evaluation procedures, a substance evaluation and 
a dossier evaluation. The latter is further subdivided into an examination of any 
testing proposal and a compliance check of the registration dossier. 
Compliance checks evaluate the substance identity description and the safety 
information in the dossier including the chemical safety report or specific parts of 
the dossier, for example the information related to the protection of human 
health. 
In the targeted compliance checks, ECHA evaluates only a specific part of the 
registration dossier (e.g. either specific endpoints in IUCLID or in the chemical 
safety report (CSR)) based on a specified concern. This allows ECHA to target 
endpoints which are identified as relevant for the safe use of substances. Rather 
than evaluating the full dossier content at once, a part of the compliance checks 
will address targeted endpoints related to, for example, the persistent, 
bioaccumulative and toxic (PBT) or carcinogenic, mutagenic or toxic to 
reproduction (CMR) status of a substance.  
ECHA may identify shortcomings that are not necessarily related to a lack of 
information. For example, the risk management measures proposed by the 
registrant may be inadequate or the proposed classification and labelling may 
not reflect the reported study results. In these cases, ECHA sends a quality 
observation letter and invite the registrant to update the dossier. A quality 
observation letter may also be sent to clarify certain aspects of the dossier. 
ECHA informs Member States about these letters and on the response of the 
registrants. If the registrant does not clarify the issue, the Member States may 
initiate some processes, for example a proposal for harmonised classification and 
labelling. 
Following the compliance check, ECHA may conclude that additional testing or 
other information is required. In these cases, it prepares a draft decision to be 
sent to the registrant for comments. Based on the comments, the draft decision 
may be modified accordingly. The draft decision is sent to the Member States 
which can propose amendments to it. If any amendments are proposed, the 
issue is referred to the Member State Committee. All draft decisions made by the 
ECHA must be unanimously supported by the Member States and will only then 
become legally binding. The agency may combine issuing a draft decision by 
sending a quality observation letter. As a result of the targeted compliance 
check, registrants may receive multiple compliance check decisions to request 
additional information on the same dossier if it is found non-compliant for more 
than one information requirement. 
2.4.5 Data protection 
All the regulatory frameworks analysed as part of this study provide data 
protection provisions. Data protection duration varies across regulatory 
frameworks according to whether the data is in support of active substances or 
commercial products, whether the active substances are considered to be 
“existing” or “new” and the reason for submission. 
Based on specific sectorial provisions duration of data protection varies between 
5 to 15 years.  
Data protection is not a de facto acquis. Whilst under the REACH Regulation, 
data protection is provided quite automatically whenever a number of conditions 




A legal framework for plant biostimulants and agronomic fertiliser additives in 
the EU………………………………………………………………………………………………………………. 43 
For example in the PPP Regulation (EC) No 1107/2009 the applicant should 
annotate the listing of individual tests and study reports to indicate whether or 
not data protection is claimed (Article 59). Due to the fact that data protection 
claims are related to product authorisations a claim for data protection cannot be 
done at EU-level at the time of approval of the active substance. However, 
according to Article 7(4) "when submitting the application the applicant shall at 
the same time join……a list of any claims for data protection pursuant to Article 
59." 
2.4.6 Confidentiality 
Confidentiality is the non-disclosure of information which must be actively 
invoked and substantiated by the concerned party. It is the responsibility of the 
applicant to identify at the stage of application the section of the registration 
dossier it wants to keep confidential. Both EFSA and ECHA recommend 
applicants to keep this confidential part as short as possible. The legal 
framework for EFSA and ECHA often provides for transparency rules in 
combination with confidentiality rules. The balance between transparency and 
confidentiality rules is determined by the approach that the maximum amount of 
information linked to agencies’ activities is to be disclosed or made accessible to 
the public and that only the essential minimum shall be kept confidential. Any 
decision against disclosure needs to be based on a rule of law that grants 
confidentiality to specific information. Only those parts which are justified as 
confidential may be retained. It should be stressed that several regulations give 
the European Commission the exclusive competence to accept/reject 
confidentiality claims of third parties. In these cases agencies are bound by the 
outcome of such decisions by the European Commission.  
Possible justifications for confidentiality include48:  
 Commercial interests of a natural or legal person, including intellectual 
property;  
 Serious harm to the decision-making processes;  
 Protection of privacy and the integrity of the individual.  
The confidentiality level is maintained throughout agencies´ operations by 
ensuring that all individuals involved in these operations have committed 
themselves to confidentiality undertakings. Therefore, members of the Scientific 
Committee and Panels, their working groups and all agencies staff sign an 
individual declaration concerning confidentiality.  
2.4.7 Data requirements 
The analysis of the data requirements sections of the guidance documents of the 
various regulatory frameworks considered during the study shows a rather high 
level of consistency. Even if data requirements are sectorial regulation specific, 
all these guidance documents are structured on the same general format and the 
following test areas can be identified in nearly all regulatory frameworks based 
on safety assessment before authorisation (not the one based on a notification 
approach): 
 Identity and biological properties; 
                                           
48
 See details in  report “Transparency in risk assessment carried out by EFSA: Guidance Document 
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 Function, mode of action, and handling; 
 Physico-chemical properties; 
 Manufacturing, quality control, and analytical methods; 
 Residues; 
 Efficacy; 
 Toxicology, pathogenicity, and infectivity; 
 Ecotoxicology; and 
 Environmental fate 
Furthermore, when risks are identified and mitigation measures need to be 
proposed, most of regulatory frameworks require considering the “conditions of 
use” in the evaluation. “Condition of use” includes several criteria e.g. dosages, 
timing, targets, optimal conditions, restriction, etc…  
Specific major data requirements are substantiated below.   
2.4.7.1 Characterisation, composition, specifications, stability & homogeneity 
Each of the regulatory frameworks under analysis has developed guidance 
documents to allow the registration of non-fully characterised products. All these 
guidance documents present a quite similar approach: 
 Step 1: Applicants present substances on the basis of their chemical 
characterisation and provide their reference number (e.g. CAS number). 
In the case of products, the detailed and complete formulation is 
presented and the active substance(s) identified. Multiple information has 
to be provided (see Excel database available with this report). OECD 
guidance documents have been set up and are available to present the 
required information49. 
 Step 2: In case the chemical characterisation cannot be provided, the 
applicant is required to describe its substance/product on the basis of one 
or several markers.  
For example the characterisation of the cloves oil PPP active substance is 
established on the basis of the presence of a minima 60% of Eugenol (its main 
components). The other components are not defined. 
The fenugrec seed powder formely coded FEN560 has been listed as an active 
substance in the PPP Regulation 1107/2009. Its identity is defined as follows: 
Chemical name (IUPAC): None. The active substance is prepared from the seed 
powder of fenugreek (Trigonella foenum graecum L.), a leguminous plant. This 
product is a complex mixture of chemical substances. 
Minimum purity of the active substance as manufactured: 100 % fenugreek seed 
powder without any additive and no extraction; the seed being of human food 
grade quality.  
Three representative markers: trigonelline; 4-hydroxyleucine ; total proteins 50 
Chapter 4 of ECHA’s Guidance for identification and naming of substances 
under REACH provides a number of useful recommendations for 
substances of unknown or variable composition, complex reaction 
products or biological materials (UVCBs). Characterisation can be based 
                                           
49
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on the use of analytical methods (mainly chromatography and 
spectroscopy techniques) that are useful for generating useful data. For 
UVCBs substances the following key points are made:  
o For cases where spectral data provide information on the 
composition of the UVCB substance, such information 
should be supplied; 
o Chromatographic and spectral images that show a 
characteristic peak distribution pattern (i.e. fingerprints) 
can be used; 
o Valid constituent separation techniques might be used 
where appropriate; 
o The chemical composition and identity of the constituents 
should still be given if available. Information on chemical 
composition can be given on the basis of well-known 
reference samples and standards; 
o “It is the responsibility of the registrant to present 
appropriate spectral data”. 
In the case of the fenugrec seed powder, the following analytical 
techniques have been used: 
For the trigonelline marker: HPLC method with UV detection (265 nm). 
The principle of the method is a reverse phase chromatography (water 
(pH 3)/Methanol; 50/50; v/v) with a LiCrirosorb SI 60-5 column (250 x 
4.6 mm, 5 µm). A standard of trigonelline (batch number CGCR1-03) was 
used as external standard. 
For the total proteins marker: The analytical method was based on the 
Bradford protein assay. The reference item was albumine. The Bradford 
protein assay is a dye-binding assay based on the differential colour 
change of a dye in response to a concentration of a given protein. 
For the 4-hydroxyleucine marker: An analytical method using HPLC with 
visible detector (463 nm) was developed to quantify 4-hydroxyisoleucine 
in fenugreek seed powder. The principle of the method is a reverse phase 
chromatography (ammonium acetate 0.02 M in water/acetonitrile; 70/30; 
v/v) with a LC-18 column (250 x 4.6 mm, 5 µm). A standard of 4 –
hydroxyisoleucine was used as external standard. 
 Step 3: The identification and use of a marker is not possible when the 
raw material being used varies considerably in its composition. In these 
cases, applicants are required to provide the complete list of raw 
materials and the percentage of each one used during manufacturing. 
This lack of complete characterisation particularly happens for plants 
extracts as plant quality varies from crop to crop. Agronomic practices 
used in cultivating the source botanical material may influence the quality 
of the botanical active substance: sufficient information on method of 
cultivation should be provided and participate to the definition of the 
technical grade. As the botanical raw material may be from more than 
one source, all these sources should be adequately described including 
geographical origin(s) of material used, region(s), country(ies), 
area/site(s) of cultivation.  
The manufacturing process shall also be described and form part of the 
botanical active substance specifications. The following information is 
considered necessary for assessing the safety of plant extracts, including 
detailing quality assurance principles that are followed such as Hazard 
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o Information on the method(s) of manufacture (e.g. the 
process by which the raw material is converted into a 
technical grade, such as physical processes, extraction or 
other procedure(s). 
o Information on substances entering the manufacturing 
process, e.g. identity of any extraction solvent, stabilisers 
e.g. antioxidants, special precautions (light, humidity and 
temperature). 
o Details of any purification processes. 
o Standardisation criteria (e.g. see European 
Pharmacopoeia). 
With the exception of the CoP Regulation (see Annex II of Regulation (EC) No 
1223/2009), all other analysed regulatory frameworks do not list prohibited 
substances/products/items.  
Stability and homogeneity of the registered items have also to be demonstrated 
as follows: 
Table 11 Data requirements addressing stability and homogeneity of 
substances/products during registration processes 
Legislation Stability and homogeneity requirements 
European legislations 
REACH  In the context of substance identification only 
PPP  
No specific guidance documents for synthesised products 
Not specified in draft guidance documents for PPP botanicals 
BPR No specific guidance documents for synthesised products 
CoP 
Homogeneity of the test solutions with respect to the content of 
the test substance, under experimental conditions, should be 
provided. 
The stability of the test substance under the experimental 
conditions of various studies should be reported. In addition, the 
stability of the test substance under storage conditions as well as in 
typical cosmetic formulations should also be provided. 
FoA 
Following information should be provided: 
The chemical/physico-chemical stability of the food additive in 
its food additive preparation and under the conditions of storage and 
effect of storage temperature, environment [light, oxygen, moisture, 
relative humidity (water activity)] or any other factor that might 
influence the stability of the food additive preparation.  
• The chemical/physico-chemical stability of the additive during 
storage of the processed food: e.g. effect of the nature of the food to 
which the substance is added, processing temperature, pH, water 
activity or any other factor.  
• The nature and reactivity of any degradation products and nature 
of interaction/reaction of degradation products with food 
components.  
• Technologically intended reactions with food constituents and the 
resulting products in food. 
FeA  
The stability of each formulation of the additive, on exposure to 
different environmental conditions (light, temperature, pH, moisture, 
oxygen and packing material) shall be studied. Expected shelf-life of 
the additive as marketed should be based on at least two model 
situations covering the likely range of use conditions (e.g., 25 °C, 
60% relative air humidity (HR) and 40 °C, 75% HR) as required by 
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Legislation Stability and homogeneity requirements 
homogeneous distribution of the feed additive (other than flavouring 
compounds) in premixtures, feedingstuffs or water must be 
demonstrated as required by (EC) No 429/2008 
  Source: compiled by Arcadia International  
2.4.7.2 Human and environmental safety requirements 
As a preliminary remark it should be indicated that several limitations inherent in 
this type of analysis should be kept in mind when reviewing this section. This 
summary aims at providing a useful overview of data requirements but it cannot 
capture the complexity of all toxicological and ecotoxicological testing and the 
use of judgment that accompanies implementation of the data requirements. For 
both scientific and practical reasons, most regulatory frameworks exercise some 
flexibility in their acceptance of data and in their waiving of certain requirements 
in certain cases. This flexibility can be very large and in certain cases data 
waiving is largely used by applicants to reduce the costs of the application 
dossier.  
This summary can hardly reflect the complexity and uncertainty of the situation. 
Therefore this presentation has been limited to some key characteristics of the 
data requirement schemes and we invite the reader to look at additional 
information in the Excel Database and in the sectorial guidance documents 
developed by regulators. The majority of the guidance documents have been 
integrated in the above mentioned Excel DB available with this report. 
2.4.7.3 Guidance in support to applicants 
Most of the regulators in charge of the analysed regulatory frameworks have 
developed guidances for applicants in support of the preparation of the 
application/registration dossier. These guidances tend to be quite prescriptive 
and include detailed information. It should be noticed that two different type of 
guidance document co-exist: guidances from the Commission which are legally 
binding and the ones by the executive agencies which do not have any legal 
dimension. 
These guidance documents generally include references to the testing guidance 
documents, mainly OECD, to be respected. In general terms, it can be concluded 
that the various regulatory frameworks use the same OECD testing methods 
whenever available. For example acute toxicity has to be measured on a set of 
similar tests based on OECD guidances across regulatory frameworks. When 
providing technical reports/studies, other than the ones based on OECD guidance 
documents, the tests and analyses shall be conducted in accordance with the 
principles of Good laboratory Practice (GLP) laid down in Directive 2004/10/EC. 
However, studies referred to from available scientific literature do not need to 
abide by the GLP requirements.  
The draft guidance document for the registration of plant extracts in the context 
of the PPP Regulation51 specifies that the history of safe use of a plant 
extract/botanical in plant protection or for other purposes shall be adequately 
taken into account. This includes the use of information from “peer reviewed” 
                                           
51
 SANCO/11470/2012– rev. 5 3 08 May 2013  Draft guidance document on botanical active 
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open literature and from other reliable public sources. Data requirements to be 
fulfilled are discussed in a pre-submission meeting with evaluators of a 
competent authority.  
The CoP guidance documents are the only ones that provide guidance to 
applicant for alternative to animal testing. The majority of the other guidance 
documents do not refer to the objective of reducing animal testing. 
Guidance documents on the registration of non-synthesised products (PPP 
Botanicals, PPP basic substances) invite applicants to present safety judgements 
based on scientific literature in addition to test results. For these types of 
products, applicants are also encouraged to request a pre-submission 
consultation with the competent authority, particularly if they are not familiar 
with the regulatory system. The main objective of pre-submission meetings is to 
discuss the information requirements. Although the data requirements are laid 
down in legislative documents, applicants may need some guidance on how to 
interpret these data requirements and whether studies, published literature 
and/or a reasoned approach can be accepted. It is up to the applicant to submit 
the relevant information. EFSA (e.g. feed additives) and ECHA have established 
dedicated helpdesks which, among other tasks, provide advice and support to 
the processing of dossier submissions.  
2.4.7.4 Tier testing 
The following table shows whether regulators have chosen to use tier testing in 
their data requirements on a formal or case-by-case basis (where tier testing 
refers to the use of a stepped testing sequence, in which tests in higher tiers are 
required only if specified hazard levels were exceeded at earlier stages.)  
As seen in the following table, tier approaches are used in some limited cases 
only.  
Table 12 Safety assessment based on tiered approaches 
Legislation Toxicology Ecotoxicology 
European legislations  
REACH  No No 
PPP  No No 
PPP botanicals Decision tree but not based on a tier approach 
BPR Partly (see below) No 
CoP No Not applicable 
FoA 
The guidance describes a tiered 
approach which balances data 
requirements against the risk, 
taking into consideration animal 
welfare by adopting animal testing 
strategies in line with the 3-Rs 
(replacement, refinement, 
reduction)52. This tiered 
approach for toxicological 
studies consists of 3 tiers, for 
Not applicable 
                                           
52
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Legislation Toxicology Ecotoxicology 
which the testing requirements, 
key issues and triggers are 
described. A minimal dataset 
applicable to all compounds has 
been developed under Tier 1, 
while Tier 2 testing, generating 
more extensive data, will be 
required for compounds which are 
absorbed by human and/or 
demonstrate (geno)toxicity in Tier 
1 tests. Tier 3 should be 
performed on a case-by-case 
basis taking into consideration all 
the available data, to elucidate 
specific endpoints needing further 
investigation of findings in Tier 2 
tests. 
FeA  No 
Yes (2 tiers). First tier lists 
mandatory test to be performed 
based a decision tree approach.  
Threshold values for endpoints 
(PEC and PNEC) have been 
established to decide whether or 
not Tier 2 has to be performed.  
Source: compiled by Arcadia International  
As an example of the possible tier approach, the tier approach for PBR could be 
required for e.g. mixtures. The possible tier options could be: 
 Tier 0: 
o Mixture assessment necessary? (Product use, composition, 
suspected synergism?); 
o Possible additive effect of concern? 
 Tier 1 
o Multiple Action Factor (MAF) (in case of low data availability, 
default value=10); 
o Predictable Environmental Concentration /predictable no-effect 
concentration (PEC/PNEC) summation (use of the most sensitive 
species for each compound); 
o Testing with the product/leakage 
 Tier 2:  
o Concentration addition (single substance data based on the same 
test, same species and the same endpoint, same assessment 
factor; no need for full concentration-response curves at the first 
stage, possible to use the basis of only NOEC and EC50 values); 
 Tier 3: 
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o E.g. Independent Action (need for defining low-dose effects of the 
single compounds means high demand, costly, resource 
demanding). 
This description has to be seen as one example in many. The Tier approach is 
adapted to individual requirements. The multiple guidances documents 
developed for each regulatory frameworks presents the different possible 
approaches.  
2.4.7.5 Data waiving and bridging 
The data requirements as listed in the various guidance documents shall be 
regarded as a minimum set by applicants. However there are situations where 
data requirements can be waived. In principle waiving practices are accepted in 
the large majority of cases and probably in all regulatory frameworks. The 
research team has not identified any restriction or prohibition in using these 
waivers.   
Generally, waivers are considered when a data endpoint is not relevant to the 
chemical, such as not requiring an acute oral toxicity study when the chemical 
exists as a vapour or gas.  
Valid reasons for not submitting a complete core data set fall into the following 
categories: 
 The study is not technically possible to perform. In some cases the 
intrinsic physico-chemical properties of the substances or product are 
such that not all the core data sets can be performed (e.g. volatile or 
unstable substances) ; 
 Other existing data can be used instead of required data (bridging – see 
below) Information on a substance/product may be derived in certain 
circumstances from other sources. For example, it may be possible to 
read across from existing data when different salts are being used with 
the same basic substance ; 
 The study is not scientifically necessary. In some cases it is not justified 
to perform a study due to the intrinsic properties of the 
substance/product. For example if the water solubility of the product is 
less than 1 mg/l, surface water study does not need to be performed. In 
cases of no exposure, data may not be required. 
All waivers and non-submission of data for a given requirement have to be fully 
justified and sufficient explanation and evidences shall be documented in the 
registration dossier. Arguments should be supported by reference to appropriate 
data and a full list of the references cited should be provided to risk assessors. 
Any literature cited to support a reasoned case should be summarised in 
sufficient detail to determine the validity of the arguments presented. If an 
applicant refers to any literature owned by another company which are not in the 
public domain, they will be required to demonstrate that they are entitled to 
make use of the data, for example, by submission of a letter of access.  
Information on technical limitations detailed in test guidance documents should 
always be respected. For any data waiving, the onus is on the applicant to make 
the case for not generating new data. Applicants should base their case on 
scientific arguments or other information which demonstrates that the 
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on the commercial implications, but such concerns should not form the main 
basis of the case and can be tackled through a confidentiality claim. Safety 
remains the core concerns of waiving procedures.  
None of the guidance documents that have been analysed list a limit to the 
usage of waivers. If properly documented, any data requirement can be waived 
if the requirement is not clearly mandatory.  
Bridging refers to the use of an existing data set to characterise the hazard for 
another chemical for which there is little or no existing data. Generally, bridging 
can be supported when data already exist and then data do not need to be 
generated in each case. This option is not clearly mentioned in any of the 
analysed guidance documents. Some references are made on the use of other 
results when technical equivalence between a substance/product and a proposed 
substance/product is established and approved by risk assessors. Specific 
guidance documents exist in most of the regulatory frameworks for establishing 
equivalence when addressing fully-characterised (synthesised) 
substances/products53.  
2.4.7.6 Efficacy/utility: proof of the claim 
As described under Section 2.1, regulatory frameworks are being structured by 
and segmented per usage (sectorial regulations) with the exception of the 
REACH Regulation which considers the chemical nature of a compound as the 
pillar of the approach without considering efficacy. 
Hence all sectorial regulations require that applicants demonstrate the efficacy 
and/or utility of the product/substance they want to commercialise. 
Efficacy can be defined as the balance between positive effects - e.g. pest 
control for PPP, improved weight growth for FeA - and negative effects - e.g. 
direct crop damage, toxicity to targets, low tolerance level. As a net result, 
efficacy should be proven through an overall improvement in crop or animal 
production sufficient to justify the use of the substance/product. 
As a general trend, the EU regulator requests that applicants provide an 
increasing amount of information to prove the efficacy/utility of the product. For 
example there was no detailed consideration of the efficacy of new active 
substances under Council Directive 91/414/EEC related to PPP. Assessments 
were conducted almost entirely at Member State level within the Annex III 
“product” package (commercial product). Regulation (EC) No 1107/2009 now 
includes requirements related to the efficacy of an active substance54 as an 
active substance may only be approved if it shows to be “sufficiently effective”.   
                                           
53
 Examples: Guidance document on the assessment of the equivalence of technical materials of 
substances regulated under Regulation (EC) No 1107/2009. See 
http://ec.europa.eu/food/plant/protection/evaluation/guidance/wrkdoc23_en.pdf  




 Regulation (EC) No 1107/2009 Annex II point 3.2 states that ‘an active substance alone or 
associated with a safener or synergist shall only be approved where it has been established for one or 
more representative uses that the plant protection product, consequent on application consistent with 
good plant protection practice and having regard to realistic conditions of use, is sufficiently effective 
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2.4.7.7 Analytical method 
The provision of an analytical method is a key requirement in all analysed 
regulatory framework. A complete report on the development of the analytical 
method(s) should be documented in the registration dossier, as well as a 
description of the final method intended for use. The method should be practical 
for control purposes and applicable to the business sector for which the 
substance/product is intended. Details pertaining to the precision, accuracy, 
variability (reproducibility), and specificity of the method should be supplied.  
Wherever possible, the method should be subjected to collaborative study, with 
data and information supplied on variations within and between laboratories. 
This is the objective of the European Union Reference Laboratories.  
Among the regulatory frameworks under analysis, only the Feed Additives 
Regulation refers to an EURL. The EURL has to validate the method proposed by 
the applicant and becomes the official analytical method used by public and 
private operators. A reference sample has to be provided to the JRC-IRMM 
centre (Joint Research Centre – Institute for reference Materials and 
Measurements).  
The question related to characterisation and analytical methods for non-fully 
defined substances is being discussed at international level. For example, the 
OECD organised a seminar in 2012 addressing analytical methods for botanicals 
to be used as PPP. 
The report of this seminar55 explains that “plant extracts usually consist of a 
mixture of a wide range of chemical compounds. Natural extracts are very 
complex mixtures and can have huge variability. Therefore to characterise them, 
there is a need for: i) metabolomics approaches combined to bioassay leading to 
identification of biomarker or fingerprint, and ii) a bio-guided purification or 
semi-purification leading to the bioactive compounds identification.  
The question was asked whether the bioactive compound could be identified 
from such techniques. It was indicated that it was possible to establish a 
biomarker, but it might not necessarily be the bioactive compound. It was 
suggested that the required analytical technique only gives a method for quality 
assurance. It was pointed out that regulators ideally need to have techniques 
that completely characterise the active substance so that its potential negative 
effects can be identified, not only in terms of efficacy but also regarding the 
effects on non-targeted crops or living organisms. It was indicated that 
biomarkers have been used for some compounds. It was also suggested that 
there was a need for a harmonised approach. Therefore, regulators and industry 
need to discuss what is needed and what is feasible.”  
 
                                                                                                                       
uniform principles for evaluation and authorisation of plant protection products referred to in Article 
29(6).’ 
55
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2.4.7.8 Post authorisation requirements (monitoring, obligations related to 
quality control) 
Requirements for post authorisation monitoring or surveillance actions are rather 
limited. However, the following requirements can be found: 
Table 13 Post-authorisation obligations 
Legislation Post authorisation obligations 
REACH  
Authorities: Once new scientific findings suggest so, consider re-
assessing classification of substance and dossier update if applicable 
PPP  
Authorisation holder: In some cases the competent authorities of 
the MS of introduction may set in the authorisation certificate a 
condition for authorisation holders to conduct stewardship programs 
to monitor for instance the impact from the use of the product on 
groundwater. Such programmes are usually specified in the 
authorisation certificate issued by the competent authority and the 
results of such stewardship programmes should be communicated to 
the competent authority. Whenever there is an obligation in the 
authorisation of the reference product, such an obligation is applicable 
to the holders of parallel trade permits 
Authorities: Monitoring actions on the impact of use of pesticides to 
be established (obligations from Framework Directive 2009/128/EC). 
 
BPR 
See as for PPP when it relates to authorisation holders. 
In accordance with Article 18 of the BPR the Commission shall analyse 
how this Regulation contributes to a sustainable use of biocidal 
products and may propose to introduce monitoring monitoring actions 
by national authorities  
 
CoP 
Authorities: MS shall ensure that the competent authorities 
"cooperate in areas where such cooperation is necessary to the 
smooth application of the Directive". The area identified to bolster 
Member States administrative cooperation is market surveillance. 
Member States are responsible for the surveillance of their market. To 
that end, they should cooperate and exchange information, including 
information on serious undesirable effects attributable to the use of 
cosmetics.  
The market surveillance authorities of all Member States established 
the Platform of European Market Surveillance Authorities for 
Cosmetics, PEMSAC. The aim of this network is, in particular, to 
facilitate cooperation by: coordinating activities, exchanging 
information, developing and implementing joint projects, exchanging 
expertise and best practices in the field of cosmetics market 
surveillance. The members of PEMSAC are the representatives of 
market surveillance authorities of all Member States. They meet twice 
a year in plenary and in two technical groups dealing with market 
surveillance and analytical methods. 
 
FoA 
Authorities: Data on the normal use level are available from the food 
industry or from post marketing surveillance by food enforcement 
authorities in Member States. In principle, a normal use level is the 
average level of the food additive determined in a number of samples 
being representative for the food consumption a given European 
Member State. It is likely that within the European Member States 
different levels of food additives are typically found for the same food 
category. If so, the maximum reported use levels within the European 
Member States, or if available sufficiently representative data on the 
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Legislation Post authorisation obligations 
cases, normal use levels are expected to be lower than the maximum 
permitted use level in a food category. The Panel will not be able to 
conclude on the safety of a food additive if only quantum satis use is 
proposed since exposure estimates cannot be calculated in this case 
 
FeA  
In the case of substances that are recognised antibiotics and its use 
shown to select resistant bacterial strains, field studies to monitor for 
bacterial resistance to the additive have to be undertaken as part of 
postmarket monitoring. For coccidiostats and histomonostats, field 
monitoring of Eimeria spp. and Histomonas meleagridis resistance 
have to be undertaken. Marketing of products consisting of, 
containing or produced from GMOs also must include a proposal for 
post-market monitoring.  
 
Source: compiled by Arcadia International  
2.4.8 Cost of registration 
This section presents the results of the cost analysis aiming at evaluating the 
cost for registration of different existing EU and national regulatory frameworks.  
The following cost items are considered: 
 Fees for applicants ; 
 Cost for applicants ; 
 Cost for authorities, including risk assessment and risk management at 
both EU and MS level as applicable. 
The estimation of these costs per regulatory framework has proven to be difficult 
to achieve as many factors interfere with the per se “registration cost”, such as: 
 Complexity of the legal frameworks, cumulating the costs from various 
pieces of legislations;   
 Heterogeneity of the authorisation procedures with various sharing of 
work between risk assessors, risk managers, reference laboratories, 
experts panels, and Member States;  
 Number & content of dossiers for scientific risk assessment review 
received by the Commission is largely variable from one sector to 
another;  
 Member States and EURL already charge fees in the framework of the 
same authorisation process in certain sectors;   
 Different types of authorisation granted (generic and holder 
authorisations). 
For example, according to EFSA's Activity Based Budget (ABB), the share of the 
budget attributed to handling applications for the scientific assessment of 
regulated products in 2012 represents 30.2% of EFSA's total budget.  In 2012 
over a total budget of € 78.76 Million, € 23.78 Million was allocated to the 
scientific assessment of regulated products. The other tasks (e.g. writing of the 
guidance documents) are indirect support activities that could not be completely 
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2.4.8.1 Fees 
Within the analysed regulatory frameworks, only those where ECHA and the 
EURL operate apply a system of fees. Other regulatory frameworks have opted 
for financing through public funds in order to strengthen the independence of the 
assessment. 
The table shows the fees requested to applicants for regulatory frameworks 
under analysis. 
Table 14 Registration fees 
Legislation Post authorisation obligations 
REACH Registration 
Application: € 1,285 to € 33,201 / substance, depending on 
tonnage band and size of applicant's company. Reduction 
applies to SMEs and micro enterprises. 
Many other fees apply56  
However, application fees represent more than 90% of the total 
ECHA fees income57 
REACH Authorisation 
Application: Base fee € 53,300, may be higher depending on 
number of uses and applicants. Reduction applies to SMEs and 
micro enterprises 
Many other fees apply58 
PPP  Fees at MS level (see below) 
BPR 
Application:   
 a.s. : € 20,000 - 120,000  
 product : € 80,000  
CoP n.a. 
FoA n.a. 
FeA  n.a.  
Source: compiled by Arcadia International  
Furthermore for feed additives, the legal framework establishes fees for the 
validation of the analytical method via the community reference laboratory. Fees 
are paid in the framework of an application for authorisation for which EFSA 
performs a risk assessment but remunerates EURL's activity in relation to 
analytical aspects: validation of the analytical method to be used for the control 
of the substance submitted for authorisation (task falling outside EFSA's remit). 
The legislation specifies the exact amount of fees that the relevant EURL can 
charge according to the type of tasks performed. For feed additives, the 
maximum amount that can be charged by the EURL is € 6,000 with descending 
tariffs for simpler applications and applications for extension of use. There are 
also fees established at national level in the case of decentralised procedures 
where the competent authority of a Member State carries out a preliminary risk 
assessment that is peer-reviewed by EFSA. This is the case for plant protection 
products (active substances and MRLs).  
The amount of fees charged by MS also varies significantly from one to another. 
In the case of active substances for PPP for instance, the range of fees charged 
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by the reporting MS varies from € 23,100 to € 450,000. In the case of MRL of 
PPP, the range of fees varies from € 200 to € 15,000. Concerning novel food, 
some MS do not charge any fee. Where a fee is in place, it ranges from € 830 to 
€ 25,000. The Novel Food Regulation foresees the possibility of a simplified 
procedure. In this case, the amount of fees requested ranges from € 900 to € 
2,000. 
2.4.8.2 Costs of registration for applicants outside fees paid to authorities 
On the basis of interviews with several business operators and competent 
authorities, the following range of costs for preparing, submitting a registration 
dossier can be reported. These costs do not involve the fees paid to authorities 
Table 15 Registration costs for applicants 
Legislation Registration costs for applicants outside fees 
REACH Registration 
(for a natural plant 
based extract) 
Total cost for the consortium: € 120-150 K  
Costs per consortium member: € 28 – 35 K  
REACH Authorisation Substance specific: > € 700 K  
PPP  
Characterisation & analytical method:  € 50 (botanicals) to € 
500 K 
Tox: € 200 K to € 3-5 million  
Ecotox: € 200 K to € 3-5 million  (in case of residues trials) 
Efficacy: € 200 K to € 1 million  (including phytotoxicity trials)  
Dossier set-up & mgt: € 200-400 K 
BPR 
Characterisation & analytical method: € 100 to € 500 K 
Tox: € 200 K to € 3-5 million  
Ecotox: € 200 K to € 1-2 million  
Efficacy: € 200-500 K 
Dossier set-up & mgt: € 150-500 K 
CoP 
Characterisation & analytical method: € 100 – 300  K  
Tox: € 200 K to € 2-3 million  
Ecotox: Not applicable 
Efficacy: € 100 to 500 K 
Dossier set-up & mgt: 20% of the total cost for producing data 
FoA 
Characterisation & analytical method: € 150-300 K 
Tox: € 200 K to € 2-3 million  
Ecotox: Not applicable 
Efficacy: € 100 to € 500 K 
Dossier set-up & mgt: € 100 to € 250 K 
FeA  
Characterisation & analytical method: € 150-300 K 
Tox: € 300 K to € 2 million  
Ecotox: € 150 K if Tier 1 only, € 800 K for Tier 1 and 2 
Efficacy: € 100 K to € 1 million  
Dossier set-up & mgt: € 100 to € 250 K 
Source: compiled by Arcadia International  
As mentioned above, these figures are overall estimations that do not consider 
possible reduction due to the application of data waiving by applicants for low-
risk products (e.g. seaweeds and plant extracts in the case of PPP, cosmetics). 
In order to better estimate costs for applicants, we have considered the case of 
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Regulation. Our estimation leads to total costs for the applicant of between EUR 
350,000 and EUR 800,000 (see  Annex III). 
A plant based product has been registered under REACH for a total cost of € 30 
per consortium member (total cost of about € 150 K with 5 consortium 
members). 
2.4.8.3 Costs for authorities 
Very few data exist when it relates to the costs borne by the risk assessors (e.g. 
EFSA or ECHA or MS risk assessment agencies). DG SANCO made some 
preparatory work concerning the possible introduction of fees with regard to the 
processing of authorisation applications submitted by industry to EFSA and 
recently published an Impact Assessment report59. While highlighting that a 
significant effort was made to gather reliable and valid data through in-house 
data collection and surveys, limited data sets have been compiled. 
In this analysis, it is mentioned that RA costs range from about € 100-200 K to > 
€ 2-3 million (from reception of the application to the publication of the 
decision/opinion). Given the number and the heterogeneity of sectors covered by 
EFSA, it is logic that the evaluation of the cost of applications for EFSA has to be 
done sector by sector. It was necessary to break down all the activities required 
to assess the applications in order to identify the time required for each activity 
and quantify each related costs. It is important to mention that overhead costs 
and cost for general services, such as the development of guidances document, 
have been added to estimations presented in the following table.  
In the following table, we have added data collected for REACH and for national 
registration systems.  


























NEW REVIEW RENEWAL 
REACH   Operating expenditure for REACH (2013): € 24 Million   
PPP 75,000 31,000 75,500 31,000 / / 
BPR 
 ECHA 2014 budget for biocides: € 25 million, 100 staff for 80 opinions to be 
published in 2014, estimation of 300 opinions to be published in 2020 60 
FoA 77,500 1,600 120,000 1,600     
FeA  55,600 2,300 55,600 2,300 33,400 1,400 
Other legislations (source: EFSA) 
                                           
59 Commission staff working document regarding the Impact Assessment on the Revision of 
Regulation 178/2002 laying down the general principles and requirements of food law, establishing 
the European Food Safety Authority (EFSA) and laying down procedures in matters of food safety on 
the establishment of fees for EFSA. (available on the IA webpage of the IA Board of the Secretariat 
General). 
60




A legal framework for plant biostimulants and agronomic fertiliser additives in 

























NEW REVIEW RENEWAL 
GMO for 
cultivation 
135,000 76,600 135,000 76,600 / / 
MRLs for PPP and 
Biocides 
6,800 / 6,800 /   
Smoke 
Flavourings  
  37,800 / 37,000 / 
Novel Foods  83,100 5,900     
Flavourings    37,800 4,000   
Food contact 
Materials 
37,800 4,000 37,800    
Animal by 
products 
130,500 4,000     
Antimicrobial 
treatments 
113,400 10,000     
Health Claims 59,300 13,700 59,300 13,700   




49,400 /     
Source: compiled by Arcadia International and Commission staff working document 
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3 Approach to a legal framework for plant biostimulants 
and agronomic fertiliser additives  
This section of the report lists the data requirements for the future legislation 
related to the placing of PB&AFA to the market and presents the regulatory 
process to be applied.  
As a starting point and in order to set-up the scene for the proposed PB&AFA 
legislation the definitions of PB and AFA are presented and the main conclusions 
of the previous tasks are summarised. 
3.1 Setting the scene: definitions of plant biostimulants and 
agronomic fertiliser additives, and their regulatory 
environment. 
This introduction to the approach to a EU regulatory framework for PB&AFA 
proposes and justifies amended definitions of plant biostimulants and agronomic 
fertiliser additives in the perspective of the future regulation (section 3.1.1), and 
presents the main conclusions of Section 2 (business & regulatory context) in 
order to set up the scene and to place the proposal as regard the global business 
and regulatory environment (section 3.1.2).  
3.1.1 Definitions of plant biostimulants and of agronomic fertiliser 
additives in the future regulation 
The definitions of plant biostimulants and of agronomic fertiliser additives laid 
down in the terms of reference of this study have been commented in Section 
2.1. Revised definitions are now proposed and justified. 
For the purpose of the future Fertiliser Regulation, the following definitions are 
proposed: 
 A plant biostimulant is any substance or microorganism, in the form in 
which it is supplied to the user, applied to plants, seeds or the root 
environment with the intention to stimulate natural processes of plants to 
benefit their nutrient use efficiency and/or their tolerance to abiotic 
stress, regardless of its nutrients content, or any combination of such 
substances and/or microorganisms intended for this use. 
 An agronomic fertiliser additive is any substance or microorganism, in 
the form in which it is supplied to the user, added to a fertiliser, soil 
improver, growing medium with the intention to improve the agronomic 
efficacy of the final product and/or to modify the environmental fate of 
the nutrients released by the fertiliser, the soil improver or the growing 
medium, or any combination of such substances and/or microorganisms 
intended for this use. 
In the above definitions, substance means a chemical element and its 
compounds, as it occurs naturally or by manufacture, including any impurity 
inevitably resulting from the manufacturing process.  
The following categories of substances can be distinguished: 
 Synthesised substances, which are based on chemical reactions that 
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 Natural or botanical substances: substances which occur in nature; 
meaning naturally occurring substances as such, unprocessed or 
processed only by manual, mechanical or gravitational means, by 
dissolution in water, by flotation, by extraction with water, by steam 
distillation or by heating solely to remove water, or which is extracted 
from air by any means.61  
In the above definitions, micro-organism means any microbiological entity 
whose composition is defined in qualitative terms by the strain62 and in 
quantitative terms by the number of viable cells or spores expressed as colony-
forming units per gram of product. 
Table 17 Justification of the amendments to the definitions 
Definition of the 
ToR 












organism, in the 
form in which is 
supplied to the user, 
(…) or a combination 
of such substances 
and/or micro-
organisms intended 
for this use.” 
The word “material” is vague and is 
avoided in the amended definition, which 
now refers to substance, micro-organism 
and their combinations, in the form in 
which they are supplied to the user. This 
latter wording also makes clear that the 
regulated item is the product as supplied 
to the user. 
“…applied to plant 
or the rhizosphere, 
…” 
“…applied to plants, 
seeds or the root 
environment, …” 
“Seeds” are generally not understood as 
“plants”, but biostimulants might be 
applied as seed-coating material; the word 
“seeds” was added accordingly. 
Rhizosphere is too restrictive, as the 
rhizosphere is limited to the narrow soil 
area which is under the influence of the 
root activity. In order to cover possible 
application of biostimulants to e.g. 
growing media, “root environment” is 
preferred to rhizosphere. 






“Nutrient use efficiency” is a well-
established concept in the ecophysiology 
of plant nutrition, which covers the 
uptake, transport and use (assimilation) of 
the nutrients. It covers all plant 
physiological activities related with the 
                                           
61
 The REACH regulation (EC) No 1907/2006, refers to complex substances in the following terms : « 
UVCB substances (substances of unknown or variable composition, complex reaction products or 
biological materials) may be registered as a single substance under this Regulation, despite their 
variable composition, provided that the hazardous properties do not differ significantly and warrant 
the same classification ».   
62
 “Strain” takes here the definition of the OECD Working Document on the evaluation of microbials 
for pest control (OECD Environment, Health and Safety Publications – Series on Pesticides No. 43, 
ENV/JM/MONO(2008)36)  : “ a strain is a population of organisms that descends from a single cell 
or a pure culture isolate. Typically, it is the result of a succession of cultures ultimately deriving from 
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Definition of the 
ToR 
Proposals of this 
report 
Justification 
efficiency of nutrition, on which many 
biostimulants will act, and seems much 
appropriate in this context. 
“…and/crop 
quality…” 
“...” (deleted) “crop quality” is vague. Many plant growth 
regulators acting on plant development 
and metabolism will impact “crop quality” 
(desirable output traits), and these 
compounds, both natural and synthetic, 
are currently regulated as PPP in EU.  
  
3.1.2 Business and regulatory environments 
From the description of the business context, it can be highlighted that: 
 The plant biostimulant and the agronomic fertiliser additives businesses 
are two separate and different ones for the majority of  criteria (see Table 
3); 
 Both product types take place in the context of global agricultural policy 
which is to “produce more and produce better”. These two types of 
products also act on the protection of the environment as they help 
reducing the needs of chemical products; 
 The number of registration dossiers to be expected is difficult to estimate 
at this stage. EBIC has estimated that for its members only about 600-
700 PB registration dossiers will have to be prepared. The number of 
registration dossiers for AFA will be limited (less than 50) as most AFA 
substances are already included in Annex I of Regulation (EC) No 
2003/2003. 
The description of the MS & international regulatory schemes (focus on PB) leads 
to the following conclusions: 
 None of the studied regulatory frameworks defines the term “plant 
biostimulants” but substances/products can be placed on the market in all 
countries covered under the study; 
 Plant biostimulants are regulated either under the fertiliser acts or the 
plant protection products acts. In some cases by both schemes (e.g. 
Canada); 
 The regulatory process are highly variable ranging from free access to the 
market to a complete registration process that includes a risk assessment 
process and including a variety of notification procedures with or without 
data requirements (see Figure 2); 
 The different regulatory schemes ask for a detailed characterisation and 
identification of the substances but allow the application of non-fully 
defined/characterised substances. In the majority of the schemes under 
study the furniture of analytical methods is not a mandatory requirement;   
 Toxicological and ecotoxicological data are required only in few schemes 
(based on a complete registration process). However, none of the legal 
texts analysed lists the tests and study results to be provided. The 
regulatory schemes remain general in indicating that safety to human 
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management measures presented. It is of the applicant responsibility to 
present the data it considers necessary to this end; 
 Efficacy has to be demonstrated in all countries. Data requirements are 
preferably based on field trial data but efficacy can also be demonstrated 
by results from lab testing or other assays. Belgium has established a 
system which obliges applicants to demonstrate field efficacy preferably 
at the moment of the submission or later on when the provisional 
authorisation has been delivered as supplementing data to confirm the 
authorisation; 
 The most demanding schemes in terms of data seems to have a long (> 1 
year) and non-predictable data examination timing (from application to 
registration). 
The analysis of comparable existing EU regulatory schemes shows that: 
 Two types of EU regulation co-exist: REACH and the other regulatory 
frameworks based on a pre-market approval (the food safety 
frameworks); 
 These other regulatory frameworks have been developed in the 1960s. 
They are all based on the assessment of chemical substances. The 
majority of them have developed specific schemes and requirements for 
non-chemical products. However it can be observed that in a majority of 
cases, these adaptations are not perceived as fully satisfactory by a 
majority of stakeholders; 
 None of these two types of approaches can be considered as fully suitable 
for PB&AFA and a novel approach should be the preferred approach: 
o Designing a regulatory approach on the basis of REACH would lead 
to the impression that PB are dangerous chemical products when 
the majority of them are not of synthetised chemical nature; 
o Applying a pre-market approval system with an in-depth risk 
assessment procedure would lead to excessive costs for applicants 
(> € 500,000).    
 Several substances that are used as PB&AFA are already registered under 
other regulatory frameworks. These substances can be ranged in three 
categories: 
o Substances already registered under REACH for fertiliser and other 
usages; 
o Substances already registered notified at MS levels; 
o Substances authorised at EU level in another EU legislation (e.g. 
seaweed extracts in cosmetics, FeA) 
Provisions have to be defined in the EU PB&AFA registration scheme to 
secure avoidance of double registration. In any case, the PB&AFA 
regulatory scheme shall allow applicants to use existing data (data 
sharing and data bridging) in order to avoid repeating studies (especially 
animal testing); 
 All studied regulatory frameworks are risk based approaches that fully 
consider the business environment of each sector.  
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 Farmers are asking for alternative products to chemical substances and 
are willing to use PB&AFA together with the existing chemical products; 
 Historical data on the efficacy of PB and AFA indicates that it tends to 
vary considerably in time and space, raising some scepticism among 
users and scientists. However several PB substances such as raw dried 
seaweeds have been used by farmers as soil improvers and fertilisers for 
decades. 
3.1.3 Who are the applicants? 
For the purpose of the future regulation “an applicant” should mean any entity 
(e.g. business operators, consortia composed of industry companies, industry 
associations, users and users association, consultancy companies, individuals, 
etc…), regardless of whether it is situated within or outside the EU, which is 
interested in submitting an application.  
The list of type of entities that could be applicants has been considered as large 
as possible to consider the case of submission of applicants for substances and 
group of substances (e.g. agronomic fertiliser additives already listed in Annex I 
of Regulation (EC) No 2003/2003). It follows the definition of applicant according 
to food additives regulations. 
 
3.2 General principles  
Data waiving: The process of providing the data and information requirements 




According to the REACH guidance document on data waiving63, “waiving of the 
information requirements for a given end-point means that the submission of the 
standard information for this particular end-point is not considered necessary in 
a specific case or in case when testing is technically impossible, either due to the 
substance’s properties or to technical limitations of the test methods or when 
substance tailored exposure driven testing may be applied”. 
In any case of waiving, applicants have to explain the reason(s) why it is not 
submitting the expected results.  
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 ECHA – Practical Guide 4: How to report data waiving. Available at: 
http://echa.europa.eu/documents/10162/13655/pg_report_data_waiving_en.pdf 
Step 1 
•  Gather and share information 
Step 2 •  Consider information needs 
Step 3 
•  Identify information gaps 
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Bridging of information & related studies from similar materials should be 
encouraged by the future PB&AFA regulation but the relevance should be 
justified by the applicant.  
Figure 3 Approach to data bridging  
  
 
Argumentation and data justification based on history of use shall be fully 
considered by the regulatory authority. This includes the use of information from 
the open literature and from other reliable public sources. Several EU legislations 
consider the possible valuation/”re-use” of history of safe use data during the 
risk assessment (e.g. PPP botanicals, FeA, REACH) which can be summarised as 
follows64: 
 History of safe use in human nutrition (food or food additives e.g. spices 
or flavours, lecithin, rape seed oil) at similar concentrations may provide 
justifications to replace some or all oral toxicity and residue studies ; 
 History of safe use in animal feeding at similar concentrations may 
provide justifications to replace some or all oral toxicity and residue 
studies. 
 History of safe use in cosmetics may provide justifications to replace 
some or all dermal irritation/sensitisation and oral toxicity studies. 
 History of safe use in pharmacopoeia (called traditional use in this 
context) may provide justifications to replace toxicity studies in particular 
chronic ones; 
 History of safe use as a biocide may provide justifications to replace 
studies as above; 
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 Extracts from the draft guidance document on botanical active substances used in plant protection 
products – SANCO/11470/2012-Rev. 5 08 May 2013 
Applicant
Agency
Submission of a registration dossier in which 
data from other EU regulatory frameworks 
or/and based on international standards  are 
included (data bridging)
Check of technical  
equivalence by the 
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 Existing exposure assessments may provide justifications to replace some 
or all ecotoxicology and environmental fate studies, but these need to be 
verified case-by-case. 
Regarding micro-organisms, the concept of Qualified Presumptions of Safety 
(QPS) has evolved in the EU for the safe introduction of micro-organisms in the 
food and feed chains. QPS is an operating tool within European regulatory bodies 
for safety assessment and priority setting by focussing on those organisms which 
represent the greatest risks or uncertainties. Data on the history of safe use and 
on taxonomic similarity are used for granting the QPS status to microorganisms 
used in the food chain, making the evaluation more proportionate to the risk. 
QPS as a concept aims at providing a generic assessment system that could be 
applied to all requests received by EFSA for the safety assessments of 
microorganisms deliberately introduced into the food chain65. This QPS approach 
is similar to the GRAS (Generally Recognised As Safe) concept develop in the 
USA. Discussion on how to implement similar QPS strategies for the safety 
assessment of Botanical substances in the food chain is on-going in EFSA 
scientific committees.  
3.3 Data requirements 
This section of the report presents the data requirements to be proposed by 
applicants in their registration dossier. It is structured by considering the 
following needs: 
 Identification and characterisation; 
 Function and mode of action; 
 Physical and chemical properties; 
 Contaminants; 
 Manufacturing, quality control and analytical methods; 
 Efficacy/utility; 
 Toxicology, ecotoxicology and environmental fate. 
3.3.1 Identification and characterisation 
Applicants are required to provide a detailed description of the composition of 
the PB&AFA product(s) they want to register. The PB&AFA has to be fully 
identified and characterised. This description is of high importance for the safety 
analysis approach.  
This description in this section shall be based on the final product(s) for which 
registration is sought. In-house identifiers should be avoided unless already 
documented in open literature. In this case a statement is required to confirm 
that the identifier(s) refers to the product(s) for which the claim is made. 
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Further information on QPS in the two next references :  
- QPS – Qualified Presumption of Safety of Micro-organisms in Food and Feed. EFSA Scientific 
Colloquium Summary report, 2005, European Food Safety Authority;  
- Opinion of the Scientific Committee on a request from EFSA on the introduction of a Qualified 
Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. 
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In the case of preparations66, they must be described in the forms in which 
they are supplied to the user, as clearly as possible; all ingredients shall be 
described. A clear distinction between the substance(s) conferring the PB or AFA 
activity and the other ingredients shall be made, giving the proportion by weight 
in the final product. Within the substances conferring the PB or AFA activity, the 
active components (where relevant) shall be listed, giving the proportion by 
weight in the final product.  
If the active part of the preparation is a mixture of active substances (i.e. 
conferring distinct PB and/or AFA functionalities), each of which is clearly 
definable (qualitatively and quantitatively), the active substance(s) must be 
described separately and the proportions in the mixture given.  
A qualitative description of the active substance shall be given. This shall include 
purity and origin of the substance or agent, plus any other relevant 
characteristics (e.g. physical state of each form of the product).  
Chemically well-defined substances should be described by generic name, 
chemical name according to the International Union of Pure and Applied 
Chemistry (IUPAC) nomenclature, other generic international names and 
abbreviations and/or Chemical Abstract Service (CAS) Number. The structural 
and molecular formula and molecular weight must be included. Where relevant, 
data on isomeric forms and accompanying structurally related compounds should 
be included.  
Requirements for formulated products are similar to the ones that can be found 
in other EU regulatory frameworks (e.g. FeA, FoA, PPP, REACH, etc.).  
For PB&AFA products non-chemically well-defined the constituents 
contributing to the claimed effects should be identified whenever possible. By 
their very nature, these types of products can raise analytical challenges and 
their characterisation demands a somewhat different approach.  
Applicants are invited to perform identification tests that should be specific to the 
preparation and optimally should be discriminatory with respect to other 
products and substances that are likely to be marketed. The major components 
should whenever possible be identified, quantified and their range or variability 
provided.  
The approach for non-chemically well-defined products described for feed 
additives can be considered in the context of the PB&AFA future regulation. 
Guidance documents for feed additives indicate that: 
“For natural products – botanically defined, the characterisation should include 
the scientific name of the plant of origin, its botanical classification (family, 
genus, species, if appropriate subspecies and variety) and the common names 
and synonyms in official European languages. Synonyms in other language(s) 
should be given only if relevant to the place of origin. The parts of the plant used 
(leaves, flowers, seeds, fruits, tubers, etc.) should be indicated. The place of 
cultivation of the plant, the identification criteria and other relevant aspects of 
the plants should be indicated. Specifications of the applicant for any plant 
material supplied by a third party should also be provided. For complex mixtures 
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 A preparation is a product, as supplied to the user, containing PB and/or AFA substance(s) and/or 
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of many compounds obtained by an extraction process, it is recommended to 
follow the relevant terminology such as essential oil, absolute, tincture, extract 
and related terms widely used for botanically defined products to describe the 
extraction process. The major components shall be identified and quantified and 
their range or variability provided. The phytochemical marker(s) characteristic of 
the plant of origin must be included.”  
For natural products of non-plant origin, an equivalent approach of the above 
may be used. 
As proposed for UVCBs substances under REACH, for the production of 
phytomarker(s)/biomarker(s) characteristics, the main analytical techniques are: 
1) Chromatography 
a. Gas chromatographic techniques (GC-MS)  
b. Liquid chromatographic techniques(HPLC) 
2) Spectroscopy 
a. H and C NMR spectroscopy  
b. FR-IT and Raman spectroscopy  
c. UV-visible spectroscopy  
3) Other techniques 
a. Refractive index measurement 
b. Polarimetry 
c. Specific gravity measurement 
d. Titration 
e. Solubility in alcohol 
f. Evaporation residue 
This list shall be considered as illustrative and other analytical techniques shall 
be proposed on a case-by-case basis by registrants.  
In the case of natural products of botanical sources, the draft guidance 
document on botanical active substances used in plant protection products 
(SANCO/14470/2012-Rev 5) stresses the need for the applicant to further 
describe the raw material as follows: 
“For identification (taxonomy) of the botanical source and botanical preparation 
it is recommended to follow as much as possible the nomenclature of the 
European Pharmacopoeia. Additional nomenclature sources are as follows: World 
Checklist of Selected Plant Families (Royal Botanic Gardens, Kew); books by 
Peter Hanelt (e.g. Mansfeld’s encyclopedia of agricultural and horticultural crops 
(except ornamentals), Hanelt et al., 2001) also available on the Internet as 
Mansfeld’s World Database of Agricultural and Horticultural Crops; and the 
database by United States Department of Agriculture.  
If a scientific name is not found in any of the above-named references, its 
existence may be checked in The International Plant Names Index 
(http://www.ipni.org).Since there have been many instances where species have 
been reclassified or renamed, the same species may be known by different 
scientific names which should be quoted Common (vernacular) names may also 
be provided, but it should be noted that a common name used in one region to 
refer to a particular plant may be used elsewhere to refer to another quite 
unrelated species. Hence common names may not uniquely identify a species 
and are not as reliable as the scientific names. The following scheme summarizes 
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 Scientific name: full systematic species name including botanical family, 
genus, species, and where relevant variety, subspecies, author’s name, 
and chemotype; 
 Synonyms: botanical name(s) that may be used interchangeably with the 
preferred scientific name; 
 Common names: vernacular name(s); 
 Biogeography: region(s), country(ies), natural habitat(s); 
 Part of plant used: e.g. root, leaf, seed, fruit; 
 Growth stage(es) of plant used. 
Identification (taxonomy) of the botanical source and botanical preparation may 
in some cases be complicated. Taxonomic confirmation of species may need to 
be made by an independent botanical expert.” 
The same draft guidance highlights the importance of providing detailed 
information on the source of botanical material as follows: 
“It is common knowledge that plant quality varies from crop to crop therefore 
sample to sample conformity of technical grade is required. 
Also agronomic practices used in cultivating the source botanical material may 
influence the quality of the botanical active substance: sufficient information on 
method of cultivation should be provided such that it can be used as part of the 
definition of the technical grade. 
The botanical raw material may be from more than one source. The sources 
should all be adequately described including geographical origin(s) of material 
used, region(s), country(ies), area/site(s) of cultivation. 
Cultivation: 
 Wild harvest or cultivated, if cultivated, seed and cultivation material 
should be specified; 
 Ecology/habitat or cultivation practices; 
 Usual agronomic conditions; 
 Where relevant, plant protection measures. 
Harvest: 
 Time of year of harvest; 
 Growth stage at harvest; 
 Method of harvest and time to storage (e.g. including any drying in the 
field). 
Post-harvest storage: 
 Storage conditions prior to any primary processing (e.g. time, humidity, 
drying, temperature) of the material from harvest to processing. Details 
should be provided indicating how storage conditions will avoid growth of 
micro-organisms e.g. the humidity has not exceeded a maximal tolerance 
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Primary processing: 
 For plant material from more than one (cultivation) source: where 
relevant, sources of material will need to be described for their 
cultivation, harvest and storage (as above); 
 Preparation of material prior to any extraction (e.g. removal of seed pods, 
crushing, milling, etc.); 
 Conditions (e.g. time, humidity, temperature) of storage of the botanical 
material prior to manufacturing process. 
 
Figure 4 Approach to data bridging 
 
 
For micro-organisms used as PB  as indicated in the guidance on additives, 
“the microbial origin (bacteria, yeasts, filamentous fungi and micro-algae) of the 
additive (NB: mutatis mutandis PB&ABA) produced by fermentation/cultivation 
should be described and any history of modification of the production organism 
should be indicated. It should be clearly stated whether the microorganism is 
genetically modified or not within the meaning of the legislation (Directive 
2001/18/EC). The name and taxonomic classification of each microorganism 
should be provided, according to the latest published information in the 
International Codes of Nomenclature. Microbial strains should be deposited in an 
internationally recognised culture collection (preferably in the European Union) 
and maintained by the culture collection for the authorised life of the additive. A 
certificate of deposition from the collection, which should specify the accession 
number under which the strain is held, must be provided.”  
3.3.2 Function, mode of action 
Any evidences to demonstrate the function and mode of action of the PB&AFA 
product should be presented in details.  
These evidences can be based on scientific publications as well as on “grey” 
literature and/or history of use. They present the function(s) and mode(s) of 
action of the active substance(s) and their individual components (when 
identified), as defined in the characterisation section of the registration dossier.  
Registrants are also invited to include additional evidences from related 
substances/active components whenever relevant.  
Applicants are required to provide a short review of all these publications and the 
full text of each publication shall also be included in the registration dossier. As 
many substances, especially of the plant biostimulants category, show multiple 
Well defined substances Non well defined substances
Description of the 
formulation by presenting 
all chemicals on the basis 
of their CAS number (or 
any other identifiers)
Characterisation of the 
substance by the use of 2 
or more biomarkers
Identification of the substance by 
presenting :
   - All raw material being used
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modes of action on the physiology of plants, the scientific review should provide 
information on the effects related with the intended use of the product (the 
“claim”) but also on any other documented effects that would be unrelated with 
the claim but could be relevant from an agronomic, environmental, and safety 
point of view.  
This information shall be used by the Agency to verify that the PB&AFA 
substance falls under the scope of the appropriate law (e.g. to verify that the 
substance is not a PPP). 
3.3.3 Physico-chemical properties  
The physical and chemical properties of PB&AFA products have to be reported by 
the applicant in individual registration dossiers.  
The chemistry and specifications of a substance (or mixture of substances), in 
terms of chemical structure(s) and physico-chemical properties, is critical 
information required for safety assessment. Applicants are invited to provide 
information on the purity of a single substance that needs to be defined by 
specifications, and adequate chemical characterisation of simple mixtures needs 
to be performed, whenever possible. It may not always be possible to fully 
characterise more complex mixtures or substances of natural origin, but as much 
information as possible is required to understand the extent to which variability 
in composition is controlled during manufacture. Information on the 
manufacturing process is used during the safety assessment to identify 
impurities, reaction intermediates, and reagents that could have an influence in 
the evaluation.  
Depending on the nature of the product to be registered the requirements are 
rather different. The requirements which are listed below are inspired by REACH 
Annexes VII for the 1-19 t/year bands for fully synthesised chemicals and by the 
French guidance on the approval of fertilising materials (“guide pour 
homologation des matières fertilisantes et support de cultures”67). 
Table 18 Physico-chemical data requirements for synthetised chemical products 
Properties Conditions 
State of the substance at 20 °C 
at atmospheric pressure (1 
atm)  
Signed declaration by the manufacturer/company 
placing the product on the market  
Melting/freezing point  The study does not need to be conducted below a 
lower limit of minus 20°C. 
Boiling point  
 
The study does not need to be conducted:  
- for gases, or  
- for solids which either melt above 300°C or 
decompose before boiling. In such cases the 
boiling point under reduced pressure may be 
estimated or measured, or  
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Properties Conditions 
- for substances which decompose before 
boiling (e.g. auto-oxidation, rearrangement, 
degradation, decomposition, etc.).  
Relative density  
 
The study does not need to be conducted if:  
- the substance is only stable in solution in a 
particular solvent and the solution density is 
similar to that of the solvent. In such cases, 
an indication of whether the solution density is 
higher or lower than the solvent density is 
sufficient, or  
- the substance is a gas. In this case, an 
estimation based on calculation shall be made 
from its molecular weight and the Ideal Gas 
Laws. 
Vapour pressure  
 
The study does not need to be conducted if the 
melting point is above 300°C. If the melting point is 
between 200°C and 300°C, a limit value based on 
measurement or a recognised calculation method is 
sufficient.  
Surface tension  
 
The study needs only to be conducted if:  
- based on structure, surface activity is 
expected or can be predicted, or  
- surface activity is a desired property of the 
material. If the water solubility is below 1 mg/l 
at 20°C the test does not need to be 
conducted.  
Water solubility  
 
The study does not need to be conducted if:  
- the substance is hydrolytically unstable at pH 
4, 7 and 9 (half-life less than 12 hours), or  
- the substance is readily oxidisable in water. If 
the substance appears ‘insoluble’ in water, a 
limit test up to the detection limit of the 




The study does not need to be conducted if the 
substance is inorganic. If the test cannot be performed 
(e.g. the substance decomposes, has a high surface 
activity, reacts violently during the performance of the 
test or does not dissolve in water or in octanol, or it is 
not possible to obtain a sufficiently pure substance). A 
calculated value for log P as well as details of the 
calculation method shall be provided.  
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Properties Conditions 
 - the substance is inorganic, or  
- the substance only contains volatile organic 
components with flash-points above 100°C for 
aqueous solutions, or  
- the estimated flash-point is above 200°C, or 
- the flash-point can be accurately predicted by 




The study does not need to be conducted:  
- if the substance is a solid which possesses 
explosive or pyrophoric properties. These 
properties should always be considered before 
considering flammability, or  
- for gases, if the concentration of the 
flammable gas in a mixture with inert gases is 
so low that, when mixed with air, the 
concentration is all time below the lower limit, 
or  
- for substances which spontaneously ignite 
when in contact with air.  
Explosive properties  
 
The study does not need to be conducted if:  
- there are no chemical groups associated with 
explosive properties present in the molecule, 
or  
- the substance contains chemical groups 
associated with explosive properties which 
include oxygen and the calculated oxygen 
balance is less than -200, or  
- the organic substance or a homogenous 
mixture of organic substances contains 
chemical groups associated with explosive 
properties, but the exothermic decomposition 
energy is less than 500 J/g and the onset of 
exothermic decomposition is below 500 °C, or  
- for mixtures of inorganic oxidising substances 
(UN Division 5.1) with organic materials, the 
concentration of the inorganic oxidising 
substance is:  
o less than 15%, by mass, if assigned to 
UN Packaging Group I (high hazard) or 
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Properties Conditions 
o less than 30%, by mass, if assigned to 
UN Packaging Group III (low hazard).  
Note: Neither a test for propagation of detonation nor 
a test for sensitivity to detonative shock is required if 
the exothermic decomposition energy of organic 
materials is less than 800 J/g. 
Self-ignition temperature  
 
The study does not need to be conducted:  
- if the substance is explosive or ignites 
spontaneously with air at room temperature, 
or  
- for liquids non flammable in air, e.g. no flash 
point up to 200°C, or  
- for gases having no flammable range, or  
- for solids, if the substance has a melting point 
≤ 160°C, or if preliminary results exclude self-
heating of the substance up to 400°C.  
Oxidising properties  
 
The study does not need to be conducted if:  
- the substance is explosive, or  
- the substance is highly flammable, or  
- the substance is incapable of reacting 
exothermically with combustible materials, for 
example on the basis of the chemical structure 
(e.g. organic substances not containing 
oxygen or halogen atoms and these elements 
are not chemically bonded to nitrogen or 
oxygen, or inorganic substances not 
containing oxygen or halogen atoms).  
The full test does not need to be conducted for solids 
if the preliminary test clearly indicates that the test 
substance has oxidising properties. Note that as there 
is no test method to determine the oxidising 
properties of gaseous mixtures, the evaluation of 
these properties must be realised by an estimation 
method based on the comparison of the oxidising 
potential of gases in a mixture with that of the 
oxidising potential of oxygen in air.  
Granulometry  
 
The study does not need to be conducted if the 
substance is marketed or used in a non solid or 
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For other products, on the basis of the requirements found, in particular, in 
the French; Italian and Hungarian existing legislation the following physico-
chemical properties should be provided: 
 
Table 19 Physico-chemical data requirements for non synthetised chemical 
products 
Properties Conditions/examples 
Dry matter In % 
pH  
N, P2O5, K2O total Major nutrients 
CaO, MgO, SO3, Na2O, Cl total Secondary nutrients 
B, Co, Cu, Fe, Mn, Mo, Zn total Micro nutrients 
As, Cd, Cr, Hg, Ni, Pb, Se total Trace elements/heavy metals 
Chemical form of any other 
fertilising material present in the 
substance 
No3, NH4, Cyanamid for nitrogen, hydroxide, 
carbonate for CaO 
Any other element, ingredient or characteristic of which the applicant wishes to claim 
efficacy 
All substances used during the manufacturing process (e.g. solvents for plant extraction, 
etc…) 
Organic matter, organic N, C/N 
ratio, microbiological analysis 
For any product containing organic matters from 
animal or crop origin 
For liquid products, it shall be indicated whether the product is a suspension or a 
solution 
Species strain contained in the product68 (including its concentration, its viability, its 
WHO classification69)7071 (for micro-organisms) 
                                           
68
 No information should be required on “relatives” of the strain because there is significant variability 
among strains within a species, in part due to the difficulties that microbiologist have applying a 
taxonomic system designed for higher life forms to micro-organisms. See the separate EBIC-
commissioned paper on micro-organisms for more details.   
69
 WHO Risk Group 1 (no or low individual and community risk): a microorganism that is unlikely to 
cause human disease or animal disease  
WHO Risk Group 2 (moderate individual risk, low community risk): a pathogen or a microorganism? 
that can cause human or animal disease but is unlikely to be a serious hazard to laboratory workers, 
the community, livestock or the environment. Laboratory exposures may cause serious infection, but 
effective treatment and preventative measures are available and the risk of spread of infection is 
limited.  
WHO Risk Group 3 (high individual risk, low community risk). A pathogen that usually causes 
serious human or animal disease but does not ordinarily spread from one infected individual to 
another. Effective treatment and preventive measures are available.  
WHO Risk Group 4 (high individual and community risk). A pathogen that usually causes serious 
human or animal disease and that can be readily transmitted from one individual to another, directly or 
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This approach may not be applicable in all cases; therefore applicants are 
requested to add information whenever requested. Data waiving can also be 
used to justify the absence of some data. 
3.3.4 Contaminants 
Depending on the nature of the PB&AFA, different information has to be 
provided. For substances of mineral nature, trace elements/heavy metals criteria 
have to be considered when organic contaminants only apply on organic 
substances. Several test results on several batches have to be reported. As an 
example, Programme 108 requires 3 tests results on 3 different batches as a 
minimum requirement.   
Trace-elements/heavy metals 
The presence of heavy metals/trace elements shall be declared by the applicant. 
PB&AFA are generally applied at much lower rates than NPK fertilisers, so higher 
limits could be considered for these products than for other categories of 
fertilising materials according to the conclusions of the stakeholders consultation 
conducted by the Commission in 2012. At the same time, PB&AFA are applied to 
either soils or through foliar application, which have very different consequences.  
EBIC recommends using the following maximum limit values: 
 Cd: 3 mg/kg;  
 Cr: 2 mg/kg;  
 Hg: 2 mg/kg;  
 Ni: 120 mg/kg;  
 Pb: 140 mg/kg;  
 As: 60 mg/kg;  
 Cu, Zn, Se: No limits, but mandatory labelling only when non-negligible 
levels of the nutrients are present72. 
These higher limits are already in force in some Member States (notably France) 
and these limits are seen as sufficient under best available scientific knowledge. 
Organic contaminants: 
The following questions can determine whether testing is necessary to control for 
biological contaminants:  
 Can the nature of the raw materials and/or of the final product exclude 
the possibility of biological contamination?  
 Can the origin of the raw materials exclude biological contamination?  
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 See also articles 2, 3 and 18 of Directive 2000/54/EC.   
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 The American Biological Safety Association (ABSA) provides a useful database of how bacteria, 
viruses, fungi and parasites have been classified in a number of key jurisdictions around the world: 
http://www.absa.org/riskgroups/index.html.   
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 Do any steps of the production process or risk management measures 
prevent or eliminate contamination?  
One of the WG established in the context of the revision of the Fertiliser 
Regulation (WG3) has outlined a two-step process to identify the presence of 
organic contaminants, using markers in the first instance to reduce the costs of 
testing.  
1. Organic contaminants: PB&AFA manufacturers should be subject to these 
measures unless they can demonstrate either that the source of raw 
materials eliminations any risk of organic contaminants or that any such 
contaminants are effectively removed by the production process. This 
approach shall apply to: 




Tresholds for these contaminants are defined in the French guidances documents 
on the basis of maximum annual flow (in gram per ha) but only for products 
based on waste raw materials. They read as follows: 
 PCB: 0.3 max /form or 1.2 for all forms 
 Fluoranthen: 6.0 
 Benzo(b)fluoranthen: 4.0 
 Benzo(a)pyren: 2.0. 
2. Pathogens/microbials: (criteria suggested by WG3)73. 
 E. Coli 
 Salmonella: recontamination of product after manufacturing  
 Helminth eggs Ascaris: marker to validate any alternative efficient 
chemical processes to reduce biological risks  
A microbial analysis is required for any product likely to contain micro-organisms 
or allowing for their growth. Where the applicant chooses not to submit this 
analysis, it must be justified, for example, specifying that the pH renders 
microbial (re)contamination impossible, that production processes would destroy 
micro-organisms or that the product contains no ingredients of animal origin 
since the indicators in question are derived from Regulation (EU) No 1069/2009 
on animal by-products. 
3. Plant pathogens/diseases/invasive species 
With regard to the concerns for maintaining plant health inside the European 
Union as laid out in Directive 2000/29/EC74, manufacturers must demonstrate 
that any products containing plant-based raw materials have been verified to be 
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 Proposals for threshold available  at http://www.anses.fr/sites/default/files/documents/DPR-Ft-
MFSC-2013-08_0.pdf. Page 38. 
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 Council Directive 2000/29/EC of 8 May 2000 on protective measures against the introduction into 
the Community of organisms harmful to plants or plant products and against their spread within the 
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not containing any of the plant pathogens or diseases listed in the annexes to 
that directive or shall demonstrate that the manufacturing process of the raw 
material and/or final plant biostimulant eliminates any risk of contamination.  
Given the naturally occurring long-range mobility of micro-organisms, the soil 
micro fauna at diverse locations around the globe are very similar, with the 
greatest variations seeming to be the result of the effect of human interventions, 
such as long-term use of fertilisers. As a result, EBIC questions whether the 
concept of invasive species is valid for microbial life forms.75. 
This question related to contaminants being heavy metals for mineral products, 
organic for organic products or pathogens is being addressed in the majority of 
the EU and national regulatory frameworks for products comparable to PB&AFA. 
For example, the French “Guide pour homologation des matières fertilisantes et 
support de cultures”76» which addresses data requirements for registration of 
PB&AFA presents the list of criteria to be analysed. This guide demonstrates the 
complexity of the issue as requirements have been defined for several categories 
of products. The same approach is included in the Hungarian legislation.  
Further expert work is required for PB&AFA as it was done in the case of heavy 
metals for mineral fertilisers. 
3.3.5 Manufacturing, quality control, and analytical methods 
Manufacturing process 
The detailed manufacturing process shall be provided by the registrant. It will 
form part of the PB&AFA product specifications. 
The following information is considered necessary: 
 Information on the method(s) of manufacture. For botanical products, the 
process by which the raw material is converted into a technical grade, 
such as physical processes, extraction and other procedures shall be 
provided; 
 Information on ALL substances entering the manufacturing process 
(Applicants shall identify all these substances and provide all relevant 
MSDS); 
 Details of any purification process; 
 Details of any cultivation process (e.g. micro-organisms); 
 Standardisation criteria; 
 Detailed quality assurance principles such as Hazard and Critical Control 
Points (HACCP)77. 
                                           
See “Ensuring the safe use of micro-organisms in agricultural biostimulants: the false problem of 
invasive species” by Dr. Rolf Arnt Olsen Professor Emeritus in Terrestrial Microbial Ecology  FRAS 
Technology, Ås, Norway . Available at : http://www.biostimulants.eu/wp-
content/uploads/2012/10/Microbial_Safety_ROlsen_Final1.pdf   for more information on this issue. 
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 Detailed information available at http://www.anses.fr/fr/content/documents-dinformation-pour-les-
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The draft guidance document on botanical active substances used in plant 
protection products (SANCO/14470/2012-Rev 5) recommends the following 
approach for the description of any extraction process: 
“The yield of all physical processes or extractions is primarily driven by the 
content of those components which can be extracted. 
In the case of physical extraction (e.g. cold pressing, crushing, milling) the 
nature (mechanical, thermal or both combined) and exact process in particular, 
the temperature can greatly influence the final composition of the technical 
grade substance. Mechanical cold extraction is less likely to alter the original 
components than extraction with application of heat. Increasing heat may also 
considerably increase the proportion of less volatile components. 
In the case of extraction, the ability of the solvent to extract substances (polarity 
and capacity of dissolving the different components) is relevant. Where possible, 
solvent(s) for extraction should be selected that maximise the botanical 
substances required and minimise harmful components or combinations of 
components although it may not be possible to guarantee the final profile. 
The extraction solvent used for the extraction and even the total ratio of water to 
a water miscible organic solvent used for extraction, will affect the contents of 
components in the extract, any change may lead to different composition. 
Therefore, the method and solvents used should be clearly defined. 
Any repeated extraction of the natural source may lead to a significant increase 
in components which were not fully extracted in the previous extraction step. 
Therefore, the number of extractions, as well as the mass relation of natural 
source to extraction solvent in each step, has to be clearly defined. 
Further, processing e.g. concentrating or purifying of the primary extract to 
increase the efficacy may in some cases lead to higher or more specific efficacy. 
In case the component(s) responsible for the efficacy is/are identical to the 
harmful component(s) the harm will not increase in relation to the benefit 
(efficacy), the margin of safety remains the same. More usual is that, harmful 
components can reasonably be expected to be reduced in the extract. Therefore, 
the processing of the primary extract has a large influence on the toxicological 
and eco-toxicological profile and has to be done in a rather standardised way 
even if the component of the chemical composition cannot be clearly identified 
and followed up by chemical analysis. Any additional processing must be clearly 
defined. 
The extraction method is an integral part of the specification of a botanical active 
substance. 
It must be provided in sufficient detail to define the active substance. It is 
recognised that there is commercial sensitivity relating to this aspect so 
information about it should be provided in the confidential sections of the 
dossiers. 
If a plant extract from another extraction method is approved and considered 
equivalent, the 'extraction method' can be added to the review report 
(respecting the confidential parts, if relevant).” 
This approach shall be considered as a model for PB&AFA which are based on 
plant or botanical extracts raw materials as it seems to be the most detailed 
guidance that has been developed so far in this area. Additional work is still 
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Analytical methods 
Analytical data (laboratory data) are required for the determination of the 
ingredients, impurities, degradation products and residues in the commercial 
products in support to the quality control scheme. 
At least one validated analytical method78 should be provided for quality control 
of the product in commercial batches. Validation of an analytical method ensures 
that the results of an analysis are reliable, consistent and perhaps more 
importantly that there is a degree of confidence in the results. Method validation 
provides the necessary proof that a method is “fit for purpose” and works on the 
appropriate parameters.  
Analytical methods can rely on biomarkers in cases where the PB&AFA is non 
fully defined. The UVCB guidance document on “analytical characterisation of 
UVCBs for REACH”79 provides good recommendations on how to develop an 
analytical strategy for products of non-fully characterised nature.  
In case none of these two approaches fits, for example for PB&AFA characterised 
only by the description of the used raw material and of the manufacturing 
process, the applicant shall provide a quality assurance scheme that should 
guarantee that the quality and properties of the raw material are stable and that 
the same manufacturing process is always applied. 
The stability and homogeneity of the PB&AFA products shall be evaluated and 
described. The information requirement for establishing the stability and 
homogeneity during storage conditions is based on the identification of hazards 
which might arise from degradation of products.  
Appropriate information should be provided on: 
 The chemical/physical-chemical stability of the product in its commercial 
preparation and under the conditions of storage and effect of storage 
temperature, environment [light, oxygen, moisture, relative humidity 
(water activity)] or any other factor that might influence the stability of 
the preparation.  
 The nature and reactivity of any degradation products and nature of 
interaction/reaction of degradation products with food components.  
3.3.6 Efficacy/utility 
As mentioned under Section 2, proving the efficacy of a substance/product is 
increasingly becoming mandatory in the large majority of EU regulatory 
frameworks and in all analysed national and international regulations. Even for 
PPP active substances that are registered at EU level, efficacy data on one crop 
as a minimum are required. 
Additionally on the basis of discussions with farmers representatives, historical 
data on the efficacy of PB and AFA indicate that agronomic efficacy may 
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considerably vary in time and space, thus raising some scepticism among users 
and scientists. Therefore it seems justified that the future regulatory framework 
for PB&AFA develop data requirements that guarantee the agronomic efficacy of 
PB&AFA. 
In the other hand, some stakeholders consider that the efficacy should not be 
regulated but left for the market to decide, and that it is ultimately up to farmers 
to test whether a product fits the intended purposes. 
Finally, it shall be highlighted that many agro-climatic conditions may influence 
the agronomic efficacy of a PB&A. Requirements for agronomic claims 
justification shall consider such sources of variation.  
On the basis on this situation, two specific options are proposed for the 
establishment of data requirements related to efficacy. 
Option A: Applicants provide data showing that a positive biological 
activity and/or some field efficacy are observed ahead of registration 
AND mandatory post-registration field studies have to be carried-out to 
confirm efficacy.  
Applicants shall report on studies aiming at demonstrating the efficacy/utility of 
the PB&AFA products under optimal conditions of use80. Both the intended effects 
referred to as “claims” and any unintended effects (e.g. absence of 
phytotoxicity) will be presented in details.  
The design, methodology and protocols of the studies will be described with a 
level of details allowing external reviewers to evaluate the quality of the data 
and the conclusions drawn from it by the applicants.  
The FAO guidelines on efficacy evaluation for the registration of PPP81 should 
provide advice to applicants on how to set-up field trials. It is the responsibility 
of the applicant to provide all relevant information for a sound evaluation of the 
conclusions. As an example, in the case of biostimulants claiming an improved 
capacity for the plant to resist abiotic stress factors, this might include records of 
the environmental stressful conditions during the crop growing seasons. The 
studies should consider common crop growing and agronomic practices in the 
European Union.  
If performed outside the EU, the studies must permit conclusions to be 
extrapolated on the efficacy of the products when used in the EU. In any case, 
the number of growing seasons and the locations of the field trials shall be 
indicated and justified. 
Studies should be designed to demonstrate the efficacy of the PB&AFA under 
conditions of use that shall include: 
 Crops or group(s) of crops on which the efficacy of the product is 
claimed; 
 Dosage (any observed phytotoxicity range should also be indicated);  
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 Optimal conditions of use: timing, preferred crop stage, agro-climatic 
limitations of efficacy. 
These studies should not be limited to laboratory and greenhouse studies. 
Applicants shall provide field data due to the expected discrepancies between 
data from controlled (e.g. under laboratory conditions) and field conditions.  
Study results should be completed by any other evidences (e.g. scientific 
publications) whenever it substantiates the efficacy of the product in optimal 
conditions.   
In each registration dossier, a summary describing the efficacy/utility of the 
product shall be presented together with the study results.  
For obligations related to post-authorisation field studies, please refer to section 
3.4.3.6.  
Option B: Applicants shall provide a minimum data set showing efficacy 
of the PB&AFA in field conditions for crops and/or group of crops it is 
requesting registration. Under this option no mandatory 
post-registration field studies results are required. 
Under this option applicants are required to provide field studies results coming 
from multi locations and multi-year data. In total it is required to submit results 
from at least 4 locations over a minimum period of 2 crop cycles.  
As for Option A, the design, methodology and protocols of the studies will be 
described with a level of details allowing external reviewers to evaluate the 
quality of the data and the conclusions drawn by the applicants from the data.  
These field trials shall include a minimum of 4 replications and the registration 
item shall be compared, whenever feasible, to a product already in use on the 
targeted crop or group of crops 
It is the responsibility of the applicant to present evidences related to the 
efficacy of its product. The volume of data to be presented by the applicants 
depends on the claim and the conditions of use. Given the variety of possible 
effects, crops/crop groups and growing conditions, applicants need flexibility to 
define volumes of required data that are adapted to the specific situation. 
Furthermore, it should be recognised that with regard to products that improve 
the availability of nutrients (notably micro-organisms), soil types and conditions 
are often more relevant than crop types.  
As an alternative, EBIC has proposed a guidance document for determining the 
number of trials needed82. 
The applicant shall analyse and comment on the statistical significance and 
biological/agronomical relevance of all differences observed between treatments. 
Sources of variability will be described. 
Both options are already in place at national levels: Option A in BE, Option B in 
ES, FR, IT, HU which are the largest markets for PB. The Option B approach 
which has been in place for several years has not fully demonstrated its efficacy. 
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Table 20 Advantages and disadvantages of the two options for the data 
requirements related to PB&AFA efficacy 
Option Advantages Disadvantages 
A  Balanced workload before 
and after authorisation 
 Secure flow of information 
down to farmer via an 
information chain 
 Preferred options for 
farmers and several 
industry players 
 Reduce risks of lack of 
efficiency 
 Add credibility to the 
sector 
 Spread the registration 
costs over a longer period
  
 Risk of registering a product 
without knowing how it will 
behave under various soil-
climatic conditions and various 
use conditions. 
 How to protect the data (and 
for how long?) when they are 
provided after registration?  
B  May provide better 
knowledge of product 
efficacy for the 
registration process. 
 Difficulties for proving reliable 
efficacy before authorisation 
 Require the provision of multi-
year and multi-location field 
trials that will make the 
registration process longer 
 
The proposal for the future registration scheme for PB&AFA shall include 
provisions to grant authorisation for group(s) of crops. Registrant shall have the 
possibility to request authorisation to place PB&AFA on the market at EU level 
based on a group of crops rather than on a particular crop. When an applicant 
will seek registration for one or several group(s) of crops, it will have to 
demonstrate efficacy for the corresponding group(s) of crops. The demonstration 
of the efficacy shall then be based on a minimum of two different crops per 
group. Registrant will have to choose two crop species representative of the crop 
group in order to demonstrate efficacy of its product. The volume of field trials 
data to be reported under Option B remains similar to what has been described 
above. 
The possible grouping of crops reads as follows (based on a proposal made by 
French fertiliser industry to its national authority):   
 Annual crops  
o Vegetables: 
 Vegetable crops whose roots, tubers and bulbs are 
harvested  
 Vegetable crops whose leaves, stalks and fruits are 
harvested  
o Cereals  
o Fodder grasses and fiber crops  
o Leguminous, oleaginous and protein crops  
o Root crops  
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o Lawns  
 Perennial crops 
o Fruit and vine crops  
o Stone fruits  
o Nuts  
o Pome fruits  
o Small fruits  
 Ornamental trees and shrubs  
Aromatic plants are grouped with either vegetables or floral plants according to 
their agronomic interest. Tropical crops are either grouped with vegetables or 
fruit crops according to agronomic interest. 
3.3.7 Toxicology, ecotoxicology and environmental fate 
This section provides a baseline on data requirements for applications supporting 
the authorisation of new PB&AFA or modifications to an already authorised 
substance.  
It seeks to describe the toxicological and eco-toxicological test results which 
shall be used (in conjunction with other data requirements e.g. data on 
characterisation) to identify potential hazards. As mentioned above, applicants 
are invited to provide detailed information on the characterisation of their 
substance. This approach leads to a better identification of the potential hazards 
and related risks. 
PB&AFA can be of variable nature ranging from an extract of a natural source 
(e.g. seaweeds, plant extracts) which has not been chemically processed to a 
synthethised chemical product. Therefore it is important that product safety is 
approached by considering this variability of nature of PB&AFA. This 
consideration leads to the proposal of a modular approach based on 3 tiers which 
balances data requirements against risk (risk-based approach). 
The various application methods of PB&AFA (e.g. application to soil, spraying on 
leaves, coating to fertilisers, seeds, etc…) also have to be considered. The way of 
application directly affect exposure routes of possibly harmed organisms, which 
renders difficult a general approach that would take into account each existing 
PB&AFA. The most important exposure routes are considered below (worst case 
scenario) when selecting adequate toxicity tests. 
Additionally, applicants shall base their dossier on sound science and state of the 
art principles of safety assessment. Additionally, in order to avoid unnecessary 
testing and experimentation or double registration registrants should be able to 
cross-reference the risk assessments of the PB&AFA being registered, subject to 
the following limitations:  
 Data from evaluations carried out for the substance(s)/mixtures in any EU 
member state or OECD country in the context of approval of fertilisers, 
plant biostimulants, food additives, cosmetics, food, feed, 
pharmaceuticals, pesticides, biocides or other chemicals can be 
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use and reflects the proposed “good agricultural practice” (conditions for 
use). Technical equivalence shall be established. 
 Risk assessments carried out for a Hazard Analysis and Critical Control 
Point (HACCP) should be eligible to meet the criteria of the safety 
assessment under the future PB&AFA registry.  
Any reference to any existing data made by the applicant in its dossier shall be 
fully documented and reports shall be added to the PB&AFA registration dossier. 
A minimal dataset applicable to all PB&AFA has been developed under Tier 1 for 
which the testing requirements, key issues and triggers are described, whenever 
possible. Tier 1 consists of simple in-vitro toxicity tests.  
Tier 2 and 3 include higher levels where toxicity was identified under Tier 1 
testing. Tier 2 testing will be required on a case-by-case basis for products for 
which the toxicity and ecotoxicity end-points should be further specified 
according to the expert judgement of the notifying companies in first instance, to 
be confirmed during the compliance check by the Agency. A detailed technical 
guidance regarding the application of this principle shall be elaborated by the 
Commission to help the preparation of the dossier  
When some level of toxicity or eco-toxicity is demonstrated under Tier 2, Tier 3 
testing shall be performed in order to generate more extensive data.  
Tier 3 only applies to PB&AFA that are classified in at least one hazard class as 
per the CLP Regulation. 
Tier 2 and Tier 3 testing should be performed on a case-by-case basis by taking 
into consideration 1) the nature of the PB&AFA and 2) all available data, to 
elucidate specific endpoints needing further investigation of findings in Tier 1 
tests. Applicants are advised to design the actual testing taking into account 
physico-chemical data of the compound, toxicity data on structurally related 
compounds and any other relevant information. 
Inherent to the rationale of a tiered approach is the concept that results of 
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Figure 5 The human and environmental safety tier approach 
 
Source: Compiled by Arcadia International 
Methodologies to be used to produce the requested information per end point for 
the majority of Tier 1 and Tier 2 requirements can be found in the Guidance on 
the application of the CLP criteria – Version 4.0 – November 201383.  
For each requirement, the following consecutive steps shall be respected 
whenever possible: 
1) A literature review presenting a summary of scientific publications 
related; 
2) In vitro testing; 
3) In vivo testing. 
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For many organic substances, the testing and interpretation of data present no 
problems when applying both the relevant Test Methods Regulation (EC) No 
440/2008 and/or OECD Test Guidelines. There are a number of typical 
interpretational problems, however, that can be characterised by the properties 
of the substance being studied. These are commonly called ‘difficult substances’. 
Testing considerations for these substances can be found in the OECD specific 
guidance on aquatic toxicity testing of difficult substances and mixtures84. 
3.3.7.1 Tier 1 requirements 
Data requirements: 
As regards Tier 1, the following toxicological information shall be provided in 
each individual dossier. Data waiving justifications are not permitted under Tier 1 
to the exception of the acute inhalation toxicity. All these tests have to be done 
under Good Laboratory Practices by a lab having received this recognition by the 
appropriate authority. 
As regard to human toxicity, the following requirements apply: 
 Topical toxicity 
o Skin irritation means the production of reversible damage to the 
skin following the application of a test substance for up to 4 hours 
or skin corrosion means the production of irreversible damage to 
the skin; namely, visible necrosis through the epidermis and into 
the dermis, following the application of a test substance for up to 
4 hours. 
The in vivo test in rabbits according to OECD TG 404 is the 
standard in vivo test for the hazard assessment under many EU 
Regulations. The EU standardised B4 method can also be used. 
In recent years, the OECD has accepted new guidelines for in vitro 
skin corrosion tests as alternatives for the standard in vivo rabbit 
skin test (OECD TG 404). Accepted in vitro tests for skin 
corrosivity are found in the EU Test Methods Regulation (EC) No 
440/2008 and in OECD Test Guidelines (OECD TG):  
 The transcutaneous electrical resistance (TER; using rat 
skin) test (OECD TG 430)  
 Human skin model (HSM) tests (OECD TG 431)  
 The in vitro membrane barrier test method (OECD TG 435) 
Three in vitro skin irritation test methods based on reconstructed 
human epidermis (RHE) technology have been recently accepted 
by the OECD in the OECD TG 439. 
o Serious eye damage/eye irritation: Serious eye damage 
means the production of tissue damage in the eye, or serious 
physical decay of vision, following application of a test substance 
to the anterior surface of the eye, which is not fully reversible 
within 21 days of application. Eye irritation means the production 
of changes in the eye following the application of test substance to 
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the anterior surface of the eye, which are fully reversible within 21 
days of application. 
The in vivo OECD Test Guideline 405 is the most common test 
being used for eye irritation. It offers a stepwise testing strategy is 
described for the determination of the eye irritation/corrosion 
properties of substances.  
o Respiratory or skin sensitisation: Respiratory sensitiser means 
a substance that will lead to hypersensitivity of the airways 
following inhalation of the substance. Skin sensitiser means a 
substance that will lead to an allergic response following skin 
contact.  
Several testing methods exist. Council Regulation (EC) No 
440/2208 proposes the B.6 (Guinea Pig Maximisation Test – GPMT 
testing) and B.42 (Local Lymph Node Assay mouse testing) 
methods. Corresponding OECD methods are TG 406, 429, 422A, 
and 422B. 
The Mouse Local Lymph Node Assay (LLNA) (EU B.42 or OECD TG 
429) should be the first choice method for in vivo testing as The 
Local Lymph Node assay is considered a reduction and refinement 
method compared to the traditional guinea pigs tests since it 
provides advantages in terms of animal welfare. Other test 
methods should only be used in exceptional circumstances. 
Justification of use of other tests should be provided  
An additional test related to phototoxicity (photo irritation) is generally 
performed to complete the topical toxicity package. It is defined as a 
toxic response that is elicited after the initial exposure of skin to certain 
chemicals and subsequent exposure to light, or that is induced by skin 
irradiation after systemic administration (oral, intravenous) of a chemical 
substance [1]. If a chemical absorbs UV or visible light, it needs to be 
determined if it is likely to cause adverse phototoxic effects when 
intended for human use. 
In the context of PB&AFA, we consider that this test is not necessary as 
skin tests have already been planned and as exposure could be 
considered as low to very low. 
 Systemic toxicity 
o Acute systemic toxicity testing involves an assessment of the 
general toxic effects of a single dose or multiple doses of a 
chemical or product, within 24 hours by a particular route (oral, 
dermal, inhalation), and that occur during a subsequent 21-day 
observation period. Acute toxicity data are common requirements 
under many regulatory frameworks to provide classification and 
labelling warning or the possible consequence of exposure to a 
chemical. Substances that require classification and labelling 
include industrial chemicals (REACH Annex VII and VIII), biocides, 
pesticides, cosmetic ingredients.  
The hazard class acute toxicity is differentiated into: 
 Acute oral toxicity; 
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 Acute inhalation toxicity. 
There are no agreed in vitro methods. The following guidelines for 
in vivo methods are currently used: OECD 401 or OECD 420 or EU 
B.1 bis: Acute oral toxicity; OECD 402 or EU B.3: Acute dermal 
toxicity; OECD 403: Acute inhalation toxicity.  
Standard environmental toxicity and fate required for Tier 1 is: 
 Aquatic toxicity: Aquatic toxicity refers to the effects of a compound to 
organisms living in the water and is usually determined on organisms 
representing the three trophic levels, i.e. vertebrates (fish), invertebrates 
(crustaceans as Daphnia spp.) and plants (algae). 
o As a first step to evaluate aquatic toxicity we propose to limit Tier 
1 testing to: 
 Short-term toxicity testing on invertebrates (preferred 
species Daphnia) (OECD TG 202 or ISO 6341) 
 Growth inhibition study aquatic plants (algae preferred) 
(OECD 201 or ISO 8692). 
These studies does not need to be conducted if there are factors 
indicating that aquatic toxicity is unlikely to occur, for instance if 
the substance is highly insoluble in water or the substance unlikely 
to cross biological membranes. The long-term aquatic toxicity 
study on Daphnia shall be considered only if the substance is 
poorly water soluble. 
Specific additional requirements may be required by PB&AFA if their nature 
justifies it, such as in the case of micro-organisms. The exposure route to 
terrestrial organisms seems to be more relevant than aquatic organisms; 
examples for tests will then be: earthworms acute toxicity test (OECD TG 207), 
soil respiration85. Some substances might not even reach water bodies because 
they accumulate in the soil or are ”controlled” or do not survive the soil 
conditions before they reach groundwater or surface water bodies. 
Microorganisms’ viability may be targeted by soil respiration tests86. In these 
cases, it is proposed that applicants discuss directly with national safety agencies 
to see whether or not additional data should be provided.  
For micro-organisms, registrants are invited to provide additional information 
such as: 
o Soil microorganisms nitrogen transformation test (OECD TG 216), 
which aims at investigating the long-term effects of chemicals, after a 
single exposure, on nitrogen transformation activity of soil 
microorganisms.; 
o Soil microorganisms carbon transformation test (OECD TG 217) which 
aims at investigating long term potential effects of a single exposure 
of agrochemicals/non agrochemicals on carbon transformation activity 
of soil microorganisms.  
                                           
85
 There is for instance an OECD standard test (carbon transformation), see http://www.oecd-
ilibrary.org/content/book/9789264070240-en. Important to note that this in an example for a test with 
which one sum parameter is measured. With other tests / other endpoints, other parameters can be 
detected which also provide useful results. To be adapted on a case by case basis. 
86
 Soil respiration refers to the production of carbon dioxide when soil organisms respire. This 
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These two tests are the most common basic tests being used when it relates to 
microorganisms testing under several EU regulatory frameworks. 
Tier 1 expert judgement: 
On the basis of all study results applicants shall present an expert judgement 
and a justification why Tier 2 testing shall/shall not apply to the PB&AFA product 
under consideration. 
This expert judgement for assessing quantitative data will be presented in the 
form of a summary of the above mentioned test results first per test study and 
secondly across test studies.  
Then applicants are required to assess the possible risks of the PB&AFA under 
registration by considering exposure of the PB&AFA in qualitative terms.  
If predicted environmental concentration or environmentally relevant 
concentrations were found to be toxic in Tier 1, go to Tier 2. If not: stop 
assessment after Tier 1. 
Applicants are invited to substantiate their conclusions on the basis the Acute 
Toxicity Estimate approach for classification as described in Annex I of CLP, 
Table 3.1.1 should be used whenever possible.  
3.3.7.2 Tier 2 requirements 
Tier 2 requirements shall complete Tier 1 by the addition of systemic toxicity 
tests such as chronic toxicity tests (repeated dose). 
The assessment is based on the respective criteria and consideration of all 
available adequate and reliable information, primarily such relating to repeated-
dose tests (chronic toxicity) but also taking into account the general physico-
chemical nature of the substance. The most useful information is generally from 
animal studies, but information obtained using read-across from similar 
substances and from appropriate in vitro models can also be used, where 
appropriate. 
 Repeated dose toxicity (chronic toxicity) comprises the adverse 
general toxicological effects occurring as a result of repeated daily dosing 
with, or exposure, to a substance for a specified period up to the 
expected lifespan of the test species. The repeated dose study is an 
integral part of the data package produced to perform quantitative risk 
assessment (QRA) of industrial chemicals, cosmetic ingredients, biocides, 
pesticides, and pharmaceuticals. The point of departure most commonly 
used for systemic toxicity safety assessment is the NOAEL (Non-Observed 
Adverse Effect Level) which is used in the calculation of the MoS (Margin 
of Safety) or MoE (Margin of Exposure). 
Several in vivo repeated dose toxicity tests are available: 
o 28-day oral toxicity study in rodents (EU B.7 or OECD TG 407); 
o 90-day oral toxicity study in rodents (EU B.26 or OECD TG 408); 
o 90-day oral toxicity in non-rodents (EU B.27 or OECD TG 409); 
o Dermal toxicity: 21/28-day study (rat, rabbit or guinea pig) (EU 
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o Dermal toxicity: 90-day study (rat, rabbit or guinea pig) (EU B.28 
or OECD TG 411); 
o Inhalation Toxicity: 28-Day Study in Rodents (EU B.8 or OECD TG 
412); 
o Inhalation Toxicity: 90-day Study in Rodent (EU B.29 or OECD TG 
413); 
o Chronic Toxicity Studies in Rodents (EU B.30 or OECD TG 452). 
It is of the responsibility of the applicant to select the most appropriate test(s) in 
line with the nature of the substance and the conclusions of the Tier 1 expert 
judgment.  
Ecotoxicological studies shall lead to an expert judgment related to hazardous to 
the aquatic environment87. The aquatic environment is considered in terms of 
the aquatic organisms that live in the water, and the aquatic ecosystem of which 
they are part. The basis, therefore, of the identification of acute (short-term) 
and long-term hazards is the aquatic toxicity of the PB&AFA, although this shall 
be modified by taking account of further information on the degradation and 
bioaccumulation behaviour, if appropriate. 
 Repeated dose toxicity (chronic fish toxicity) should also be 
performed (long term exposure that covers life-cycle of the fish and 
determine No Observed Effect Concentration – NOEC, ECx).  
This endpoint shall start with a fish acute toxicity test (EU C.1 or OECD 
TG 203) which allows conducting a limit test, where fish are exposed to a 
single concentration (100 mg/L). If no mortality is observed at this 
concentration it is concluded that the LC50 is greater than 100 mg/L and 
in consequence the substance not toxic to fish. Then the chronic fish 
toxicity tests are not required. 
When chronic fish toxicity has to be performed, the following test 
study(ies) should be carried out: 
o Fish early-life stage toxicity (OECD TG 210); 
o Fish short-term toxicity test on embryo and sac-fry stages (EU C. 
15 or OECD TG 212); 
o Fish juvenile growth (EU C.14 or OECD TG 215). 
For each of these two set of endpoints, registrants shall select test study(ies) 
to be carried out on a case by case basis. Data waiving justifications are 
permitted. 
A second expert judgment (similar to the one described under Tier 1) shall be 
carried out at the end of the Tier 2 level and will complete the one done for 
Tier 1. If the conclusions of this analysis leads to the conclusion that the 
PB&AFA is subject to a minima one hazard classification (based on CLP 
Regulation), then Tier 3 applies. 
 
                                           
87
 In principle the assessment of ecotoxicity the substance should address all organism taxa as defined 
in the majority of the EU regulatory frameworks. However ecotoxicity to aquatic organisms should be 
the preferred approach whenever relevant exposure is observed. In other cases, soil toxicity may be 
more relevant, in particular if the substance is not exposed to fresh water nor marine water nor 
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3.3.7.3 Tier 3 requirements 
Tier 3 shall then be developed on a case-by-case basis. Applicants have the 
obligations to carry out additional tests on the basis of the identified hazard and 
to present a complete exposure assessment and mitigations measures. 
Registrants in that situation are invited to contact their national RA Agency to 
discuss about their strategy for the completion of this Tier. This strategy could 
usefully be discussed with ECHA at the end of the compliance check that will 
apply de facto to all PB&AFA reaching Tier 3. 
This Tier may include a large number of test studies and exposure analysis. 
Environmental fate criteria such as biodegradation, long term persistence in the 
soil and residues & metabolites in plants should also be considered whenever 
necessary.  
For ecotoxicity assessment, applicants are invited to justify their approach on the 
basis of the following steps: 
1) Consider most relevant exposure routes; 
2) Readily biodegradable: ( yes or no); 
3) Upon 1 and 2 decide which tests are relevant; 
4) Test concentrations that cover the predicted environmental concentration 
PEC; 
5) If only concentration several ranges above PEC are toxic in tests -> no 
further assessment needed -> no tier of higher level necessary. 
The environmental risk shall be identified by a comparison of the predicted 
environmental concentration (PEC) and the predicted no-effect concentration 
(PNEC) for a group of test species covering various parts of the ecosystem in 
question. The risk is assessed for as well the soil compartment as for adjacent 
freshwater systems. Data needed for the generic risk assessment includes data 
on physicochemical properties and ecotoxicological effect data for a group of 
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3.3.7.4 Summary of the toxicology, ecotoxicology and environmental fate data requirements 
Table 21 Summary of the toxicology, ecotoxicology and environmental fate data requirements 
 Test guidelines 
Expert 
judgement 





1) Human toxicity - Topical toxicity 
1.1) Skin irritation/corrosion 
OECD TG 430, 431, 
435, 439 
OECD TG 404 (M) Required Not permitted 
1.2) Eye damage/irritation  OECD TG 405 (M) Required Not permitted 
1.3) Respiratory/skin sensitisation   EU B.42 or OECD TG 429 (M) Required Not permitted 
2) Human toxicity - Systemic toxicity 
2.1)     Acute systemic toxicity testing 
2.1.1)  Acute oral toxicity 
No agreed method 
OECD 401 or OECD 420 or EU 
B.1 bis (M) 
Required Not permitted 
2.1.2)  Acute dermal toxicity OECD 402 or EU B.3 (M) Required Not permitted 
2.1.3)  Acute inhalation toxicity OECD 403 (M) Required Not permitted 
3) Environmental toxicity 
3.1)    Aquatic toxicity 
3.1.1)  Short-term toxicity testing on 
invertebrates (preferably Daphnia) 
 OECD TG 202 or ISO 6341 Required Permitted (justification 
to be provided) 
3.1.2)  Growth inhibition study aquatic 
plants (algae preferred) 
 OECD 201 or ISO 8692 Required Permitted (justification 
to be provided) 
3.2)  Soil toxicity (mainly for microorganisms) 
3.2.1)  Nitrogen transformation test 
 
OECD TG 216 Required 
Permitted (justification 
to be provided) 
3.2.2)  Carbon transformation test 
 
OECD TG 217 Required 
Permitted (justification 
to be provided) 
3.2.3)  Earthworms acute toxicity test 
 
OECD TG 207 Required 
Permitted (justification 
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 Test guidelines 
Expert 
judgement 





1) Human toxicity 
1.1) Repeated dose toxicity (chronic 
toxicity) 
 
One or several tests in the list 
below to be carried out 
Required Permitted 
1.1.1) 28-day oral toxicity study in rodents  EU B.7 or OECD TG 407  
1.1.2) 90-day oral toxicity study in rodents  EU B.26 or OECD TG 408 
1.1.3) 90-day oral toxicity in non-rodents  EU B.27 or OECD TG 409 
1.1.4) Dermal toxicity: 21/28-day study  EU B.9 or OECD TG 410 
1.1.5) Dermal toxicity: 90-day study  EU B.28 or OECD TG 411 
1.1.6) Inhalation Toxicity: 28-Day Study in 
Rodents 
 
EU B.8 or OECD TG 412 
1.1.7) Inhalation Toxicity: 90-day Study in 
Rodent 
 
EU B.29 or OECD TG 413 
1.1.8) Chronic Toxicity Studies in Rodents  EU B.30 or OECD TG 452 
2) Environmental toxicity 
2.1)   Repeated dose toxicity (chronic fish toxicity) 
2.1.1) Fish acute toxicity test  EU C.1 or OECD TG 203 (M) Required Not Permitted 
2.1.2) Fish early-life stage toxicity  OECD TG 210 Required Permitted 
2.1.3) Fish short-term toxicity test on 
embryo 
 
EU C. 15 or OECD TG 212 Required Permitted 
2.1.4) Fish juvenile growth 
 
 
EU C.14 or OECD TG 215 Required Permitted 
Tier 3 
Data requirements based on experts judgements from Tier 1 and Tier 2 (hazard identification). The possible list of tests and the data waiving 
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3.4 Registration process and responsibilities 
3.4.1 Authorisation procedure 
3.4.1.1 Pre-registration meeting & registration support 
Applicants are encouraged to request a pre-submission consultation with the 
helpdesk structure, particularly if they are not familiar with the regulatory 
system or don’t have clear view on how to classify their product(s) and which 
data to be generated and included in the registration dossier. The main objective 
of pre-submission meetings is to discuss the information requirements.  
Although the data requirements are laid down in legislative documents applicants 
may need some guidance on how to interpret these data requirements and 
whether studies, published literature and/or reasoned approach can be accepted. 
This approach is considered in several EU legislations and in particular in the 
draft guidance document on botanical active substances used in PPP and a pre-
registration helpdesk, managed by EFSA, exists for feed additives.  
This helpdesk structure should be available in each Member State to allow SME 
applicants to talk to local experts before submitting an EU dossier. One option is 
that this support is organised by the private sector (national fertiliser’s 
associations). Another option would be the national helpdesks which have been 
set up in the context of the REACH Regulation with their associated costs. 
3.4.1.2 Application 
An application “dossier” shall consist of: 
 An accompanying letter; 
 An administrative dossier including a checklist: the applicant has to fill 
in and submit the checklist in order to verify that the dossier is complete. 
The checklist shall be drafted in accordance with the model that shall be  
developed by the Commission as part of the Guidance for applicants; 
 A technical dossier that consists of all data required for risk assessment 
and the data required for risk management as well as all expert 
judgments required to conclude on the risk and on the efficacy 
assessment ; 
 A summary of the dossier. The applicant shall propose an overall 
conclusion on the safety of the proposed uses of the product. The overall 
evaluation of potential risk to human health and to the environment shall 
be made in the context of known or likely human and environmental 
exposure. Efficacy of the product in optimal conditions of use shall be 
demonstrated.  
Application dossiers shall be written in English.  
3.4.1.3 Data protection and data confidentiality 
Generating data to secure regulatory approval in sectors, such as the food safety 
and agricultural chemicals in which product safety and efficacy are of key 
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provide an incentive to undertake such data generation efforts by protecting 
their investment against so-called “free riders”. This protection applies via data 
protection and data confidentiality. 
De facto, data protection cannot extend to the complete dossier as e.g. public 
literature may be included to evaluate the safety and/or efficacy of a product. 
Article 59 of the PPP Regulation indicates the conditions under which data 
protection applies. Under REACH Regulation, data protection is automatically 
granted. 
The protection of data generated for regulatory purposes prevents from direct or 
indirect use of the data filed in support of a marketing authorisation by 
subsequent applicants seeking marketing authorisation for the same substance. 
The protection applies unless the subsequent applicant has obtained the consent 
of the first party that filed the data and obtained the original marketing 
authorisation. Data protection starts when authorisation is granted. Data 
protection does not have to be requested by applicants. It is granted 
automatically and applies to those parts of the dossiers specified in the 
Regulation.  
Protection is granted for a limited time, so that subsequent applicants can use 
the information free of charge after an appropriate period. It is proposed that 
data protection applies for a period of 20 years. Although the protection of 
regulatory data has its origin in laws regulating confidential information and 
indeed is addressed in the same article of the Agreement on Trade-Related 
aspects of Intellectual Property Rights (TRIPS) that mandate the protection of 
confidential information, it is a separate right subject to discussions in the legal 
experts’ community. 
As under similar regulatory frameworks (e.g. cosmetics, REACH, etc.) a data 
sharing mechanism shall be provided for if other applicants apply for a similar or 
equivalent substances.  
On the other hand, away from protecting the investment in studies through data 
protection, other submitted data may be deemed worth of protection by the 
applicant, notably for commercial reasons. Existing regulatory frameworks have 
expressly provided for the possibility to grant confidentiality to product 
compositions or manufacturer processes as they are the intellectual property of 
the company that has developed them. All information is not eligible for 
confidentiality. For example some information related to the hazard of the 
products has to be clearly mentioned on the Material Data Safety Sheet (MSDS) 
and on the product label to allow users to protect themselves against these 
hazards. This information cannot remain confidential and have to be made freely 
available to third parties. 
As for the majority of EU regulatory frameworks under analysis, provisions have 
to be defined in the future EU PB&AFA legislation to enable maintenance of 
confidentiality of data which goes beyond the above-mentioned MSDS. 
Applicants should have the right to request a confidential treatment of certain 
sections of their application dossier. It is the responsibility of the applicant to 
indicate which sections and data they wish to be treated as confidential and give 
justification for each part for which a confidential treatment is required. General 
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3.4.1.4 Submission of application registration dossier 
In order to reduce administrative burden, it is proposed that submission is 
performed by electronic interfaces. The IT tools that have been developed for 
REACH (REACH-IUCLID) should be further studied and a similar system should 
preferably be set up for plant biostimulants and agronomic fertiliser additives. 
Applicants will be required to submit their data via this IT portal of the 
responsible EU Agency (ECHA or EFSA).  
The submission of the registration file requires a number of practical steps with 
which the applicant should be familiar with before attempting it. Guidance 
documents shall be developed to support applicants during the process. 
In case of joint submission of data, each applicant shall be required to submit its 
own registration dossier for each of his substances but certain data will be 
submitted together. For a given “joint substance” all commercial product names 
shall be provided. 
The information submitted by the applicant in the IT system will have to be kept 
up-to-date and it will be of the applicant responsibility to update its information 
whenever required and communicated to relevant authorities whenever relevant 
(to be defined). 
Where applicable, application fees will have to be paid at the same time the 
application is submitted.  
When the dossier is complete, applicants will receive an electronic mail indicating 
that their application is accepted for processing.  
3.4.1.5 What happens after the application has been accepted for processing? 
All dossiers electronically submitted to the responsible Agency and accepted for 
processing shall undergo a completeness check in order to ensure they can be 
handled properly and that the required regulatory process as described below 
can be successfully carried out.  
Completeness check 
A completeness check will be performed for each application. This check aims at 
verifying the completeness of the dossier and will ideally include the following 
actions: 
1) Verification of whether all required fields are filled correctly and all testing 
proposals, derogation statements, waiving statements etc. are included;  
2) Verification that the substance falls under the scope of the Regulation and 
that it can be considered as a PB or an AFA; 
3) Verification that the substance categorisation proposed by the applicant is 
correct; 
4) Verification that fee payment (if occurs) has been received by the Agency 
administration. 
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 Option 1: The objective is to have a completeness check fully performed 
electronically and therefore actions 2 and 3 will have to be moved to the 
compliance check procedure; 
 Option 2: Completeness check is performed electronically for actions 1 
and 4 and manually by Agency staff for actions 2 and 3. 
Table 22 Advantages and disadvantages of the two options for the completeness 
check process 
Option Advantages Disadvantages 
1  Reduces workload and 
administrative burden 
 Quicker procedure  
 Actions 2 and 3 not performed on 
all substances as compliance 
check doesn’t apply on all 
registration 
 Possible wrong classification of 
substances 
 Possible insertion of a non PB & 
AFA in the Register 
2  Secures substances 
classification 
 Avoids that non 
PB&AFA substances 
are inserted in the 
Register 
 Requires involvement of expert 
staff 
 Longer procedure 
 
Where necessary, the Agency may request additional information from the 
applicant on matters regarding the validity of the application and inform the 
applicant of the period within which that information shall be provided. The 
Agency will set a reasonable deadline for providing the necessary missing 
information. This deadline will be dossier specific. 
When the application does not fall within the scope of the Fertilisers Regulation 
as outlined in the definition or when it does not contain all the elements required 
the application shall be rejected. In that the Agency shall inform the applicant in 
writing indicating the reasons why the application is considered not valid.  
The completeness check shall also be used to check the claim justification/proof 
of claim. Registrants shall provide enough evidences indicating that the proposed 
claim falls under the scope of the legislation (proof of claim). This has not to be 
confused with guaranteeing efficacy which is discussed later under this section. 
Completeness check shall be based on a check list document (evaluation form) 
that will have to be developed. It is proposed to follow the approach as described 
in document 1663/VI/94 rev. 8 of 22 April 1998, “Guidelines and criteria for the 
preparation and presentation of complete dossiers and summary dossiers for the 
inclusions of active substances in Annex I of Directive 99/414/EEC ( Articles 5.3 
and 8.2)”. Additionally this check list document should include the following 
requirements (on the following list is an extract from the above mentioned 
guidelines): 
Date: should be given as YY-MM-DD 
Information test/study provided: Four answers (yes, in part, no, not 
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Yes: The data or information are available 
at the time when the dossier is being 
submitted. 
In part: A part of the data is available in a 
physically prepared form but 
supplementary studies are still missing 
as well as possible justifications.  
No: There is no data or information 
available. This answer is also correct, if 
in column two (justification provided) 
the place of the justification in the 
dossier (e.g. Doc. MII) is given. 
Not relevant: – Data and information which would 
not be necessary owing to the nature 
of the substance/product or its 
supported uses are not provided, or 
- If it is not scientifically necessary or 
technically possible to supply 
information and/or data. 
=> Data waivers justifications 
Justification provided: If Y (=yes) the chapter in the 
application dossier shall be mentioned 
(e.g. Doc. MII). 
N stands for no. 
Undertaking provided: If Y (=yes) give date (YY-MM-DD).  
N stands for no 
The Agency will undertake the completeness check of a registration dossier 
within one week under option 1 and one month under option 2 of the submission 
date. 
Notification of registration 
After the completion of the completeness check, the Agency will notify the 
applicant of the outcomes of the completeness check. . 
This information will either include: 
 The grant of the registration and therefore the Agency will deliver a 
registration number which will then allow the placing on the market of the 
plant biostimulant or the agronomic fertiliser additive under the 
conditions specified by the registrant (i.e. conditions of use) and reported 
in a transparent way in the EU Registry. This Register will be updated by 
the Agency and the applicant will be informed of the registration of its 
substance(s) by electronic means (this letter will include the registration 
number to be indicated on the product label) but there will be no other 
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The registration will remain valid for a period of 10 years during which 
granted data protection and data confidentiality will apply. Registrations 
are renewable for 10-year periods (application for renewal sent to the 
Agency at least 1 year before expiration) 
 The refusal of the registration. In any case the Agency shall motivate 
the reasons for which the granting of registration has been refused. The 
product may then be included in a negative list88 by delegated acts. 
Figure 6 The registration process: from registration decision to notification 
 
The EU Register will take the form of a “catalogue” that will include several 
listings: 
 A positive list for plant biostimulants; 
 A positive list for agronomic fertiliser additives; 
 A negative list for plant biostimulants to be up-dated after the adoption of 
the appropriate delegated act by the Commission; 
                                           
88
 As a result of several consultations organised with Member States and stakeholders, the 
Commission has indicated that the future Fertilisers Regulation proposal would include as a safety net 
for fertilising materials and additives which cause concern for health, for the environment or which 
obviously do not deliver the expected functionalities, a negative list. The latter will be amended on a 
regular basis and could include total bans or restrictions for a specific or a group of fertilisers, soil 
improvers, growing media, plant biostimulants or agronomic fertilisers additives, on the basis of a 
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 A negative list for agronomic fertiliser additives to be up-dated after the 
adoption of the appropriate delegated act by the Commission. 
For each of the two positive lists, sub-lists (per category, functional group, type 
of product) may be developed if it helps the transparency of the information. 
Each list will include the following information89: 
 Product (in case of generic registration all commercial products linked to 
the generic authorisation shall be listed); 
 Registration number; 
 Category/functional group (if apply); 
 Registration type (holder or generic); 
 Registration holder(s); 
 Date of Registration/expiry; 
 Date of first registration; 
 Conditions of use (crop, dosage, recommendations of optimal use). 
The Agency shall be responsible for updating and maintaining the Register and 
the different lists.  The Register being electronic, it is considered that any 
changes can be automatically communicated to a list of bodies and individuals 
that have indicated their interest for being informed of these modifications. This 
approach would allow sending modifications to national competent authorities 
and any other relevant official bodies.  
3.4.1.6 What happens after the registration has been granted? 
Compliance check 
After registration decision and notification to applicants, the Agency may 
examine any dossier to verify if the information submitted by the applicant fully 
complies with the legal requirements. More precisely, compliance checks will aim 
at: 
1) Evaluate in details the substance identity description and the safety 
information in the dossiers; 
2) Assessing whether data waivers in Tier 2 and Tier 3 dossiers are well 
justified; 
3) Assessing the quality of the data sets and evaluating the conclusions and 
expert judgements made by the applicant; 
4) Actions 2 and 4 of option 2 of completeness check. 
The compliance check will not apply to all dossiers. Applications will be selected 
for compliance check on the basis of the following principles: 
 30% of Tier 1 dossiers will be selected randomly; 
 All dossiers where data required under Tier 2 and/or Tier 3 are presented; 
and  
                                           
89
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 A minimum of one dossier per applicant company will be selected for 
compliance checking. 
In the targeted compliance checks, the Agency shall first evaluate the overall 
dossier and then shall focus on specific parts of the technical dossier based on 
specific safety and efficacy concerns.  
The compliance check could lead to two main possible outcomes: 
1) There is no administrative action if the dossier is considered as compliant 
with the information requirements.; 
2) The compliance exercise may identify shortcomings that are not 
necessarily related to a lack of information. For example, the risk 
assessment data proposed by the applicant may be inadequate or the 
expert judgement may not reflect the reported study results. In these 
cases, the Agency will invite the registrant by written procedure to update 
and complete the dossier. When severe shortcomings are observed, the 
Agency may decide to delete the substance from the Register and 
therefore to withdraw the registration. 
Following the compliance check, the Agency may conclude that additional testing 
or other information is required (e.g. modification of the mitigation measures). 
In these cases, the Agency prepares a draft decision to be sent to the applicant 
for comments. Based on the replied comments, the draft decision may be 
modified. The draft decision is sent to the Member States which can propose 
amendments. The final decision is drafted by the Agency after the examination 
of all received comments. 
Whilst completeness check can be performed by administrative staff, the 
compliance check has to be performed by experts (toxicologists, eco-
toxicologists, regulatory experts). Plant physiologists and agronomists are also 
required for checking compliance of the proposed claim (efficacy/utility). These 
experts should either be part of the Agency staff or/and could be part of 
dedicated experts panels or external consultants.    
When a dossier is selected for compliance, the Agency shall provide its 
conclusions within a period of 6 months90 of the date the Agency received a valid 
application. This period may be extended where the Agency requests additional 
information from applicants on matters related to compliance check. In 
exceptional circumstances the time limits for compliance may be extended if the 
nature of the matter in question so justifies. 
Review of the registration conditions by Member States 
At any moment after the granting of the registration, data submitted by 
registrants could be examined by MS competent authorities on a voluntary basis 
in view of changing or confirming the conditions of the existing registration.  
If a MS concludes on the basis of its own analysis that there is a need for 
reconsidering an existing registration, it is of the responsibility of the MS CA to 
submit a request to the Agency.  
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This request for review shall include a detailed scientific based argumentation on 
the reason(s) why the MS considers that the registered product can lead to 
human and/or environmental safety issues.  
This argumentation shall be based on data included in the dossier validated at 
the end of the completeness/compliance procedure. MS will not be authorised to 
ask for additional data to the applicants but can based its judgement on third 
relevant data. 
The Agency will then organise a peer-review of the conclusions drawn by this 
MS. This peer-review will be circulated to all MS for comments and possibly for 
revision before a final decision (to withdraw, confirm or modify the authorisation 
consent) is taken.  
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Labelling obligations & MSDS 
For each registered PB&AFA a MSDS shall be prepared by the registration holder. 
This MSDS shall be made available by publishing it online. It shall be developed 
according to the Global Harmonised System (GHS)91. 
PB&AFA shall be labelled with the following information: 
 EC plant biostimulant or EC agronomic fertiliser additive followed by EU 
authorisation number; 
 Substance name including its concentration in the commercial product. In 
case of microorganisms, the strain name and its concentration shall be 
mentioned on the label. In case of mixture of substances, each individual 
substance and its concentration in the final product shall be listed; 
 Commercial name; 
 Registry claim(s); 
 Indication of conditions of use (dose rate, crops, group of crops, timing of 
applications, optimal conditions of use, others) as listed in the EU 
Register; 
 Net mass or volume for fluid products at time manufacture measured and 
expressed as kg or L 
 Expiration date; 
 Batch number; 
 Name and address of the distributor. When the product has been 
manufactured in another MS, the country of manufacturing shall be 
inserted (example: “manufactured in Belgium”) ; 
 Link to the website where the MSDS of the product can be consulted. 
When a registered PB&AFA is mixed with an EC fertilising materials, labelling 
obligations of the EC FM and of the PB&AFA apply. 
Products distributors are allowed to add additional information on the label but 
shall not claim additional benefit than the ones listed in the Register.  
The items of information shall be clearly separated by means of a printed border 
from any other information provided, with the exception of the batch code which 
may be printed elsewhere on the package.  
If the PB&AFA is packed, the information shall appear on the packages or on 
labels attached. The labels printed on the package must be placed in a 
conspicuous position and must be and must remain visible, indelible and clearly 
legible.  
If the PB&AFA is delivered in bulk, the same information shall appear on the 
accompanying documents. In the case of PB&AFA delivered in bulk direct to the 
end-user by the manufacturer, the documents containing the labelling 
                                           
91
 They have been made an integral part of the system of Regulation (EC) No 1907/2006 (REACH). 
The original requirements of REACH for SDSs have been further adapted to take into account the 
rules for safety data sheets of the Global Harmonised System (GHS) and the implementation of other  
elements of the GHS into EU legislation that were introduced by Regulation (EC) No 1272/2008 
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information shall accompany the goods and be accessible for inspection 
purposes, whether the goods are in loose form or in generic packaging.  
The labelling and the accompanying documents must appear in at least the 
national language or languages of the Member State(s) in which the plant 
biostimulant is marketed.  
Post registration efficacy studies  
These requirements apply to Option A only (see section 3.3.6). 
The future fertiliser regulation shall refer to the possibility of requesting the 
marketing registration holder(s) to conduct post-registration efficacy studies, 
complementing data that have been made available at the time of initial 
registration. This applies to both holder and generic registrations.  
Post-registration efficacy studies are not without precedent in the European 
Union’s regulatory framework as it applies to the human medicinal products 
legislation and has been used for many years in the PPP regulatory framework. 
PPP were placed on the market on the basis of provisional authorisation of sale 
for a given period during which the registrant was asked to provide additional 
efficacy data. The Belgian authorities accept to deliver an authorisation for 
PB&AFA (called “derogation”) on the basis of efficacy data performed in 
laboratories only. In these cases, registration holders are required to provide 
field trials data within a given period of time (defined on the case by case basis). 
Finally, the French bureau in charge of drafting new standards for fertilisers and 
other fertilising materials have made this proposal of establishing post-
authorisation requirements for further proving field efficacy of PB.  
It should be stressed from the outset that post-registration data should not lead 
to premature granting of marketing registrations. They cannot be used to 
compromise the initial level of evidence that is required to grant a standard 
registration (see chapter on data requirements). 
The obligation to conduct post-registration trials addresses the impossibility to 
demonstrate efficacy in all agro-environmental EU conditions before registration. 
This approach also leads to the need for registration holders to perform 
agronomic trials together with independent advisory groups (e.g. Universities, 
technical institutes, etc.) for a couple of years. 
These field trials shall preferably be performed under Good Experimental 
Practices even if no standardised protocols exist for PB&AFA. 
A general summary92 of these post-registration trials shall be submitted to the 
Agency by the registration holder(s) within a 3-year period after registration. 
This summary is meant to provide the Agency with additional key information of 
the efficacy of the PB&AFA under general and/or specific growing and climatic 
conditions, in order to either complement initial evidence or to verify whether the 
marketing registration should be maintained as granted, modified or even 
withdrawn on the basis of the new data resulting from the study. In case no data 
is submitted, the Agency shall decide to withdraw the registration. 
A guidance document shall be provided on how information should be submitted. 
Data waiving can apply to this requirement.  
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Modification of registration 
At any time after registration, the registration holder may request for a 
modification of its registration, by submitting a notification to the Agency in 
charge of the EU registry including all relevant data supporting the request for 
the changes.  
After validation these modifications will be inserted in the Registry by the 
Agency. In case, the modification is deemed as unacceptable by the Agency, it 
shall motivate by writing its decision to the notifier. An appeal procedure shall be 
developed. 
3.5 Costs of implementation 
This section presents a preliminary approach to the implementation costs. 
Ideally this approach should consider the costs for the registrants in one hand 
and the cost for authorities in the other hand and then should segment between 
one-time cost at implementation and recurring costs. 
This approach seems feasible for registrant costs and is presented below but for 
authority costs too many variable are unknown at this stage: 
 The exact role of the Commission vs the responsible Agency is not yet 
sufficiently defined ; 
 The responsible Agency is unknown. If EFSA is preferred no fees system 
will probably applied. If ECHA is the preferred choice then fees will have 
to levied; 
 The number of registration dossiers will depend on the regulatory process 
to be anticipated. In 2011, DG ENTR asks EBIC to estimate the number of 
registration dossiers to be anticipated. EBIC estimated that its members 
would bring about 600-700 dossiers. However this estimation does not 
include the non-EBIC members; 
 The exact registration process remains to be decided. 
When consulting ECHA to discuss about the fees approach they would take if 
they would be the responsible Agency and then the costs of implementation, 
ECHA’s responsible persons indicate that it is far too early to start estimating the 
required budget. Instead ECHA proposed to follow the approach applied for 
biocides which seems to have demonstrated efficiency. This approach relies on a 
detailed description of tasks for the Agency and on a pre-notification approach 
that would allow estimating the number of applications. 
As our proposal leads to the possibility of having joint submissions, the details of 
the costs presented below apply to dossier and not to registrant to the exception 
of the post-registration costs that will certainly be company specific as part of 
the technical development strategy of each of them. 
3.5.1 Costs per dossier 
The costs per dossier93 can be grouped under several cost items and reads as 
follows: 
1) Fees: Fees shall apply at application time and other fees shall be paid for 
additional tasks performed by the Agency. DG ENTR proposed to set-up 
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the fees for application at € 1,758 per dossier and then to apply € 2,000 
annual fees per dossier94. Some industry representatives met during the 
study considers that that level of fees is acceptable for application but too 
high for annual fees. According to them the additional fees should be 
based on true tasks carried out by the Agency and not a flat annual fee. 
2) Production of the required data: 
a. Characterisation & identification of the PB&AFA (including 
analytical method, the proof of homogeneity and stability). These 
costs are highly dependent of the nature of the PB&AFA.  
 
Type of PB&AFA 
Cost estimation (in €) 
Low High 
Synthetised PB&AFA with 
fully defined formulation 
100,000 500,000 
PB&AFA defined by its raw 




All synthetised chemicals are subject to REACH registration and 
therefore these costs will apply anyway and no substantial extra 
costs will be required due to the use as PB or AFA (with the 
exception of an adaptation of the analytical method for instance)  
b. Safety data package (toxicology & ecotoxicology). Cost related to 
the production and analysis of the safety data largely depends on 
the volume of data that are included in registration dossier. 
Therefore these costs are estimated per Tier and may vary if some 
data are already available from REACH/CLP obligations and/or 
other sources (national registration, registration in other EU 
regulatory frameworks). 
 
Tox & Ecotox  
Cost estimation (in €) 
Low High 
Tier 1 only 10,000 30,000 
Tier 1 + Tier 2 100,000 350,000 
Tier 1 + Tier 2 + Tier 3 <500,000 Up to 1-2 million 
 
c. Efficacy data package 
Efficacy  
Cost estimation (in €) 
Low High 
Option A   
- Pre application data 10,000 30,000 
- Post-authorisation data 20,000 > 50,000 
Option B 30,000 60,000 
 
Option A – pre application data have the objectives to 
demonstrate the biological activity of the PB&AFA by any means 
and particularly literature review and laboratory testing. It is 
preferred to add field testing results but it is not a mandatory 
requirements as field trials will be performed after authorisation. 
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Under Option B, field trials are mandatory. On the basis of 
interviews with companies running field trials under GEP (e.g. 
Staphyt), it shall be noticed that individual trials are more 
expensive than trials for e.g. PPP as the protocol has to be drafted 
per type of product and as field efficacy is more difficult to 
establish. Our estimation is based on a unit cost of a minimum of 
€ 5,000 for a replicated trial including 4-5 entries. 
3) Registration dossier preparation and submission. This cost item includes 
the preparation of the registration dossier, the formulation of all expert 
judgements and the overall coordination with the Contract Research 
Organisations (VROs) in charge of carrying out the study tests. On 
average, regulatory consultants estimate the costs for these tasks at 20% 
of the total study costs.   
4) Post application costs other than post-authorisation efficacy trials (follow-
up and submission of additional data when required). These costs are 
highly depending of the outcome of the registration process. Industry is 
invited to provision these additional costs but no cost estimation can be 
given at this stage. 
 
Table 23 Summary of cost for registrant  
(Estimation per dossier - in €) 
 
Cost estimation (in €) 
Low High 
Fees 
Fees for application  1,000 
Annual fees per dossier 2,000 
Identification, characterisation, analytical methods & quality 
control 
Well defined substances 100,000 500,000 
NOT well defined substances 10,000 20,000 
Tox, ecotox and environmental costs 
Tier 1 only 10,000 30,000 
Tier 1 + Tier 2 100,000 350,000 
Tier 1 + Tier 2 + Tier 3 <500,000 Up to 1-2 million 
Efficacy 
Option A 
Pre application data 10,000 30,000 
Post-authorisation data 20,000 > 50,000 
Option B 30,000 60,000 
Preparation of registration dossier 
 About 20% of above mentioned costs 
Preparation of registration dossier 
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Annex I: Cost of OECD test studies 
 
 
No. Title Price in Euros
SECTION 1 - PHYSICAL-CHEMICAL PROPERTIES 
Summary of Considerations in the Report from the OECD Expert Group on Physical Chemistry 
105 Water Solubility  4250
SECTION 2 - EFFECTS ON BIOTIC SYSTEMS 
Summary of Considerations in the Report from the OECD Expert Group on Ecotoxicology 
201 Freshwater Alga and Cyanobacteria, Growth Inhibition Test 1695 -2120
202 Daphnia sp. Acute Immobilisation Test 1695-2120
203 Fish, Acute Toxicity Test 1695-2120
204 Fish, Prolonged Toxicity Test: 14-Day Study 5985
Supported analysis 5145
205 Avian Dietary Toxicity Test 4150-8250
207 Earthworm, Acute Toxicity Tests 1995
208 Terrestrial Plants, Growth Test 7650
211 Daphnia magna Reproduction Test 16280
Supported analysis 8190
212 Fish, Short- term Toxicity Test on Embryo and Sac-fry Stages 22230
213 Honeybees, Acute Oral Toxicity Test 2420-3300
214 Honeybees, Acute Contact Toxicity Test 
216 Soil Microorganisms: Nitrogen Transformation Test 8890
217 Soil Microorganisms:Carbon Transformation Test 8890
219 Sediment-Water Chironomid Toxicity Using Spiked Water 
222 Earthworm Reproduction Test (Eisenia fetida/Eisenia andrei) 5565
223 Avian Acute Oral Toxicity Test 3530-5880
237 Honey bee (Apis mellifera) larval toxicity test, single exposure
SECTION 3 - DEGRADATION AND ACCUMULATION 
Summary of Considerations in the Report from the OECD Expert Group on Degradation/Accumulation 
301 Ready Biodegradability 301A : DOC Die-Away Test 4450
301 301B : CO2 Evolution Test 5960
301 301C : Modified MITI Test (I) 5560
301 301D : Closed Bottle Test 2600 or 3070
301 301E  : Modified OECD Screening Test 3445
301 301F : Manometric Respirometry Test 2600
Bioaccumulation in Fish: Aqueous and Dietary Exposure
Prelim study of 28 days 20000
Main study 45000 to 65000
SECTION 4 - HEALTH EFFECTS 
Summary of Considerations in the Report from the OECD Expert Groups on Short and Long Term Toxicology 
401 Acute Oral Toxicity 1050 - 1600
402 Acute Dermal Toxicity 1050 - 1600
403 Acute Inhalation Toxicity 11450 - 15950
404 Acute Dermal Irritation/Corrosion 1000
405 Acute Eye Irritation/Corrosion 3000
406 Skin Sensitisation 5950
407
Repeated Dose 28-Day 
Oral Toxicity Study in Rodents
39950
408
Repeated Dose 90-Day 
Oral Toxicity Study in Rodents
87250
409
Repeated Dose 90-Day 
Oral Toxicity Study in Non-Rodents 
129950
410 Repeated Dose Dermal Toxicity:90-Day 62950
411 Subchronic Dermal Toxicity: 90-day Study 112995
424 Neurotoxicity Study in Rodents 70000
451 Carcinogenicity Studies 699950
452 Chronic Toxicity Studies 289950
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Annex II: Comparison between EFSA and ECHA  
Extract from Commission staff working document Impact Assessment on the 
Revision of Regulation 178/2002 laying down the general principles and 
requirements of food law, establishing the European Food Safety Authority 
(EFSA) and laying down procedures in matters of food safety on the 
establishment of fees for EFSA. (Available on the IA webpage of the IA 
Board of the Commission Secretariat General). 
 
13.  ANNEX VII DIFFERENCES BETWEEN ECHA AND EFSA SYSTEMS  
As it happens for substances/products authorised within the EFSA system, chemical 
substances/products are used in many different end products. The EU chemicals industry 
has a key position in the value chain.  A series of operators (biocides, plastics, pesticides 
for example) are also concerned by the two legislative frameworks governing chemical 
safety and food safety.  
The chemical and food legislative framework on safety are however based on completely 
different premises.  
The ECHA system relies on the principle that chemical substances might contain 
hazardous properties but, if managed properly, can be safely used.  The distinction 
between hazard and risk is, therefore, key to the safe management of chemicals. 
Chemicals are mainly used by industry and only a limited range of products are sold to 
final consumers. The approach adopted within the ECHA system is that industry itself is 
best placed to ensure that the chemicals it manufactures and puts on the EU market do 
not adversely affect human health and environment. To this end, industry has to have 
sufficient knowledge of the properties and characteristics of chemical substances to be 
able to manage their potential risks properly.   
The EU chemical sector is therefore based on the principle "no data, no access to the 
market" and a registration system was established to put in a concrete form this principle. 
The registration of chemical substances aims at providing data on all chemical substances 
produced and imported in the EU in a tonnage per year exceeding 1 tonne. The 
registration and other tools linked to it (i.e. classification and labelling, safety data 
sheets) ensure that sufficient knowledge on substances is given to the relevant actors of 
the chemical chain in order to adequately manage the risks.   
Only substances of very high concern are submitted to restrictions and authorisation. 
Where there is an unacceptable risk to health or the environment, restrictions at the EU 
level concerning the manufacture, placing on the market or use or prohibition of any of 
these activities may also be imposed. Proposals for restrictions may be prepared by a 
Member State or by the Agency on behalf of the Commission in the form of a structured 
dossier that shall demonstrate that there is a risk to human health or the environment 
that needs to be addressed at EU level and to identify the most appropriate set of risk 
reduction measures. ECHA manages several tools and support the whole system.   
The food legislative system on safety and the tools used in that field are based on 
different principles due to the specificity of risks linked to food. The risk of exposure 
always exists in that sector since food is consumed every day by final consumers. In 
addition, consumers cannot take any risk management measures on substances 




A legal framework for plant biostimulants and agronomic fertiliser additives in 
the EU………………………………………………………………………………………………………………. 110 
safe food can be put on the market. This principle implies that all substances added to 
food or that can be present as residues in food are subject to an authorisation before 
being put on the market (pre-market approval). Such pre-market approvals exist since 
the beginning of the EU (the harmonisation of national systems is in place since the 
beginning of the XX century) and they now cover all safety issues linked to the addition of 
substances in food.  Since substances ingested by animals can be found in food pre-
market approvals cover also feed. 
The use of a registration system instead of a pre-market approval would not guarantee an 
adequate protection to consumers. Even if the latter knew the characteristics of 
substances contained in food or sold as a food (e.g. sweeteners) they could not take any 
measure at their level to avoid the risk or limit it, except by not consuming it. Labelling 
and information are not sufficient to protect them.  
As a consequence, it is not possible to align the chemical safety system and the food one 
because each one is tailored to the specificity of the risks in its own area.   
Also, from a legal point of view, the putting in place of a registration system for EFSA 
would require the modification of the legislation regulating the 19 sectors falling under 
EFSA's mandate. In addition, historically the REACH system required the registration of all 
chemical substances because 99% of the substances on the market were unknown. This 
involved a rather high cost for industry (€2.1 billion for the first registration period95). A 
similar need for registration of substances used in the food sector does not exist because 
they have been subject to a pre-market approval since a long time and they are thus 
known.                   
As far as the fee system is concerned, the number of applications received by the two 
agencies is significantly different. ECHA received roughly 6 900 applications per year from 
2008 to 2011, while EFSA from 2003 to 2010 received on average 189 (without reviews) 
applications per year. This has a great impact on the income the Agency can get from 
fees. However, in the food legislative framework,  it  is  not  possible to identify a larger 
series of operators as fee-payers than applicants for generic and individual authorisation. 
It would also not be justified to create a system requiring a large number of operators to 
register because the safety of substances/products added to food have already been 
assessed and authorised since a long time.        
Moreover, tasks of ECHA mostly relate to the registration of chemicals substances. This is 
reflected in its system of fees that provide for the payment of a fee in the following cases:      
 Submission of a registration;   
 Request (in a registration submission) that certain information is kept 
confidential;   
 Update of a registration submission that refers to a change in the tonnage range;  
 Update of a registration submission that relates to a change in the identity of the 
legal personality of the registrant;   
 Update of a registration submission that relates to a change in the access granted 
contained in the registration submission;   
 Notification to the Agency of product and process orientated research and 
development activities, with a view to obtain an exemption from the obligation to 
register;  
 Application for an authorisation under Article 62 of the REACH Regulation;   
                                           
95
  See, CSES, Interim Evaluation: Functioning of the European chemical market after the introduction of 
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 Appeals to the Board of Appeals of the Agency against decisions of the Agency 
listed in Article 91(1) of the REACH Regulation.   
On the contrary, the tasks of EFSA relate to the risk assessment process linked to the 
authorisation of substances/products added to food or that can be present as residues in 
food (residues of pesticides for example).    
If a registration system was not to be put in place for EFSA, only ECHA authorisation 
tasks and the correlated fee could be considered as a relevant example for EFSA. 
However, the procedure for authorisation foreseen in the ECHA system is rather peculiar 
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Annex III: Estimated application cost of an active 
substance based on a plant extract in the context of the 





Analytical methods for characterisation Development of 3 markers 50,000.0            150,000.0          
Analytical methods for impurities ELISA methods for mycotoxins 10,000.0            20,000.0            
Analytical methods for residues No data submitted
Physical & chemical properties 9 studies provided 50,000.0            150,000.0          
Monitoring/enforcement methods No data submitted
Classification & proposed labelling see consultancy & mgt costs
Impact on human and animal health
Absorption, distribution in mammals No data submitted
Acute toxicity
Rat LD50 oral 1,050.0               1,600.0              
Rat LD50 dermal Not required
Rat LC50 inhalation Not required
Skin iritation, rabbit OECD 404 1,000.0               1,000.0              
Eye irritation, rabbit OECD 405 3,000.0               3,000.0              
Skin sensitization LLNA - OECD 429 5,950.0               5,950.0              
Short term tox
Relevant oral NOAEL 90-day oral rat 112,000.0          113,000.0          
Genotoxicity AMES test OECD 471 50,000.0            50,000.0            
Long term tox No data provided
Reproductive target No data provided
Neurotoxicity No data provided
Other tox studies Literature data on genotoxicity of 4-
hydroxyisoleucine, trigonelline, flavonoids: 
not mutagenic.
Medical data No data provided
Residues No data provided
Metabolism in livestock No data provided
Consumer risk assessment Not relevant
Processing factors No data provided
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Fate & behaviour in the environment
Route of degradation in soil No data submitted
Soil adsorption/desorption No data submitted
Mobility in soil No data submitted
PEC (soil) Value see consultancy & mgt costs
Route of degradation in water No data submitted
PEC (surface water) Value see consultancy & mgt costs
PEC (sediment) Value No data submitted
PEC (groundwater) Value No data submitted
Fate and behaviour in air No data submitted
Ecotox
Effects on terrestrial vertebrates
Acute tox to mammals (see above) (see above)
Sub-chronic tox to mammals (see above) (see above)
Acute tox to birds 3,600.0               6,000.0              
Tox data for aquatic species
Oncorhynchus mykiss (acute) 1,695.0               2,120.0              
Daphnia (acute) 1,695.0               2,120.0              
Scenedesmus (acute) 1,695.0               2,120.0              
BCF Not required
Oral tox on bees
Acute contact on bees
Other arthropod species No data submitted
Effects on earthworms
Acute tox OECD 207 1,900.0               2,000.0              
Effect on micro-organisms
Nitrogen mineralisation 8,800.0               8,900.0              
Carbon mineralisation 8,800.0               8,900.0              
Efficacy 30,000.0            50,000.0            
343,605.00       580,010.00       
85,901.25          145,002.50       
429,506.25       725,012.50       
2,420.0               3,300.0              
Total (cost of studies)
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Annex IV: EBIC proposal: Guidance document for 
determining the number of trials needed 
“EBIC suggests the following guideline to help applicants determine the 
appropriate number of trials, depending on the nature of the claim and to 
prevent excessive requests for trials from reviewing authorities. Notwithstanding 
this guideline, applicants will need to adapt their trial regime to the specific claim 
being made, especially as several of the examples listed below may apply. 
Where applicable, appropriate scientific literature may be substituted for one or 
more of the trials suggested: 
 
Claim that can credibly be 
made on this basis 
Suggested number of trials 
Effect claimed for a specific crop 
Example: Improves strawberry 
ripening 
2 trials on the crop either over two years 
or in two different growing contexts96 
during the same year. 
Example: Product is successfully 
demonstrated on strawberries in the field 
in a single location over two years or 
tested in the field and in a greenhouse the 
same year. 
Effect can be claimed for the entire 
crop group 
Example: Fosters fruit setting in 
pome fruits 
2 trials on 2 different crops within a single 
group either over two years or in two 
growing contexts the same year. 
Example: Product is successfully 
demonstrated on apples and pears in a 
single location over two years or in two 
different locations with different growing 
conditions in a single year. 
Effect can be claimed without being 
required to limit it to any specific 
crop grouping 
Example: Helps crops tolerate 
drought stress in open-air growing 
contexts 
3 trials on 3 crops from 3 different 
groups. 
Example: Product is successfully 
demonstrated on cereals, apples and 
peppers. 
Effect can be claimed without 
having to restrict it to any specific 
3 trials in 3 different growing contexts 
Example: Product is successfully 
                                           
96
 Robust descriptions of the growing contexts including variables such as climate, soil 
conditions/growing media, irrigation versus rain-fed, etc. should be provided by the applicant in the 
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Claim that can credibly be 
made on this basis 
Suggested number of trials 
growing contexts 
Example: Fosters tomato ripening 
under most growing conditions 
demonstrated under greenhouse 
conditions, in irrigated semi-arid 
conditions and in a temperate agricultural 
zone. 
 
The nature of the claim is important because it may naturally limit the variations 
in trials needed to demonstrate an effect. For example, it would make no sense 
to submit a trial on cereals for a biostimulant that fosters fruit ripening or sugar 
content of fruit. 
Broadening claims 
If at any point, the applicant wants to broaden the registered product claims, it 
must notify the implementing agency and provide results from two trials to 
validate the new parameter(s). GEP/GLP certification is not required for this data 
as long as the quality can be considered substantially equivalent to what a 
certified facility would achieve.” 
 
 
